Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,ligand-gated ion channel activity (GO:0015276),0.7573956352867268,2.1108460294239384,0.0,0.015407079427004238,0.015,12/30,6.20%,GRIA3;CHRNB4;GRID2;GRIN2B;GRID1;GRIK2;GRIK5;GRIA4;GRIA1;GRIK4;GRIN2A;GRIK1
prerank,ligand-gated channel activity (GO:0022834),0.760346261828298,2.108904383261208,0.0,0.008185010945596,0.016,12/29,6.20%,GRIA3;CHRNB4;GRID2;GRIN2B;GRID1;GRIK2;GRIK5;GRIA4;GRIA1;GRIK4;GRIN2A;GRIK1
prerank,retinoid binding (GO:0005501),-0.6622073254206818,-2.0058034626952552,0.0,0.054407392233773715,0.046,7/22,6.77%,PTGDS;ALDH1A2;CYP26B1;RBP1;RBP4;RXRA;CRABP2
prerank,ionotropic glutamate receptor activity (GO:0004970),0.7835986439176174,1.918025346866004,0.0017482517482517483,0.1232566354160339,0.265,9/17,6.20%,GRIA3;GRIN2B;GRIK2;GRIK5;GRIA4;GRIA1;GRIK4;GRIN2A;GRIK1
prerank,amino acid:sodium symporter activity (GO:0005283),0.8060650330721595,1.8887457529447156,0.0034904013961605585,0.14275622031583615,0.378,2/11,1.38%,SLC1A3;SLC6A13
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.6666381090625821,1.8503368368859898,0.0015723270440251573,0.18527013010972596,0.523,10/28,10.51%,CHRNB4;GRID2;GRID1;GABRA1;GRIK2;GRIK5;GRIK4;GRIK1;GABRG3;GABRG2
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.654476233988559,-1.8403714834887668,0.002320185614849188,0.26510268568809353,0.345,7/17,8.54%,PITPNC1;ATP10A;PITPNM2;PLTP;PITPNA;ABCA3;ATP8B1
prerank,transmitter-gated ion channel activity (GO:0022824),0.6478780465026498,1.7912231020759353,0.0031847133757961785,0.3066971748438031,0.77,13/29,13.82%,GRID2;GRID1;GABRA1;GRIK2;GRIK5;GRIA4;GRIK4;GRIK1;GABRG3;GLRA3;GABRG2;GLRA2;GABRB1
prerank,glutamate receptor activity (GO:0008066),0.6972232062862731,1.7810534734943342,0.004975124378109453,0.29466039404145605,0.807,12/19,18.14%,GRID2;GRID1;GRIK2;GRIK5;GRIA4;GRIA1;GRIK4;GRIK1;GRM5;GRM7;GRM1;GRIA2
prerank,insulin-like growth factor I binding (GO:0031994),-0.6768834462246485,-1.7806114608548316,0.0023923444976076554,0.33924609275176554,0.556,9/13,11.86%,IGFBP6;IGF1R;IGFBP5;ITGA6;IGFBP3;INSR;IGFBP2;ITGB4;ITGB3
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.5967693653890199,-1.7800781224460966,0.004914004914004914,0.25683489569178475,0.559,7/23,15.34%,PLCE1;PLCB1;EDNRA;BDKRB2;PLCB4;PLCG2;PLCH1
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.6961382803452013,1.778962435881299,0.00333889816360601,0.26396660299547103,0.814,9/19,10.51%,GRID2;GRID1;GABRA1;GRIK2;GRIK5;GRIK4;GRIK1;GABRG3;GABRG2
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.6815837344947738,1.7753477899950687,0.00792393026941363,0.2431964690109766,0.82,13/21,14.01%,POLG;POLK;POLQ;POLA1;POLL;POLE4;REV3L;POLH;POLN;POLB;POLE3;REV1;POLI
prerank,cGMP binding (GO:0030553),-0.7351692183485421,-1.7703298680237074,0.004555808656036446,0.22467052557711267,0.589,3/11,8.57%,PDE5A;RAPGEF2;PDE11A
prerank,ligand-gated calcium channel activity (GO:0099604),0.697347897482354,1.7659140258235375,0.011419249592169658,0.24044673330768487,0.844,10/19,18.00%,TRPA1;ITPR1;GRIN2B;RYR2;GRIN2A;P2RX4;TRPM2;RYR3;MCOLN1;RASA3
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.7345114176007026,1.7535403732642925,0.008680555555555556,0.24948963844864816,0.889,2/15,0.34%,SLC1A3;SLC1A5
prerank,LRR domain binding (GO:0030275),-0.6605699756841035,-1.7419700111279772,0.009389671361502348,0.2514119366619478,0.705,3/14,1.33%,PAWR;ERC1;ROBO1
prerank,signal sequence binding (GO:0005048),0.6081420356715461,1.7414765857584014,0.006211180124223602,0.25702539273278424,0.92,6/35,5.92%,CEMIP;KDELR3;KDELR2;NUP214;KCNIP2;POM121
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.6818711329736691,-1.7389059998795513,0.006864988558352402,0.22143961040804822,0.717,8/12,25.65%,KDM4A;KDM4C;PHF8;HR;KDM4B;KDM3B;PHF2;KDM1A
prerank,DNA polymerase activity (GO:0034061),0.6498395003795094,1.726023051995876,0.012326656394453005,0.27399416731004167,0.949,13/22,14.01%,POLG;POLK;POLQ;POLA1;POLL;POLE4;REV3L;POLH;POLN;POLB;POLE3;REV1;POLI
prerank,tropomyosin binding (GO:0005523),-0.6192601608902102,-1.715845039530962,0.011933174224343675,0.2421662360209144,0.79,3/16,1.10%,NEBL;TMOD3;CALD1
prerank,phospholipid transfer activity (GO:0120014),-0.5803102899797639,-1.7145728547575663,0.005333333333333333,0.21905198441833076,0.793,9/21,15.25%,PITPNC1;PITPNM2;CERT1;PLTP;PITPNA;ABCA3;TNFAIP8L3;PRELID2;PRELID1
prerank,cadherin binding (GO:0045296),-0.35404811297002325,-1.7097138157051421,0.0,0.20610800352088396,0.805,107/315,18.20%,PHLDB2;PKP4;PTPRB;TJP1;TMOD3;PICALM;BAIAP2L1;ERC1;CALD1;PDLIM5;VCL;PTPRJ;FNBP1L;BSG;EGFR;AFDN;WASF2;ITGB1;NOTCH3;EZR;CDH1;PACSIN2;AHNAK;F11R;PROM1;ITGA6;BMPR2;CSNK1D;RDX;IQGAP1;FXYD5;KDR;EIF5;COBLL1;PLEC;NDRG1;ANLN;CDH8;HSPA8;MRTFB;S100A11;RPS2;ANXA1;APC;CTNND1;CHMP2B;GIPC1;TRIM25;CAPZB;YWHAB;NCK1;TJP2;EPN2;VAPA;LDHA;SLC3A2;CLINT1;ACVR1;RANGAP1;ZC3HAV1;EEF1G;EHD4;EPS8L2;CLIC1;PPFIBP1;VAPB;ARHGAP18;IST1;NIBAN2;TAGLN2;PTPN1;UBFD1;RPL34;PPL;GAPVD1;UBAP2;CD2AP;USO1;BAG3;PRDX1;PKM;RPL29;LIMA1;ENO1;FLNA;RAN;MACF1;PLIN3;EEF1D;BAIAP2;TES;CDH5;PSMB6;CTNNA1;RAB1A;PAK2;PKN2;EIF3E;RPL23A;EIF4H;EPHA2;CHMP4B;HNRNPK;ALDOA;DLG1;CDH4;SERBP1
prerank,hyaluronic acid binding (GO:0005540),0.7656878575186589,1.7067590024991142,0.007312614259597806,0.3007819568495068,0.969,1/10,0.02%,CEMIP
prerank,glycine binding (GO:0016594),0.7472839168437246,1.6752681617165517,0.015463917525773196,0.3699624947409393,0.988,7/11,17.61%,GLDC;GRIN2B;GLRA3;GLRA1;GLRA2;GLRB;GRIN3A
prerank,CXCR chemokine receptor binding (GO:0045236),0.751639336799131,1.6628384311671072,0.01818181818181818,0.38686213498743455,0.992,2/11,1.71%,CXCL10;CXCL1
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.7116977437777952,1.6574400879068287,0.015873015873015872,0.38138185949271886,0.994,3/14,2.38%,ADH1A;RDH10;RDH11
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.7505262260095499,1.6544761174890286,0.024475524475524476,0.368539479766084,0.995,7/11,18.00%,TRPA1;ITPR1;RYR2;TRPM2;RYR3;MCOLN1;RASA3
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.6366762700020044,1.6518467270100126,0.029411764705882353,0.35598462465551894,0.995,4/21,2.74%,PDE1C;PDE9A;PDE7B;PDE4B
prerank,chemokine activity (GO:0008009),0.5839355245107847,1.6343634648242193,0.01957831325301205,0.3897028152567884,0.997,5/31,10.56%,XCL1;CXCL10;CXCL1;CCL15;CCL25
prerank,calcium-release channel activity (GO:0015278),0.6610413369135577,1.6239939570851927,0.03425774877650897,0.4002630842807143,0.998,9/17,18.00%,TRPA1;MCOLN2;ITPR1;TPCN1;RYR2;TRPM2;RYR3;MCOLN1;RASA3
prerank,exonuclease activity (GO:0004527),0.5457700009738639,1.621529865998681,0.014970059880239521,0.38911629575587403,0.998,18/46,19.04%,ENPP1;POLG;FAN1;FEN1;PDE12;ENPP3;REV3L;EXOSC9;ISG20L2;EXOSC10;CNOT7;EXOSC8;EXOSC5;APEX2;DXO;WRN;REXO4;TRIR
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.6118671221899882,1.6197006362541395,0.03376205787781351,0.3768035729430384,0.998,4/23,2.74%,PDE1C;PDE9A;PDE7B;PDE4B
prerank,sialyltransferase activity (GO:0008373),-0.5592432374496935,-1.619617386081827,0.015345268542199489,0.4241061073766354,0.978,11/20,15.79%,ST3GAL6;ST6GAL1;ST8SIA4;ST3GAL4;ST3GAL1;ST6GALNAC2;ST6GALNAC3;ST3GAL3;ST8SIA2;ST3GAL5;ST3GAL2
prerank,potassium channel activity (GO:0005267),0.47737725571148143,1.615367141968275,0.01045751633986928,0.37301983706473535,0.999,21/89,12.39%,KCNK2;KCNS2;KCNT2;GRIK2;GRIK5;KCNQ3;KCNMA1;GRIK4;GRIK1;KCNG1;KCNH4;TMEM38B;KCNC2;TMEM175;HCN2;HCN1;KCND2;HCN3;KCNK1;KCNN2;KCNH7
prerank,platelet-derived growth factor binding (GO:0048407),0.7183122660197614,1.6140512864408287,0.04152249134948097,0.3616041541517894,0.999,3/11,6.76%,PDGFRA;COL4A1;COL1A2
prerank,sterol binding (GO:0032934),0.518268157623847,1.61392877532112,0.017167381974248927,0.34777037456627347,0.999,6/56,3.45%,APOD;RORA;VDAC2;GRAMD1B;OSBPL3;OSBPL6
prerank,protein phosphatase 1 binding (GO:0008157),-0.5623261889228323,-1.611552896182101,0.019417475728155338,0.41623433078190936,0.985,10/21,17.80%,SHOC2;PPP1R16A;AKAP11;PPP1R3B;SH3RF2;PPP1R16B;PHACTR4;KCNQ1;PPP1R3C;PPP1R11
prerank,sodium channel activity (GO:0005272),0.5610406078027811,1.6067875780467247,0.009448818897637795,0.3526509291069859,0.999,13/37,13.61%,ASIC2;GRIK2;GRIK5;GRIK4;CACNA1G;GRIK1;ASIC1;HCN2;HCN1;HCN3;KCNK1;SCN1A;SCN2A
prerank,1-phosphatidylinositol binding (GO:0005545),-0.5952217807353904,-1.604962378183448,0.02857142857142857,0.4051422254270601,0.986,4/15,6.66%,PICALM;EEA1;WDFY3;SCARB1
prerank,anion transmembrane transporter activity (GO:0008509),-0.6433158053314804,-1.5948628633713933,0.029339853300733496,0.407064830970335,0.989,4/12,5.80%,ABCG2;SLC22A6;SLC26A11;SLC39A8
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.4998697525616708,1.5876598317766943,0.009831460674157303,0.38975096237999785,0.999,11/60,4.82%,ROR1;PDGFRA;NTRK3;EPHA7;ROR2;MERTK;NTRK2;ERBB4;EPHB1;FGFR1;EPHA6
prerank,outward rectifier potassium channel activity (GO:0015271),0.7106517233723553,1.5874109529987142,0.023423423423423424,0.37684255262299804,0.999,4/11,10.52%,KCNK2;KCNT2;KCNIP2;KCND2
prerank,phosphatidylinositol binding (GO:0035091),-0.3904900210636387,-1.5860484493462426,0.0,0.40880220988200167,0.994,35/91,23.50%,PITPNC1;PICALM;SNX24;PITPNM2;EEA1;MTM1;MCF2L;HIP1R;PARD3;ITPR2;MITD1;WDFY3;SCARB1;PITPNA;MAPT;TNFAIP8L3;PIGU;MYO1E;CCDC88A;GPAA1;SNX17;ESYT3;HIP1;DENND1A;PLEKHF2;BCAS3;DENND1B;NUMA1;EXOC8;FES;WDR45;PIGK;PASK;PITPNM1;EPB41
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.6749722866460492,1.584223602566733,0.02577319587628866,0.3732685972013172,0.999,3/14,8.61%,SLC1A3;SLC7A11;SLC25A22
prerank,hexosaminidase activity (GO:0015929),0.6862927613925491,1.5831130289662718,0.04130808950086059,0.36464456732581196,0.999,2/12,5.09%,CEMIP;CEMIP2
prerank,ligand-gated cation channel activity (GO:0099094),0.4890162934557614,1.5831021493122228,0.011004126547455296,0.35324942459688036,0.999,22/75,18.55%,GRIA3;CHRNB4;GRIN2B;ASIC2;GRIK2;GRIK5;GRIA4;GRIA1;GRIK4;GRIN2A;GRIK1;ASIC1;P2RX4;TRPM2;KCNK1;KCNN2;KCNJ8;KCNJ10;MCOLN1;GRIN3A;GRIA2;KCNJ3
prerank,PDZ domain binding (GO:0030165),-0.414294788951053,-1.5781642445886486,0.007246376811594203,0.4070553058666526,0.997,24/61,19.16%,CRIM1;RAPGEF2;ERC1;DOCK4;CXADR;F11R;SLC22A4;USHBP1;ATP2B1;FZD4;FZD7;ATP2B2;SNTG2;CXXC4;CRIPT;MAP2K2;PLEKHA2;FZD3;CCDC88C;KIDINS220;LLGL2;FZD8;SLC26A6;TGFBR3
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.49861780007682616,-1.5752441421797778,0.0273972602739726,0.3918963835062478,0.997,8/27,7.97%,XPR1;SLC26A7;SLC26A2;ANO1;SLC22A6;SLC26A11;SLC39A8;SLC22A8
prerank,chemokine receptor binding (GO:0042379),0.5410523131612615,1.5722890342284797,0.03328509406657019,0.3710830096083578,0.999,5/35,10.56%,XCL1;CXCL10;CXCL1;CCL15;CCL25
prerank,transcription coactivator binding (GO:0001223),0.6173569916463303,1.5634715057841158,0.04111842105263158,0.38444061790837414,0.999,4/20,4.13%,RORA;PGR;PPARD;TEAD2
prerank,actinin binding (GO:0042805),-0.5168514200052301,-1.5514099749756196,0.02925531914893617,0.4424897499099723,1.0,6/21,12.19%,CACNA1C;PDLIM5;NFKB1;PROM1;DAG1;CSRP2
prerank,Wnt-activated receptor activity (GO:0042813),0.6390872770844986,1.544623953452929,0.04310344827586207,0.4277665552340391,0.999,1/15,0.05%,ROR1
prerank,leucine zipper domain binding (GO:0043522),-0.6397009661355739,-1.5325858682535414,0.029545454545454545,0.48028981751052674,1.0,2/10,0.80%,PAWR;ERC1
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.5927927669383012,-1.51430309500471,0.05869074492099323,0.518683805961976,1.0,5/12,14.67%,VEGFD;VEGFC;CCDC88A;ITGB3;CDH5
prerank,voltage-gated potassium channel activity (GO:0005249),0.45330280580880145,1.5087027027654156,0.024423337856173677,0.528307683615904,1.0,25/80,20.65%,KCNK2;KCNS2;KCNT2;KCNQ3;KCNMA1;KCNIP2;KCNG1;KCNH4;KCNC2;HCN2;HCN1;KCND2;HCN3;KCNE4;KCNK1;KCNN2;KCNH7;KCNJ8;KCNH8;KCNA6;KCNJ10;KCNJ3;KCNH1;KCNJ16;KCNS3
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.607617932822708,-1.502222265879975,0.05543237250554324,0.5364030388388578,1.0,3/11,3.71%,MAP3K1;EGFR;MAP3K5
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.6271330227894382,-1.4993790816928743,0.0611353711790393,0.5211374726705581,1.0,3/10,4.03%,SLCO2A1;SLCO1C1;SLC22A6
prerank,rRNA binding (GO:0019843),-0.42454531086313,-1.4951641891408942,0.03,0.5120695739649291,1.0,22/42,31.19%,CAVIN1;RPS14;RPS9;DDX21;RPL5;ERI1;RPS5;RPL11;RPLP0;NGRN;MRPS7;UTP23;MRPL16;MRPS18A;RPL23;GTF3A;PTCD3;RPF2;FASTKD2;MRPL18;NOP53;MRPL11
prerank,glucuronosyltransferase activity (GO:0015020),-0.5198352948335003,-1.4939447510873836,0.04433497536945813,0.4947783357468425,1.0,3/19,8.23%,CSGALNACT1;EXT1;LARGE1
prerank,semaphorin receptor binding (GO:0030215),-0.4935345653917669,-1.4918263032845698,0.021164021164021163,0.4816014343140158,1.0,10/23,18.22%,SEMA3D;SEMA3C;SEMA7A;SEMA6A;SEMA4B;PLXNB1;SEMA5B;SEMA6C;SEMA3G;SEMA6B
prerank,phosphatidic acid binding (GO:0070300),-0.5173407666899038,-1.491300160502605,0.0546875,0.4640220201898544,1.0,7/19,5.29%,PITPNC1;RAPGEF2;MARK1;RAPGEF6;PACSIN2;SMPD3;PLTP
prerank,insulin-like growth factor binding (GO:0005520),-0.5428474349393181,-1.4895477661031105,0.05755395683453238,0.45173545055100567,1.0,10/15,14.35%,IGFBP6;IGF1R;IGFBP5;ITGA6;IGFBP3;INSR;IGFBP2;ITGB4;ITGB3;IGF2R
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.5868851905100161,1.4855468867850794,0.05555555555555555,0.5963736909962873,1.0,4/18,17.79%,HSD11B1;HSD17B8;RDH5;HSD17B2
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.46872464484259974,1.4850743065732444,0.032303370786516857,0.582529509651272,1.0,11/60,4.82%,ROR1;PDGFRA;NTRK3;EPHA7;ROR2;MERTK;NTRK2;ERBB4;EPHB1;FGFR1;EPHA6
prerank,solute:proton symporter activity (GO:0015295),0.6060764698772632,1.4823286117553487,0.07321131447587355,0.577790169345074,1.0,2/16,0.39%,SLC15A1;SLC2A13
prerank,actin binding (GO:0003779),-0.32665364157709714,-1.4793536334972848,0.0,0.4655870679948983,1.0,40/170,14.38%,SORBS1;PAWR;ABLIM1;SYNE2;MICAL2;CALD1;PDLIM5;VCL;MYRIP;ITGB1;EZR;NOS3;TPM1;PARVB;RDX;FXYD5;GSN;ANLN;PHACTR1;GIPC1;CAPZB;COBL;MAPT;EPS8L2;SSH1;DMD;CAP1;PHACTR4;COTL1;CCDC88A;DAG1;CEACAM1;SHROOM2;TMOD1;MYH10;LIMA1;TRPV4;MACF1;TLNRD1;TMSB4X
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.5195247120120883,-1.4687964777943345,0.08398950131233596,0.4793294934456197,1.0,5/18,5.01%,TMOD3;BAIAP2L1;PDLIM5;S100A11;ANXA1
prerank,CCR chemokine receptor binding (GO:0048020),0.5241146224909571,1.4548988091963544,0.05247376311844078,0.6682820701463088,1.0,5/28,10.56%,XCL1;MSMP;CCL15;CNIH4;CCL25
prerank,calcium ion binding (GO:0005509),0.3795011352579514,1.451197139616699,0.0010706638115631692,0.6670372908633344,1.0,68/323,14.83%,SCUBE1;ENPP1;ADGRL3;LRP1;PLSCR4;CLEC4E;S100A3;CDH6;PLA2G2C;PAM;ADGRV1;ASTN2;ITPR1;MASP1;NRXN1;FKBP9;TCHH;RYR2;LOXL2;KCNIP1;DCHS1;CEMIP2;CDH11;CAMKK2;CDH15;CDH3;CLEC3B;KCNIP2;ATP2A2;NOL3;CAPN3;RASGRP2;S100A7A;ENPP3;CALB1;MAN1C1;SYT3;AMY1A;AMY1B;AMY1C;KCNIP4;MICU3;PVALB;ITSN1;SYT7;MAN1B1;PPP3CB;RCN3;CABYR;S100A2;TRPM2;SYT5;S100A1;CDH10;HSP90B1;TESC;EML1;S100G;SPARCL1;BGLAP;RYR3;ASPH;MELK;PCLO;STIM1;HSPA5;NDUFAB1;FBN1
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.4722376713390454,-1.4493179857121639,0.06417112299465241,0.5220976031217422,1.0,11/25,24.25%,ART3;SIRT3;TNKS2;ZC3HAV1;PARP10;PARP9;PARP4;SIRT1;SIRT5;PARP1;PARP2
prerank,pentosyltransferase activity (GO:0016763),-0.43121515254414167,-1.4471373660325615,0.030120481927710843,0.5127234262435133,1.0,13/36,18.85%,UPP2;ART3;SIRT3;TNKS2;ZC3HAV1;LARGE1;LACC1;PARP10;PARP9;PARP4;SIRT1;QPRT;SIRT5
prerank,protein tyrosine kinase activity (GO:0004713),0.42135639736942193,1.4458484987298987,0.03018867924528302,0.6712855335465135,1.0,21/108,11.12%,ROR1;PDGFRA;NTRK3;EPHA7;ROR2;MERTK;NTRK2;PEAK1;TXK;ERBB4;EPHB1;FGFR1;JAK1;EPHA6;CAMKK2;PTK2;EPHB6;AXL;FGR;EPHA3;FYN
prerank,AMP binding (GO:0016208),-0.5717402261908551,-1.4451273964131484,0.09251101321585903,0.5034684053397369,1.0,5/11,20.07%,PRKAG2;MPPED2;PRKAG3;PFKL;APRT
prerank,copper ion binding (GO:0005507),0.4767848068686602,1.4441368668264378,0.04630969609261939,0.6623700512964118,1.0,11/42,14.03%,PAM;TYR;LOXL3;LOXL2;CCS;ACR;COMMD1;TP53;P2RX4;HEPH;ATP7A
prerank,cholesterol binding (GO:0015485),0.47766719732276597,1.4384831087097119,0.06499261447562776,0.6674504380181466,1.0,5/47,3.45%,APOD;VDAC2;GRAMD1B;OSBPL3;OSBPL6
prerank,GTPase inhibitor activity (GO:0005095),-0.5488480093477314,-1.43737231320069,0.0883054892601432,0.5108087966047882,1.0,7/13,21.30%,SLIT2;IQGAP1;CPEB2;ARL2;GPS1;RHOH;IQGAP2
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.6094928137076018,1.4367846415318413,0.09121621621621621,0.6592518097043701,1.0,6/14,18.69%,CAPN5;CAPN3;CAPN6;CAPN15;CAPN10;CAPN2
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.6309001548288912,1.4358254749440795,0.0880281690140845,0.648478949034969,1.0,4/12,10.16%,HDAC1;FOS;GTF2A1;TBPL1
prerank,GDP binding (GO:0019003),-0.37370753021419,-1.4245570600348192,0.028070175438596492,0.5349118931957176,1.0,21/63,19.30%,MRAS;KRAS;RRAS2;RASL12;RAP1A;RAB21;RAB5A;RAB5C;RAB31;MIEF1;RRAGC;RAB35;RALB;RAN;RRAS;RAP2C;RAP2B;RERG;DYNC1LI1;RAB4A;RAB8B
prerank,histone demethylase activity (GO:0032452),-0.45530165383598253,-1.4223486329664692,0.06084656084656084,0.5263343692396664,1.0,12/27,25.65%,KDM4A;KDM4C;RIOX2;PHF8;FBXL19;JARID2;HR;KDM4B;KDM3B;PHF2;KDM2B;KDM1A
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.588481441379041,-1.4222635802235433,0.08222222222222222,0.5119806729972267,1.0,4/11,10.34%,SGMS1;SGMS2;AASDHPPT;GNPTAB
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.5233282843935999,-1.4209427724120403,0.07990867579908675,0.5016897853034779,1.0,7/15,22.27%,SLC26A7;SLC26A2;SLC39A8;SLC4A3;SLC4A8;SLC26A6;CFTR
prerank,tau-protein kinase activity (GO:0050321),-0.48482267983835137,-1.4200776284210017,0.06483790523690773,0.4905929717673869,1.0,13/20,29.29%,ROCK2;MARK1;MARK4;SIK3;GSK3B;MARK3;PRKAA1;MARK2;TTBK1;TAOK2;BRSK1;PHKG2;TTBK2
prerank,cytokine activity (GO:0005125),0.40130084470899197,1.417393148055868,0.029232643118148598,0.7037880124960405,1.0,10/131,5.33%,IL33;IL34;XCL1;CXCL10;NRG1;WNT5A;CXCL1;IL16;TSLP;CCL15
prerank,myosin V binding (GO:0031489),0.58342457513926,1.415495174385421,0.08629441624365482,0.6973709570853142,1.0,3/15,6.42%,NPC1L1;RAB8A;RAB3C
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.5384353952496176,1.4058290883613942,0.10586319218241043,0.7230322273958417,1.0,10/22,18.58%,CPEB1;RBM24;RBMS3;ELAVL4;ZFP36L2;NUDT21;DHX36;EXOSC9;EXOSC8;ILF3
prerank,death domain binding (GO:0070513),-0.5805902727698175,-1.4055938695575156,0.08447488584474885,0.5194551928201925,1.0,5/11,9.83%,BCL2L1;MCL1;CRADD;DAPL1;BAX
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.5901630891695421,-1.4028612295616556,0.09656652360515021,0.5136431210932588,1.0,6/10,22.73%,KDM4A;KDM4C;RIOX2;PHF8;KDM4B;KDM2B
prerank,FAD binding (GO:0071949),-0.4658310901601165,-1.4001277042633478,0.06611570247933884,0.5088951589230732,1.0,10/24,17.98%,DDO;MICAL2;PRODH;CYB5R3;NQO2;MTHFR;CYB5R1;MICAL3;AIFM1;NDOR1
prerank,triglyceride lipase activity (GO:0004806),0.5386029666125811,1.399025514562631,0.09046849757673667,0.7350525006130884,1.0,3/20,5.09%,CEL;LIPH;LIPC
prerank,ion channel activity (GO:0005216),0.42680059745666604,1.3972396331411847,0.06182795698924731,0.7280411466003142,1.0,15/80,6.85%,GRIA3;NALCN;CHRNB4;GRID2;GRIN2B;GRID1;GRIK2;GRIK5;GRIA4;GRIA1;GRIK4;GRIN2A;TRPV3;GRIK1;TMC3
prerank,frizzled binding (GO:0005109),-0.4289787513160025,-1.3957882284643042,0.062111801242236024,0.50899614051008,1.0,13/34,18.77%,WNT5B;WNT9A;RNF43;WNT4;DVL1;FZD7;LRP6;WNT6;SFRP1;CCDC88C;WNT16;SDCBP;WNT11
prerank,phospholipase binding (GO:0043274),0.5799615882800412,1.3916593845529288,0.11209964412811388,0.7354658251477166,1.0,4/13,11.12%,ARHGAP6;PDPK1;DGKQ;FYN
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.4807019994976108,1.380677028509945,0.09447674418604651,0.7649033536283942,1.0,13/34,14.84%,OGT;GAB2;MYO10;GBF1;MYO1B;FCHSD2;ADAP2;CYTH3;COMMD1;ARAP2;MYO1G;DAPP1;FERMT2
prerank,guanyl ribonucleotide binding (GO:0032561),-0.30373676855152654,-1.3788471883353592,0.0,0.5470014518788157,1.0,65/196,21.92%,PDE5A;RAPGEF2;RHOBTB1;MRAS;KRAS;MPPED2;RRAS2;GBP7;RASL12;RAP1A;INSR;DRG1;RHOQ;RHOBTB2;RAC1;GBP5;CDC42;ARL6;RAB21;ADSS2;GBP4;RAB5A;RHOC;RAB5C;GBP2;GCH1;RAB31;PDE11A;MIEF1;DRG2;EEF1A1;RRAGC;RAB13;ARL2;RAB35;REM1;GBP6;RALB;TGM2;RAN;RAB38;RRAS;GNL1;RAP2C;ATL3;NOA1;ARL1;TUBB2A;RAB6A;RAP2B;TSR1;RERG;DYNC1LI1;RAB4A;RAB8B;RRAGB;MFHAS1;ARL4C;TUBA1C;RAB1B;SCG5;RHOH;TUBA4A;TUBB2B;MTG2
prerank,tau protein binding (GO:0048156),-0.41136787134764424,-1.3784594164809645,0.06050955414012739,0.5356121665937145,1.0,15/40,25.27%,PICALM;ROCK2;MARK1;ACTB;MARK4;APOE;GSK3B;MARK3;PRKAA1;MARK2;HDAC6;TTBK1;BAG2;TAOK2;BRSK1
prerank,transcription corepressor binding (GO:0001222),0.4949319074919437,1.3736378350568252,0.10031347962382445,0.7789491244564806,1.0,5/27,9.48%,RORA;PER3;ZBTB16;PER2;WIZ
prerank,voltage-gated cation channel activity (GO:0022843),0.3961561738467435,1.3702402091983945,0.06701030927835051,0.7788453730798677,1.0,25/97,17.61%,KCNS2;CACNA1E;ITGAV;GRIN2B;CACNG3;KCNQ3;KCNMA1;GRIN2A;KCNG1;CATSPER3;KCNH4;KCNC2;CACNB4;HCN2;HCN1;CACNG4;KCND2;HCN3;KCNK1;KCNH7;KCNH8;CACNA2D1;NCS1;KCNA6;GRIN3A
prerank,nucleotide diphosphatase activity (GO:0004551),0.570108071050478,1.3660576737435235,0.12020033388981637,0.7819436717227576,1.0,3/14,10.38%,ENPP1;FHIT;NUDT13
prerank,"DNA binding, bending (GO:0008301)",-0.5150676969343069,-1.3642668834416303,0.08048780487804878,0.5645329983716137,1.0,6/14,17.70%,LEF1;FOXC1;FOXD1;FOXL1;HHEX;HMGB2
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.38294537160725406,-1.363437310667982,0.05555555555555555,0.5546956553484227,1.0,9/42,5.01%,TMOD3;CD200;BAIAP2L1;PDLIM5;BSG;ESAM;SIRPA;S100A11;ANXA1
prerank,chloride channel inhibitor activity (GO:0019869),-0.5727639262644284,-1.3627728421769676,0.12967032967032968,0.5448910546366174,1.0,4/10,9.43%,WNK4;WNK1;STX1A;STX7
prerank,phospholipase inhibitor activity (GO:0004859),-0.584032235420161,-1.3617506362916851,0.13073394495412843,0.5361839614541629,1.0,6/10,37.02%,ANXA5;ANXA1;ANXA4;ANXA9;APOC1;SNCB
prerank,protein tyrosine kinase binding (GO:1990782),-0.34432183177798514,-1.3612041250392322,0.04230769230769231,0.5265912748932712,1.0,23/71,14.89%,EPHA4;DOCK4;PITPNM2;ITGB1;BMPR2;SIRPA;SQSTM1;PTPN14;GRB14;NEDD9;NCK1;TJP2;ACVR1;PTPN2;PTPN1;RNF41;CEACAM1;PCNA;NOX4;CPNE3;ELMO2;CDH5;TOB1
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),-0.36743764900442427,-1.3591048787369924,0.04912280701754386,0.5225029915344646,1.0,17/55,16.27%,SLC13A3;SLC16A2;SLC6A6;SLC38A11;SLC25A32;SLC22A4;SLC16A6;SLC16A11;SLC7A1;SLC16A1;SLC16A4;SLC38A5;SLC38A10;SLC7A5;SLC16A9;SLC36A4;PDPN
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.5852038823121317,1.3577661314260892,0.12365591397849462,0.8017931981195704,1.0,2/12,9.45%,GPR88;GPR52
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.5921106074009614,1.3517108025003888,0.1267361111111111,0.8119763292419141,1.0,3/12,5.40%,PIK3R1;GAB2;IRS1
prerank,hydro-lyase activity (GO:0016836),-0.38893988302115,-1.3482119779933301,0.06086956521739131,0.542777014103022,1.0,18/41,27.89%,HACD4;HACD1;CA4;ACO1;ECHDC1;L3HYPDH;ACO2;ENO1;PCBD2;HADHA;CDYL;AUH;CBS;FAHD2A;CYP2S1;ALAD;PARK7;HACD2
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.5657791475807854,1.346812968290174,0.15640599001663893,0.8187622314990409,1.0,7/13,15.70%,GABRA1;GABRG3;GLRA3;GABRG2;GLRA1;GLRA2;GLRB
prerank,nuclear export signal receptor activity (GO:0005049),0.6004941018315374,1.3454616937587383,0.16606498194945848,0.8104605249836323,1.0,6/11,19.93%,CSE1L;NUP214;NUP42;EIF4ENIF1;XPO6;XPO1
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),-0.3040010783931477,-1.3445142370603818,0.0125,0.5429455639015164,1.0,44/147,14.85%,PLCE1;DOCK5;RAPGEF2;RAPGEF5;ARHGEF18;DOCK4;DENND4A;FGD5;FNIP1;DOCK1;RAPGEF6;ARHGEF28;CYTH1;RASGRF1;RAP1A;RIN3;DENND3;RAPGEF1;NUCB1;ARHGEF15;LAMTOR5;EPS8L2;NGEF;MADD;SPATA13;GAPVD1;RGL2;RAB3IP;CCDC88A;DENND2C;DENND5B;ALS2;EIF2B4;HERC2;DENND6A;LAMTOR3;CCDC88C;BCR;EEF1D;DENND1A;DENND4C;ARHGEF11;RAPGEF3;MON1A
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.3720187328796584,-1.3428027589647642,0.06624605678233439,0.5373107392853701,1.0,4/48,1.22%,TRPM3;TRPM6;SLC12A7;PIEZO2
prerank,neuropeptide hormone activity (GO:0005184),0.5183513057118686,1.3419227243786833,0.13957307060755336,0.8114605644116044,1.0,3/22,8.90%,HCRT;SPX;NPY
prerank,ADP binding (GO:0043531),-0.43096127821802876,-1.3395755047746973,0.09947643979057591,0.5363691718035426,1.0,11/25,23.79%,PRKAG2;GCLC;PGK1;MIEF1;ME1;MYH10;ERN1;ATP5F1D;MYO18A;MYH9;COQ8A
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.4155437923794331,-1.3340256813041766,0.10451977401129943,0.5418045230894835,1.0,8/26,9.96%,ABCG2;SLC16A2;SLC6A6;SLC16A6;SLC16A11;SLC16A1;SLC16A4;MPC1
prerank,voltage-gated sodium channel activity (GO:0005248),0.5055616058965156,1.3324614625157927,0.128500823723229,0.8374493172420046,1.0,10/22,21.35%,SCN2B;CACNA1G;HCN2;HCN1;HCN3;SCN1A;SCN2A;SCN1B;SCN8A;CACNA1I
prerank,mRNA methyltransferase activity (GO:0008174),-0.5203212194318749,-1.327031997450864,0.12558139534883722,0.5519035575646563,1.0,3/12,8.67%,NSUN2;TRMT61B;CMTR1
prerank,transforming growth factor beta binding (GO:0050431),-0.43773712205995885,-1.3253350094435996,0.10173697270471464,0.5463011255285934,1.0,13/23,24.23%,LTBP4;THBS1;CD109;ACVR1;ACVRL1;LRRC32;TWSG1;TGFBR3;VASN;TGFBR2;NRROS;TSKU;HYAL2
prerank,ferrous iron binding (GO:0008198),0.49721850486790753,1.3252744409147952,0.14553990610328638,0.8540993961325097,1.0,7/21,13.45%,HIF1AN;DNAJC24;EGLN2;FXN;HEPH;FTO;ALKBH3
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.5983640399009791,1.3216920095774907,0.14207650273224043,0.8563567701829816,1.0,1/10,1.38%,SLC6A13
prerank,MAP kinase activity (GO:0004707),-0.5057995844938213,-1.3209986058270518,0.1360544217687075,0.5484331353057575,1.0,3/14,6.48%,MAPK4;MAPK9;MAPK14
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.5490232968098258,-1.3202634149101513,0.1513859275053305,0.5407288350784324,1.0,3/10,4.65%,B4GALT1;B3GALT1;B4GALT5
prerank,lipase activator activity (GO:0060229),0.5929081756180234,1.3183142619016546,0.16399286987522282,0.8573595266144386,1.0,3/10,11.12%,ARHGAP6;PDPK1;FYN
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.4861168435812399,-1.3173543003199388,0.1598173515981735,0.5390065671787092,1.0,7/14,22.95%,CASP8AP2;MAL;BAD;CTSH;ATP2A3;BCL2L13;APAF1
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.4885983795111829,1.3161681955667723,0.15457413249211358,0.8283146111431607,1.0,7/22,20.18%,HTR2B;HTR5A;HTR1A;HTR2C;HTR4;HTR6;CHRM2
prerank,G protein-coupled amine receptor activity (GO:0008227),0.4885983795111829,1.3161681955667723,0.15457413249211358,0.8283146111431607,1.0,7/22,20.18%,HTR2B;HTR5A;HTR1A;HTR2C;HTR4;HTR6;CHRM2
prerank,serotonin receptor activity (GO:0099589),0.4885983795111829,1.3161681955667723,0.15457413249211358,0.8283146111431607,1.0,7/22,20.18%,HTR2B;HTR5A;HTR1A;HTR2C;HTR4;HTR6;CHRM2
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.564780604183394,-1.3136236336245313,0.14823008849557523,0.5398591420329028,1.0,6/10,19.62%,SHANK3;GNAS;SQSTM1;SHANK1;SHISA7;IGSF11
prerank,BMP binding (GO:0036122),-0.5320674151628572,-1.3120360599633476,0.16179775280898875,0.5350404369099284,1.0,2/11,2.75%,NBL1;BMPR2
prerank,cAMP binding (GO:0030552),0.5802117791792346,1.3114194409439965,0.17383512544802868,0.8360713056090552,1.0,5/11,14.26%,RAPGEF4;PDE4B;CNBD2;HCN1;PDE4A
prerank,sequence-specific mRNA binding (GO:1990825),0.5845925937378657,1.3064915547395424,0.17647058823529413,0.8434550607029802,1.0,7/10,25.54%,RBM24;FMR1;LARP6;DHX9;SSB;ETF1;SHFL
prerank,phosphoric diester hydrolase activity (GO:0008081),0.4542720587729524,1.3040702318608381,0.15501519756838905,0.8409471477741178,1.0,8/35,7.72%,ENPP1;PLCL1;GPLD1;PLCXD3;SMPD4;PLCXD1;ENPP3;ENPP6
prerank,kinase activator activity (GO:0019209),-0.3996865473678837,-1.3020748785483984,0.10714285714285714,0.5527438833784133,1.0,13/30,24.21%,PRKAG2;RPLP1;GPRC5C;WNK1;MADD;CAB39;WNT11;MARK2;RGCC;MOB1B;DUSP19;BCL10;MT3
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.5489159226255784,-1.296912980620211,0.17471264367816092,0.5577257771905131,1.0,3/10,3.33%,CD200;CXADR;SIRPA
prerank,solute:anion antiporter activity (GO:0140323),-0.4766974631533444,-1.2958230247557077,0.14553990610328638,0.5519683282696964,1.0,4/14,6.46%,SLC26A7;SLC26A2;SLC26A11;SLC4A3
prerank,general transcription initiation factor binding (GO:0140296),0.4755626328445707,1.2941362763282716,0.16169544740973313,0.8692963095455046,1.0,10/25,22.14%,TAF12;THRA;GTF2A1;TAF1B;PSMC5;AR;THAP7;TAF11;GTF2B;GTF2A2
prerank,anion:anion antiporter activity (GO:0015301),-0.4617483825610752,-1.2938439470829066,0.13734939759036144,0.5487291002828729,1.0,8/17,26.68%,SLC26A7;SLC26A2;SLC26A11;SLC4A3;SLC25A5;SLC26A6;SLC25A4;SLC25A11
prerank,peptidoglycan binding (GO:0042834),-0.5348620998520328,-1.2927959602870813,0.15604395604395604,0.5432300265846233,1.0,7/10,39.86%,HK1;PGLYRP1;RNASE7;NOD2;JCHAIN;NLRP3;TLR2
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.4651993688131487,-1.2915841307159834,0.15270935960591134,0.5382849004997146,1.0,8/18,22.99%,LTBP4;BMPR2;ACVR1;ACVRL1;ACVR2B;TGFBR3;TGFBR2;ACVR2A
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.4961132491560407,1.2900591382746258,0.16065573770491803,0.8749717341375154,1.0,6/20,15.02%,CASK;MAGI3;DLG2;AK4;AK8;AK3
prerank,cytokine receptor activity (GO:0004896),0.38632198017150066,1.2900103065443205,0.11469072164948453,0.863369008296349,1.0,10/83,9.52%,GHR;IL15RA;IL2RA;IL1R2;IL18RAP;ACKR2;CCR9;IL17RD;IFNLR1;IL1RAP
prerank,MAP kinase phosphatase activity (GO:0033549),0.55703332939571,1.2858796621495951,0.20774647887323944,0.8685741026973638,1.0,5/12,22.62%,DUSP1;DUSP8;DUSP10;DUSP6;DUSP7
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.5039884808380326,1.2857307090481958,0.17880794701986755,0.8577663405664144,1.0,3/21,10.64%,CHRNB4;GRIA1;GRM5
prerank,ribonuclease P activity (GO:0004526),0.5616278143033266,1.285603986063498,0.18213660245183888,0.8471517593057581,1.0,4/11,9.76%,RPP40;POP5;PRORP;POP7
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.52686269694798,-1.2854292400470744,0.18284424379232506,0.5464858442440936,1.0,3/10,9.46%,MECOM;ASH1L;PRDM16
prerank,ligand-gated anion channel activity (GO:0099095),0.5205792262471695,1.2850905251976807,0.18057921635434412,0.838117960913374,1.0,8/17,15.70%,GABRA1;GABRG3;GLRA3;GABRG2;GLRA1;GLRA2;GABRB1;GLRB
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.5316747043432515,-1.28471405368746,0.17420814479638008,0.5408277670027809,1.0,6/11,24.61%,NUDT3;NUDT4;NUDT7;DCPS;NUDT16;NUDT16L1
prerank,phospholipase activator activity (GO:0016004),0.5837719432781052,1.2815456449294909,0.1891891891891892,0.8411972827661522,1.0,3/10,11.12%,ARHGAP6;PDPK1;FYN
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.4135876690596725,-1.2807491269785438,0.15027322404371585,0.5434278251640138,1.0,9/27,12.90%,SLC9B2;ITPR2;ATP2B1;SLC41A1;MRS2;CNNM2;CNNM4;SLC4A8;ATP2A3
prerank,peptidase activator activity (GO:0016504),-0.4278545808771812,-1.2803924420525519,0.13101604278074866,0.5371100132010613,1.0,9/22,13.34%,CAV1;CASP8AP2;PCOLCE2;VCP;MAL;APH1A;CLPX;APH1B;PSME3
prerank,GDP-dissociation inhibitor activity (GO:0005092),-0.49532734136967127,-1.277806272321075,0.1747787610619469,0.5365331717622263,1.0,5/13,11.40%,EIF5;SH3BP4;ARHGDIB;ITGB1BP1;CCDC88A
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.49558343547288397,-1.2764617395527753,0.17248908296943233,0.5327282366758452,1.0,7/12,28.57%,CASP8AP2;BAD;CTSH;ATP2A3;BCL2L13;APAF1;CASP1
prerank,glycerophospholipid flippase activity (GO:0140333),-0.5247603473239573,-1.2741152496453862,0.19724770642201836,0.5313717520724405,1.0,6/11,18.60%,ATP10A;ATP8A1;ABCA3;ATP8B1;ABCB4;ATP8A2
prerank,adenylate cyclase binding (GO:0008179),0.5824832890467295,1.273950438001896,0.21915285451197053,0.8604372388749773,1.0,4/10,13.23%,ADCY5;AKAP5;ADCY2;AKAP6
prerank,gated channel activity (GO:0022836),-0.49500179544276257,-1.273739410948596,0.2034313725490196,0.5253485711406645,1.0,7/14,21.47%,PIEZO2;TMC7;TMC6;TMEM266;PACC1;TMEM63B;PIEZO1
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.4827197600398423,-1.266356806714223,0.178743961352657,0.5365369675694222,1.0,3/14,4.04%,SLC26A7;SLC26A2;SLC26A11
prerank,dipeptidyl-peptidase activity (GO:0008239),0.5772606687637976,1.2662966885877585,0.19439579684763572,0.8804622812675831,1.0,3/10,3.37%,DPP6;FAP;DPP10
prerank,titin binding (GO:0031432),-0.48005115073065685,-1.2651864934974633,0.19451371571072318,0.5327219526157583,1.0,4/13,13.14%,ACTN2;CAMK2D;CALM1;TRIM63
prerank,GTPase activator activity (GO:0005096),-0.2622066253720359,-1.264476943443902,0.01282051282051282,0.5277071416508834,1.0,93/313,16.17%,RANBP3L;PLCE1;DOCK5;TBC1D4;PLCB1;RAPGEF2;RAPGEF5;ARHGEF18;DOCK4;DENND4A;FGD5;CHN2;RGS3;SIPA1L1;FNIP1;RGS6;DOCK1;RAPGEF6;ARHGEF28;RGS5;NRP1;CYTH1;SIPA1L2;RASGRF1;IQGAP1;TBC1D8;RAP1A;RIN3;RAP1GAP2;ARHGAP10;DENND3;ARHGAP42;TBC1D22B;ARHGAP17;ARAP3;RASGRP3;SRGAP2;RAPGEF1;ERRFI1;BNIP2;NUCB1;ARFGAP2;ARHGEF15;RANGAP1;RUNDC1;RALBP1;LAMTOR5;EPS8L2;ELMOD3;NGEF;MADD;ARHGAP18;SGSM2;ELMOD2;SPATA13;GAPVD1;RGL2;RAB3IP;GMIP;GRTP1;CCDC88A;DENND2C;ARHGAP27;PGAM5;RP2;ARHGAP28;DENND5B;TBC1D7;ALS2;EIF2B4;HERC2;EVI5L;DENND6A;TBC1D22A;LAMTOR3;CCDC88C;BCR;TBC1D10B;EEF1D;DENND1A;ARHGAP15;DENND4C;ASAP2;ARHGEF11;RAPGEF3;MON1A;TBCK;RAP1GDS1;TBC1D13;RGS10;SBF1;ARHGAP44;LLGL2
prerank,nuclease activity (GO:0004518),0.4153812187164577,1.2597232196312746,0.16161616161616163,0.8964876909580263,1.0,13/52,20.19%,ENPP1;ANKLE1;FEN1;ERCC5;PDE12;DIS3L2;NME1;RNASEH1;ISG20L2;RNASE12;WRN;REXO4;DDX1
prerank,DNA polymerase binding (GO:0070182),0.5028743475425238,1.2556182991717701,0.18107667210440456,0.9022770889439357,1.0,2/18,2.23%,FANCI;NAT10
prerank,metalloendopeptidase activity (GO:0004222),0.3881093921519524,1.255552813317099,0.14682539682539683,0.8916732582371061,1.0,15/76,10.23%,ECE1;ECE2;ADAMTS14;ADAMTS6;MBTPS2;MMP28;MMP24;MMP25;ADAM19;OMA1;ADAMTS12;MMP11;ADAMTS2;NRDC;PITRM1
prerank,R-SMAD binding (GO:0070412),-0.43166786431911774,-1.255441532247892,0.1770573566084788,0.5429404349995336,1.0,4/18,8.34%,SMAD6;DDX5;DROSHA;SMAD3
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.5486023717536965,1.2536011022310152,0.21654929577464788,0.8888298806499253,1.0,6/12,16.72%,SDHB;CISD3;FXN;CISD2;AOX1;ISCA1
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.5409933960069873,1.2524198656523002,0.2202797202797203,0.8833317558113112,1.0,2/12,2.74%,PDE7B;PDE4B
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.5618785871931387,1.2479071514407634,0.2184115523465704,0.8809938719797856,1.0,5/10,22.62%,DUSP1;DUSP8;DUSP10;DUSP6;DUSP7
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.5618785871931387,1.2479071514407634,0.2184115523465704,0.8809938719797856,1.0,5/10,22.62%,DUSP1;DUSP8;DUSP10;DUSP6;DUSP7
prerank,retinoic acid receptor binding (GO:0042974),0.49928463693096314,1.2475904256495747,0.2097560975609756,0.8722960376151233,1.0,8/17,15.19%,NSD1;SNW1;CNOT1;NRIP1;MED1;MED25;ASXL1;PRMT2
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.40290103722257514,1.2453509338696567,0.1652542372881356,0.8710884524649651,1.0,7/53,8.61%,SLC1A3;SLC1A5;SLC7A11;SLC43A1;SLC7A8;SLC66A1;SLC25A22
prerank,chloride channel regulator activity (GO:0017081),-0.4689229250647129,-1.2442608035342113,0.17882352941176471,0.5639350570481052,1.0,4/14,9.43%,WNK4;WNK1;STX1A;STX7
prerank,transcription coregulator binding (GO:0001221),0.40557075206524457,1.2441072947452727,0.16475644699140402,0.8663625095653282,1.0,8/50,9.48%,RORA;PER3;PGR;PPARD;TEAD2;ZBTB16;PER2;WIZ
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.5558352111259947,1.243113759781235,0.22323049001814882,0.8608705629838617,1.0,1/11,2.20%,CHRNB4
prerank,GTP binding (GO:0005525),-0.27803687432777896,-1.2424773889017615,0.015037593984962405,0.5613510664999685,1.0,63/172,24.20%,RHOBTB1;MRAS;KRAS;RRAS2;GBP7;RASL12;RAP1A;INSR;DRG1;RHOQ;RHOBTB2;RAC1;GBP5;CDC42;ARL6;RAB21;ADSS2;GBP4;RAB5A;RHOC;GBP2;GCH1;RAB31;DRG2;EEF1A1;RRAGC;RAB13;ARL2;RAB35;REM1;GBP6;RALB;TGM2;RAN;RAB38;RRAS;GNL1;RAP2C;ATL3;NOA1;ARL1;TUBB2A;RAB6A;RAP2B;TSR1;RERG;DYNC1LI1;RAB4A;RRAGB;MFHAS1;ARL4C;TUBA1C;RAB1B;SCG5;RHOH;TUBA4A;TUBB2B;MTG2;LANCL2;RAB9A;RAP1B;NUDT16;RHOU
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.5073920265094176,1.2417428410591247,0.2089041095890411,0.8569773762469305,1.0,2/15,3.26%,ACKR2;CCR9
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.4591082120755617,-1.240361498705003,0.18246445497630331,0.5600375370682703,1.0,7/15,14.15%,HS3ST3A1;HS3ST4;HS3ST1;NDST1;NDST3;HS3ST2;HS3ST3B1
prerank,phosphatidate phosphatase activity (GO:0008195),0.5351024609843986,1.2376073633712674,0.22644927536231885,0.8634315801758505,1.0,5/13,15.43%,LPIN3;PLPPR3;PLPPR2;PLPP5;LPIN2
prerank,phosphatase inhibitor activity (GO:0019212),0.48001451986529997,1.2375288222082006,0.20135363790186125,0.8545962326119435,1.0,2/20,4.56%,PTN;BOD1
prerank,N-acetyltransferase activity (GO:0008080),0.4877167807165414,1.235358489033675,0.21087314662273476,0.8537788929611455,1.0,4/19,10.37%,NAA10;NAT10;NAA50;NAT8L
prerank,dynactin binding (GO:0034452),-0.49764828126938193,-1.234066326760376,0.20754716981132076,0.5696901011742267,1.0,6/12,26.57%,GSK3B;MAPT;SNX6;BICD2;BICDL1;BICD1
prerank,low-density lipoprotein particle binding (GO:0030169),0.49943688380190276,1.2339876391478926,0.23887973640856672,0.8497818337828541,1.0,3/16,5.25%,COLEC12;LIPC;SORL1
prerank,phospholipase C activity (GO:0004629),-0.40234432623939,-1.2331490190571472,0.1628498727735369,0.5652093429886426,1.0,7/25,15.34%,PLCE1;PLCB1;EDNRA;BDKRB2;PLCB4;PLCG2;PLCH1
prerank,GABA-A receptor activity (GO:0004890),0.489192246648941,1.230775600026802,0.238562091503268,0.8525283369420719,1.0,5/18,13.82%,GABRA1;GABRD;GABRG3;GABRG2;GABRB1
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.5084398454022948,-1.2294292324747484,0.22950819672131148,0.5683500889135454,1.0,6/12,21.19%,LTBP4;BMPR2;ACVR1;ACVRL1;TGFBR3;TGFBR2
prerank,TBP-class protein binding (GO:0017025),0.46805869563761165,1.2291357326018846,0.20521172638436483,0.8502198357284515,1.0,8/21,22.14%,TAF12;THRA;GTF2A1;TAF1B;PSMC5;TAF11;GTF2B;GTF2A2
prerank,phosphatidylglycerol binding (GO:1901611),-0.4788217724012767,-1.2289167502959388,0.20347394540942929,0.5627983054661961,1.0,3/13,6.69%,PITPNC1;PLTP;PITPNA
prerank,gamma-tubulin binding (GO:0043015),-0.4144717846477063,-1.2284564672126599,0.18604651162790697,0.55761515610002,1.0,10/21,25.27%,MARK4;NDRG1;OFD1;TUBGCP5;GIT1;RAD51D;CDK5RAP2;DIXDC1;RAB11FIP5;BRSK1
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.4668030980682582,1.2282076301171299,0.22388059701492538,0.8452805244886618,1.0,4/21,15.70%,CHRNB4;GRIK2;P2RX4;GLRB
prerank,pyridoxal phosphate binding (GO:0030170),0.4758999970166129,1.2279348974742157,0.20588235294117646,0.8377980801785708,1.0,4/20,6.15%,THNSL2;GLDC;PDXK;ABAT
prerank,semaphorin receptor activity (GO:0017154),-0.4935987297602134,-1.2241467834738549,0.21307506053268765,0.5619340268603903,1.0,4/11,2.72%,PLXNA2;PLXNA4;NRP2;NRP1
prerank,FMN binding (GO:0010181),0.5369040165185326,1.2212986187699737,0.25265017667844525,0.8526761114258717,1.0,3/11,6.89%,POR;MTRR;DUS2
prerank,poly-purine tract binding (GO:0070717),0.4445885650215715,1.2205854559156695,0.21020092735703247,0.8473519726613811,1.0,5/27,6.64%,RBMS1;EIF4A3;RBMS3;FMR1;ELAVL4
prerank,single-stranded DNA helicase activity (GO:0017116),0.4755851398016742,1.2198659369736544,0.215311004784689,0.8418246721296864,1.0,7/19,21.65%,MCM7;POLQ;PIF1;RFC3;DHX9;HELQ;RFC4
prerank,manganese ion binding (GO:0030145),-0.3384380141200737,-1.2185205979393037,0.15705128205128205,0.570009297982072,1.0,12/48,14.15%,B4GALT1;MPPED2;XPNPEP3;SOD2;ADPRM;MGAT1;LARGE1;GYG1;DYRK2;ME1;PRIMPOL;GALNT1
prerank,calcium:sodium antiporter activity (GO:0005432),-0.5089250879330384,-1.2178780978683272,0.22247706422018348,0.565351538563615,1.0,3/10,6.91%,SLC24A3;SLC8A3;SLC3A2
prerank,single-stranded DNA binding (GO:0003697),0.35915139042823147,1.2176734866689154,0.16578947368421051,0.8413824416848237,1.0,28/93,18.64%,RBMS1;ERCC1;MCM7;ERCC5;MSH3;RTF1;NEIL3;POLA1;RPA1;HMCES;ERCC4;WBP11;XPC;BRCA2;MCM4;DHX36;TOP3A;SPRTN;RAD52;LONP1;MCM10;SSBP2;DHX9;CRY2;MCMDC2;FBH1;SSBP1;REXO4
prerank,poly(A) binding (GO:0008143),0.4673542959718276,1.2162045062289426,0.21864951768488747,0.8389681641050248,1.0,4/21,6.64%,RBMS1;EIF4A3;RBMS3;ELAVL4
prerank,miRNA binding (GO:0035198),0.43565222152421323,1.2114378972904765,0.2102874432677761,0.8485412996573455,1.0,9/30,11.21%,AGO4;SPOUT1;FMR1;DND1;ZC3H7B;ZNF346;HNRNPA2B1;SOX2;AGO3
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.435594903893639,1.208816094690555,0.21898928024502298,0.8500196279938942,1.0,11/28,17.54%,RPP40;POP5;FEN1;PRORP;MRPL44;POP7;DBR1;AGO3;EDC3;RNASEH1;RPP21
prerank,clathrin adaptor activity (GO:0035615),-0.4457522150580326,-1.2083145010912235,0.21951219512195122,0.5832560575376351,1.0,9/15,35.49%,HIP1R;DAB2;AP2A1;HIP1;AP2S1;AP2B1;AP1M1;AP1G1;AP1G2
prerank,protein phosphatase inhibitor activity (GO:0004864),0.4398496433943598,1.204078925445005,0.23300970873786409,0.8588298317065464,1.0,3/26,7.43%,PTN;BOD1;PPP1R14A
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.38190585989369424,-1.20278525797532,0.1780821917808219,0.590761269247174,1.0,8/27,16.43%,SLC9A2;SLC8A3;SLC9B2;SLC3A2;SLC41A1;CNNM4;SLC4A8;SLC9A5
prerank,endopeptidase activator activity (GO:0061133),-0.5017640387809232,-1.202577178074706,0.24161073825503357,0.5850213297594008,1.0,8/10,34.19%,APH1A;APH1B;PSME3;PSME2;ADRM1;VSIR;PSME1;NLRC4
prerank,NADP binding (GO:0050661),0.41374641201187484,1.2021687035526993,0.2345679012345679,0.8579029493896831,1.0,5/32,8.28%,HSD11B1;GRHPR;MTRR;DUS2;KCNAB1
prerank,histone methyltransferase binding (GO:1990226),-0.4978398847718007,-1.2019579204616744,0.2475,0.5804353539276152,1.0,5/11,22.24%,LCOR;CBX3;CBX1;LCORL;PHF1
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.542447919099665,1.2010440229291204,0.25728987993138935,0.854329494353253,1.0,1/11,0.86%,ROR2
prerank,metal ion binding (GO:0046872),0.3081155217333764,1.1989450706231564,0.08539094650205761,0.8541127703334012,1.0,85/477,14.56%,SCUBE1;ENPP1;ADGRL3;LRP1;PLSCR4;CLEC4E;HRG;S100A3;CDH6;PLA2G2C;PAM;ADGRV1;ASTN2;ITPR1;MASP1;PDXK;NRXN1;FKBP9;TCHH;RYR2;FAN1;FEN1;LOXL2;KCNIP1;CISD3;DCHS1;CEMIP2;CDH11;CAMKK2;CDH15;CDH3;LRRK2;CLEC3B;KCNIP2;ATP2A2;NOL3;CAPN3;CLYBL;RASGRP2;S100A7A;ENPP3;CALB1;ADCY2;CDC42BPA;PRKACB;MAN1C1;SYT3;PIF1;AMY1A;AMY1B;AMY1C;PINK1;KCNIP4;MICU3;PVALB;OPA1;ITSN1;SYT7;MAN1B1;PPP3CB;DHX36;RCN3;CABYR;S100A2;TRPM2;SYT5;S100A1;CDH10;HSP90B1;FIGNL1;YDJC;DIS3L2;TESC;EML1;S100G;SPARCL1;BGLAP;RYR3;ASPH;MELK;PCLO;NME1;STIM1;HSPA5;NDUFAB1
prerank,growth factor activity (GO:0008083),0.355634013261482,1.1975552656258426,0.18157543391188252,0.8508917521381637,1.0,13/74,16.73%,PTN;NRG1;CXCL1;AMELX;NRG3;IL12A;ENDOU;IGF2;CLEC11A;FGF5;AREG;GDNF;JAG1
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.43843308741706044,1.1973136415552526,0.21935483870967742,0.8444245193191813,1.0,8/30,17.97%,SLC25A37;SLC30A10;SLC30A5;SLC39A7;SLC30A3;ATP7A;SLC39A13;SLC39A14
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.4554261430697285,1.1959002746489276,0.2544861337683524,0.8419131565584609,1.0,7/21,13.23%,AKAP5;AKAP7;RYR2;WASF3;PRKACA;ACBD3;AKAP6
prerank,filamin binding (GO:0031005),-0.493118041951534,-1.1870716224647246,0.25,0.6111052519852296,1.0,2/11,0.72%,NEBL;DPYSL3
prerank,death receptor activity (GO:0005035),0.5320628096618867,1.1869095121651203,0.2874564459930314,0.8656354679359634,1.0,3/11,7.98%,EDA2R;NGFR;TNFRSF19
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.4369083406209122,-1.1824467706864774,0.23486682808716708,0.6170130420657314,1.0,8/15,30.24%,PLA2G4A;SH3PXD2B;JPH2;SNX3;PLA2G4E;LANCL2;RUBCNL;VEPH1
prerank,ATPase activator activity (GO:0001671),0.45634780416478715,1.1803674022626065,0.25601374570446733,0.881775467761955,1.0,5/20,13.75%,DNAJC19;DNAJC1;DNAJC24;DNAJC10;DNAJC15
prerank,endodeoxyribonuclease activity (GO:0004520),0.45820576850950934,1.178082206432867,0.2305194805194805,0.8824388420757963,1.0,5/20,13.74%,ERCC1;FEN1;ERCC5;ERCC4;MBD4
prerank,GABA receptor activity (GO:0016917),0.45682483531921864,1.1779014687813223,0.2696078431372549,0.875581734411537,1.0,6/21,15.97%,GABRA1;GABRD;GABRG3;GABRG2;GABRB1;GABBR2
prerank,ubiquitin protein ligase binding (GO:0031625),-0.25593767042542176,-1.177788564186212,0.08080808080808081,0.622560776680576,1.0,94/254,26.33%,SNCAIP;SMAD6;FOXO1;VCL;EGFR;NPLOC4;TRIB2;KDM4A;BECN1;UBE2G1;LAPTM4B;NEK6;SQSTM1;TMBIM6;HSPA8;ARIH1;ACTG1;SKI;GABARAP;DBT;APC;RPL5;HLTF;CUL1;TXNIP;GABARAPL1;JKAMP;FZD4;UBB;GSK3B;PRR5L;SLC22A18;RNF8;VCP;TPI1;PCBP2;SMAD3;RPL11;CASP8;NFKBIA;UBE2A;RALB;OTUB1;HERC2;PSMA3;SMG5;PRKAR2A;SLC25A5;PRKAR2B;UBE2N;CKB;USP25;UCHL1;TRAF3;CDKN1A;HSPBP1;UBE2L6;PER1;NEDD8;CUL3;FZD8;ISG15;LAPTM5;UBC;CBS;MAP1LC3A;AMBRA1;ERBB3;APBB1;MFHAS1;HDAC6;RPL23;FAF2;MAP1LC3B;RTN4;TRAF1;MID1;RFFL;UBA52;SMAD7;IKBKE;BCL10;AXIN2;HSPD1;RNF20;RPA2;IKBKG;SUMO1;NDUFS2;CHEK2;HSPA1A;BRCA1;ARRB2;RB1
prerank,ubiquitin-like protein ligase binding (GO:0044389),-0.25313691542526073,-1.1774474619131274,0.043010752688172046,0.6170912504771807,1.0,98/269,26.33%,SNCAIP;SMAD6;FOXO1;VCL;EGFR;NPLOC4;TRIB2;KDM4A;BECN1;UBE2G1;LAPTM4B;NEK6;SQSTM1;TMBIM6;HSPA8;ARIH1;ACTG1;SKI;GABARAP;DBT;APC;RPL5;HLTF;CUL1;TXNIP;GABARAPL1;JKAMP;FZD4;UBB;GSK3B;PRR5L;SLC22A18;RNF8;VCP;TPI1;PCBP2;SMAD3;RPL11;CASP8;NFKBIA;UBE2A;PARP9;SUMO3;RALB;OTUB1;HERC2;PSMA3;SMG5;PRKAR2A;SLC25A5;PRKAR2B;PTPRN;UBE2N;CKB;USP25;UCHL1;TRAF3;CDKN1A;HSPBP1;UBE2L6;PER1;NEDD8;CUL3;FZD8;ISG15;LAPTM5;UBC;CBS;MAP1LC3A;AMBRA1;ERBB3;APBB1;MFHAS1;HDAC6;RPL23;FAF2;MAP1LC3B;RTN4;TRAF1;MID1;RFFL;UBA52;SMAD7;IKBKE;BCL10;AXIN2;HSPD1;RNF20;RPA2;IKBKG;SUMO1;DTX3L;NDUFS2;CHEK2;HSPA1A;BRCA1;ARRB2;RB1
prerank,protein homodimerization activity (GO:0042803),0.29993896826405436,1.175799139725334,0.09805924412665985,0.8751702585770501,1.0,127/589,18.07%,TBX18;ENPP1;HSD11B1;PDGFRA;ECE1;GHR;XCL1;TENM3;PTPRT;ACOX2;TIMM10;NTRK2;HIF1AN;NR2F2;GLDC;ERBB4;PIP4K2A;ABCD2;MASP1;PDXK;FAP;ODC1;CIP2A;PHETA2;FGFR1;RABL3;TPST1;EPRS1;TYR;JUP;POU3F3;TENM4;SOX6;KMT2A;RNF40;ERCC5;KYNU;MTCL1;CPQ;FMR1;ZBTB16;GRHPR;MSH3;LRRK2;PEX7;MTMR1;ACTN1;ADCY8;MTHFD1L;TENM2;SRF;DSCAML1;TRIM37;PTPRO;SYNDIG1;QTRT2;GLIPR2;TERF1;CIDEA;UXS1;TRIM8;APPL2;CPOX;TENM1;COMMD1;CR2;IRAK1;NUDT21;HOGA1;EIF2AK1;PRPS1L1;PRPS1;PTPA;PYCARD;ACOT7;SLK;BCL2L2;HMGCS1;PDK2;SLC4A1;ACSL6;S100A1;ZNF318;GALE;KCNN2;CISD2;RAB11FIP3;CADM3;PEX11A;TESC;SYNE1;AXIN1;SDCBP2;NECTIN3;TSG101;RDH5;SNF8;BAK1;RIPK1;TFAP4;ABCB7;PRMT2;GDNF;PHETA1;CENPF;ZHX3;FGFR2;AOX1;CRPPA;MMAA;ZDHHC2;CYP2R1;HARS1;SLC39A13;RRAGA;MMUT;SARS1;ADRA2A;VPS4B;GOLGA5;LDB1;GNPTG;TOP2A;CAMK2A;MSH6;DPYD;WRN
prerank,G protein-coupled receptor activity (GO:0004930),0.3110610550745825,1.1726259678583466,0.16815144766146994,0.879421132273297,1.0,29/239,10.95%,ADGRL3;GPR88;RXFP3;ADGRV1;CALCRL;PDGFRL;GPR3;NPFFR1;C5AR1;P2RY1;GPR37L1;ADGRB2;ADGRB1;ADORA2A;CRHR2;MRGPRE;GPR22;LPAR3;ADGRB3;TRHR;GPR183;GPR176;ADGRL1;NPY;TAPT1;GPR52;LPAR1;GRM5;GPR26
prerank,MHC class II protein complex binding (GO:0023026),-0.46739649747066436,-1.1715690533562138,0.2780487804878049,0.6262717570752325,1.0,4/11,17.22%,HSPA8;ANXA11;PKM;CD74
prerank,NF-kappaB binding (GO:0051059),0.43617856245658676,1.1715065924154278,0.25862068965517243,0.8762302845847585,1.0,4/24,7.08%,HDAC1;HIF1AN;CDKN2A;BRMS1
prerank,GTPase regulator activity (GO:0030695),-0.25477522338654535,-1.1694327603959382,0.06293706293706294,0.6254790421097608,1.0,61/212,15.41%,RANBP3L;TBC1D4;PLCB1;RAPGEF2;CHN2;SLIT2;RGS3;SIPA1L1;RGS6;DOCK1;RGS5;RGS12;NRP1;SIPA1L2;SIRPA;IQGAP1;TBC1D8;ARL2BP;RAP1GAP2;EIF5;ARHGAP10;ARHGAP42;SH3BP4;TBC1D22B;ARHGAP17;ARAP3;RASGRP3;SRGAP2;ERRFI1;BNIP2;ARFGAP2;RANGAP1;RUNDC1;RALBP1;ITGB1BP1;ELMOD3;ARHGAP18;SGSM2;CPEB2;ELMOD2;ARL2;GMIP;GRTP1;CCDC88A;ARHGAP27;PGAM5;RP2;ARHGAP28;TBC1D7;ALS2;EVI5L;TBC1D22A;BCR;IPO7;TBC1D10B;ARHGAP15;ASAP2;TBCK;RAP1GDS1;TBC1D13;RGS10
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.45344113571364075,1.1681207378388172,0.2912621359223301,0.8743284604873892,1.0,8/21,17.24%,CDK14;CDK8;CDKL3;CDK13;CDKL1;CDK10;CCNK;CDK5
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.45344113571364075,1.1681207378388172,0.2912621359223301,0.8743284604873892,1.0,8/21,17.24%,CDK14;CDK8;CDKL3;CDK13;CDKL1;CDK10;CCNK;CDK5
prerank,neuropeptide receptor activity (GO:0008188),0.419515511944645,1.1672916606978445,0.25949367088607594,0.8699684433855076,1.0,2/29,2.03%,SORCS3;NPFFR1
prerank,metallopeptidase activity (GO:0008237),0.3420634510386531,1.1631359241400956,0.21773142112125163,0.8776838441046004,1.0,28/113,17.31%,ECE1;ECE2;ADAMTS14;ADAMTS6;MBTPS2;MMP28;MMP24;MMP25;EIF3H;ADAM11;ADAM19;METAP1D;OMA1;ADAMTS12;MMP11;ADAMTS2;NRDC;ADAM12;PITRM1;SPRTN;ADAMTS20;ADAMTS10;ADAM2;ADAMTS19;DPEP1;PSMD14;RNPEP;ADAM8
prerank,monocarboxylic acid binding (GO:0033293),0.4564764063959265,1.1591897276677703,0.27946127946127947,0.8843830400031236,1.0,2/18,2.85%,NR2F2;NR1H4
prerank,calcium channel regulator activity (GO:0005246),0.3982569887626916,1.1573767458443087,0.2685459940652819,0.8841165959083944,1.0,9/37,15.57%,ITPR1;NRXN2;NRXN1;STIMATE;NPY;CACNG4;STIM1;PACSIN3;SGK1
prerank,voltage-gated ion channel activity (GO:0005244),0.49120986465559574,1.1522364328127832,0.30201342281879195,0.8961038066347629,1.0,4/14,10.52%,VDAC2;CACNA1E;HCN1;KCND2
prerank,sulfotransferase activity (GO:0008146),0.40643492652049396,1.1513060832136386,0.28205128205128205,0.8925735918048128,1.0,2/33,3.16%,CHST8;TPST1
prerank,nucleotidase activity (GO:0008252),-0.4231825653629638,-1.1509819122419311,0.27455919395465994,0.6684202288097356,1.0,8/15,32.64%,NT5DC3;NT5E;NT5C3B;NT5C1A;NT5M;ACP3;BPNT1;NT5C2
prerank,leak channel activity (GO:0022840),0.4662025589936773,1.1506721226702468,0.3161397670549085,0.8879799660977891,1.0,5/18,15.93%,KCNK2;NALCN;TMEM175;KCNK1;KCNK13
prerank,protein kinase activator activity (GO:0030295),-0.304344076812874,-1.1504049896471435,0.20553359683794467,0.6637225412382805,1.0,19/60,19.40%,PRKAG2;AFAP1L2;RICTOR;IQGAP1;RPLP1;GPRC5C;WNK1;CALM1;MADD;CAB39;MAP2K2;ALS2;ETAA1;CDKN1A;PAK2;ERBB3;WNT11;MARK2;RGCC
prerank,lipoprotein particle binding (GO:0071813),0.44772312985725526,1.1490931350038145,0.28594771241830064,0.8868845995542676,1.0,3/20,5.25%,COLEC12;LIPC;SORL1
prerank,vinculin binding (GO:0017166),0.5133308482362787,1.148624299912523,0.30849220103986136,0.8816715682440981,1.0,3/11,6.32%,UTRN;CORO2B;ACTN1
prerank,secondary active transmembrane transporter activity (GO:0015291),-0.31350097547945494,-1.1433944817479254,0.21498371335504887,0.6761123749835016,1.0,24/51,32.05%,SLC16A2;SLCO2A1;SLCO1C1;SLC22A4;SLC22A6;SLC25A3;SLC22A8;SLC35D2;SLC7A5;SLC20A1;MFSD2A;SLC35E4;TMEM241;SLCO5A1;SLC35C2;MCU;SLCO4A1;SLC25A11;SLC5A6;SLCO4C1;SLCO1B1;SLC5A5;SLC35E2A;SLC35E2B
prerank,pyrophosphatase activity (GO:0016462),0.3677480438726497,1.1410261681847345,0.2608695652173913,0.901687825644955,1.0,11/50,14.93%,ENPP1;ENTPD2;ENTPD5;ENPP3;ITPA;NUDT9;TRPM2;ENTPD7;BNIPL;PLPP5;DHX9
prerank,steroid hydroxylase activity (GO:0008395),0.46960795384792675,1.1400257940125218,0.32081911262798635,0.8986535721157328,1.0,1/16,0.29%,CYP7B1
prerank,beta-tubulin binding (GO:0048487),0.39775043536544974,1.1391694873327387,0.2978395061728395,0.8950408595439364,1.0,5/31,10.91%,DLEC1;CCT5;LRPPRC;ARL8B;IFT74
prerank,Toll-like receptor binding (GO:0035325),0.5196938459737619,1.1390533897419222,0.3121597096188748,0.8889013261019698,1.0,4/11,17.67%,UNC93B1;TLR6;TIRAP;MYD88
prerank,CoA-ligase activity (GO:0016405),0.48176598215927546,1.138167607450113,0.32521739130434785,0.8853418616933292,1.0,1/14,1.09%,ACSS3
prerank,ribonuclease P RNA binding (GO:0033204),0.5075937573895934,1.1359611581953917,0.3251318101933216,0.8862465215904788,1.0,3/10,9.76%,RPP40;POP5;POP7
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.47020408981070744,1.1341939746930314,0.327150084317032,0.8856594532762382,1.0,4/14,9.76%,RPP40;POP5;PRORP;POP7
prerank,protein kinase C activity (GO:0004697),0.4749024492849738,1.131879715508151,0.2991596638655462,0.8873548954386145,1.0,5/14,9.16%,PRKD3;PRKCI;PRKD1;PRKCA;PRKCB
prerank,hexose transmembrane transporter activity (GO:0015149),-0.4465392804238574,-1.1304470430985223,0.31777777777777777,0.7051218353718262,1.0,8/12,47.47%,SLC2A1;SLC2A4;SLC2A2;PPBP;SLC5A3;SLC2A5;SLC2A3;SLC2A6
prerank,chloride transmembrane transporter activity (GO:0015108),-0.41413954010104514,-1.129747224259956,0.290167865707434,0.70044233764224,1.0,6/16,22.27%,SLC26A7;SLC26A2;SLC1A1;SLC4A8;SLC26A6;CFTR
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),-0.3057643961157538,-1.1289687191956483,0.23885350318471338,0.6959101283718475,1.0,19/49,24.53%,SQSTM1;ABRAXAS2;VCP;PARP10;OPTN;MINDY1;RNF169;BRCC3;TAB2;PSMD4;RAD23B;TNFAIP3;HDAC6;ZFAND2B;IKBKE;ZRANB3;ZFAND6;IKBKG;ATRIP
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.4476489280647767,1.1284106690154116,0.31596638655462184,0.8919017229565604,1.0,6/20,17.97%,SLC30A10;SLC30A5;SLC39A7;SLC30A3;SLC39A13;SLC39A14
prerank,organic cation transmembrane transporter activity (GO:0015101),0.4600841808683821,1.1283408046442707,0.32642487046632124,0.8858464622822702,1.0,5/16,18.50%,SLC18A3;SLC7A8;SLC25A26;SLC25A17;SLC44A1
prerank,nuclear localization sequence binding (GO:0008139),0.45018657460590744,1.1263383883879938,0.3185689948892675,0.8860408090616586,1.0,9/18,22.51%,NUP214;POM121;TNPO1;KPNA1;CABP1;TNPO2;KPNB1;KPNA2;IPO4
prerank,3'-5' DNA helicase activity (GO:0043138),0.4656791700835238,1.1262662251817652,0.3228476821192053,0.8801692581626869,1.0,7/16,18.20%,MCM7;NAV2;RECQL;DHX9;HELQ;WRN;FBH1
prerank,carboxylic acid binding (GO:0031406),0.3834736496750839,1.1242759372676316,0.2990936555891239,0.8806372654850311,1.0,11/38,17.61%,THNSL2;HIF1AN;GLDC;GRIN2B;GLRA3;GLRA1;GLRA2;GLRB;GRM7;CASTOR1;GRIN3A
prerank,tumor necrosis factor receptor binding (GO:0005164),0.49299791938663007,1.124240879779216,0.3303886925795053,0.8747251433359509,1.0,2/12,7.21%,TRAF4;TRIM37
prerank,5'-nucleotidase activity (GO:0008253),-0.42450126178315145,-1.12396028107407,0.30845771144278605,0.7033844564601595,1.0,7/13,32.64%,NT5DC3;NT5E;NT5C3B;NT5C1A;NT5M;ACP3;NT5C2
prerank,hexosyltransferase activity (GO:0016758),-0.26575072817712747,-1.120011102191881,0.2222222222222222,0.7071003537890718,1.0,24/101,16.13%,B4GALT1;TMTC2;CSGALNACT1;B3GALT1;TMTC1;ALG9;B4GALT5;EXT1;GBE1;TMTC4;LARGE1;GYG1;HEXB;HYAL1;MGAT4B;ALG12;MTAP;B3GALNT1;FUT9;LFNG;DPY19L4;GCNT1;MFNG;B3GLCT
prerank,UDP-glycosyltransferase activity (GO:0008194),-0.2860580546853558,-1.1173117326921396,0.23863636363636365,0.708110755179457,1.0,17/70,20.29%,B4GALT1;CSGALNACT1;B3GALT1;GXYLT2;EXT1;LARGE1;HEXB;HYAL1;MGAT4B;B3GALNT1;LFNG;GCNT1;MFNG;B3GLCT;B3GNT2;HAS1;GXYLT1
prerank,amino acid binding (GO:0016597),0.39237080171296496,1.1159992181328489,0.29411764705882354,0.8967531825108586,1.0,10/31,17.61%,THNSL2;GLDC;GRIN2B;GLRA3;GLRA1;GLRA2;GLRB;GRM7;CASTOR1;GRIN3A
prerank,alanine transmembrane transporter activity (GO:0022858),-0.4366837113848596,-1.1135940327309262,0.31894484412470026,0.7118901166132932,1.0,5/12,21.01%,SLC6A6;SLC3A2;SLC38A5;SLC36A4;SLC38A7
prerank,thyroid hormone receptor binding (GO:0046966),0.40544486632194576,1.1118004090471256,0.31230283911671924,0.9051271401298873,1.0,10/28,20.81%,MED12;NCOA3;BRD8;NSD1;HMGN3;MED1;GTF2H1;PRMT2;TAF11;GTF2B
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.5047056704259725,1.1114542727778265,0.3467153284671533,0.9002741686184251,1.0,4/10,16.89%,STAMBPL1;ATXN3;YOD1;STAMBP
prerank,deoxyribonuclease activity (GO:0004536),0.4614338599976243,1.1108813936241344,0.33222591362126247,0.8965313196708683,1.0,4/14,14.15%,ERCC5;ERCC4;MBD4;NME1
prerank,receptor ligand activity (GO:0048018),0.29507992369630687,1.1095429372552936,0.25646794150731156,0.8947952794031083,1.0,12/245,2.18%,IL33;PTN;IL34;EPHA7;CXCL10;NRG1;EDN3;EDA;WNT5A;CXCL1;SEMA5A;IL16
prerank,cytokine receptor binding (GO:0005126),0.333094101775569,1.1069952921916595,0.3157894736842105,0.8974246141734208,1.0,11/83,12.10%,IL34;IL1RN;XCL1;JAK1;TSLP;SPRED1;SPRED2;IL1RAP;CCL25;PYCARD;IL12A
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.39004044114189435,-1.106191897320552,0.31654676258992803,0.7267654109658499,1.0,6/18,22.48%,SMAD6;TGFB2;SMAD3;TGFBR3;TGFBR2;SMAD7
prerank,NAD+ binding (GO:0070403),-0.4360374588275505,-1.1045845961485854,0.32286995515695066,0.7245916642953959,1.0,7/12,18.85%,SIRT3;ZC3HAV1;PARP9;CRYL1;HADH;SIRT1;SIRT5
prerank,damaged DNA binding (GO:0003684),0.37016995875673986,1.1039785265703224,0.3251798561151079,0.9015204912935023,1.0,11/44,15.54%,ERCC1;FEN1;POLQ;ERCC5;NEIL3;RPA1;ERCC4;XPC;XRCC1;ERCC2;CRY2
prerank,sequence-specific DNA binding (GO:0043565),0.281026439417129,1.099793083687343,0.22816032887975335,0.9099371409332485,1.0,97/590,16.31%,TBX18;RORA;ZBTB20;ISL2;MSC;ATF5;ETV1;PKNOX2;RUNX2;PPARA;HOXC10;TEAD1;ETV5;TEF;NR2F2;TCF7L2;TCF4;SMAD5;NR1H4;ZIC4;MEIS2;NFATC3;ZNF740;POU3F3;PPARD;TEAD2;TBX3;FOS;ZIC1;KMT2A;HOXC9;ZNF423;FOXN2;CXXC1;MYCN;DMRTA2;EPAS1;HLF;LIN28B;E2F4;GLIS1;MBD3;ZCWPW1;SRF;CSRNP3;NPAS2;PAX9;ZBTB2;BCL6;ALX4;NR2C1;TERF1;CSRNP2;ZKSCAN3;PIF1;ERH;SOX2;OLIG2;BHLHE22;GLI3;ZBTB43;HOXC8;SOX10;MSX1;HOXB9;ZBTB26;RFX2;FOXJ2;SOX9;TFEB;HOXB4;DMRTA1;PRDM5;NFIX;HOXC4;ZFP1;RFX4;SREBF1;CUX2;MYRF;ARNT2;LONP1;ELK1;BPTF;CREB3L1;ZBTB32;HNRNPD;TFAP4;SAFB2;ATF2;FOXJ3;KLF11;HOXA9;MAFB;KDM2A;ZBTB7A;ONECUT2
prerank,calmodulin-dependent protein kinase activity (GO:0004683),-0.35368917712174286,-1.0997079084423802,0.30927835051546393,0.7314210142744675,1.0,11/24,27.64%,DAPK1;CAMK2D;CAMK2B;CAMK2G;EEF2K;PTK2B;MKNK1;CAMK1G;CAMKK1;PHKA2;PHKG2
prerank,NADPH binding (GO:0070402),0.4632834411498747,1.0995870251964843,0.35335689045936397,0.9048140719745842,1.0,4/13,8.28%,GRHPR;MTRR;DUS2;KCNAB1
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.4929200530712958,1.0989969283262897,0.3575418994413408,0.9010381438626239,1.0,2/11,9.94%,HCN2;HCN1
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),0.4454797256775335,1.098283403803101,0.3333333333333333,0.8922176711262256,1.0,6/16,10.69%,PTPRT;PTPRR;PTPRN2;PTPRU;PTPRO;PTPRA
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),0.4454797256775335,1.098283403803101,0.3333333333333333,0.8922176711262256,1.0,6/16,10.69%,PTPRT;PTPRR;PTPRN2;PTPRU;PTPRO;PTPRA
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.44289337843227655,-1.0980355186332578,0.3723150357995227,0.7231603234479933,1.0,6/11,30.00%,HSPH1;BAG3;HSPBP1;BAG2;SIL1;BAG4
prerank,adenyl nucleotide binding (GO:0030554),-0.44289337843227655,-1.0980355186332578,0.3723150357995227,0.7231603234479933,1.0,6/11,30.00%,HSPH1;BAG3;HSPBP1;BAG2;SIL1;BAG4
prerank,signaling receptor complex adaptor activity (GO:0030159),-0.3204486164305041,-1.0977683832088505,0.3,0.7176997917722133,1.0,10/38,11.77%,SORBS1;SHANK3;MAGI2;MAPK8IP3;NCK1;SHANK1;SPAG9;FRS2;SH2B1;DLG5
prerank,androgen receptor binding (GO:0050681),-0.35902369286890545,-1.0975480499165342,0.29365079365079366,0.712141955176862,1.0,5/25,7.65%,FOXP1;DDX5;KDM4C;SMARCA4;TMF1
prerank,voltage-gated chloride channel activity (GO:0005247),-0.45733900220522805,-1.0973977275786968,0.3464052287581699,0.7065071963340703,1.0,3/10,8.51%,ANO6;ANO1;CLCN5
prerank,hormone activity (GO:0005179),0.36100178553741014,1.0973212671434767,0.32905982905982906,0.8898852231079194,1.0,7/54,11.19%,HCRT;EDN3;SPX;TRH;NPY;CCL25;ERFE
prerank,tubulin binding (GO:0015631),0.2887477828028795,1.0971986144781898,0.29653679653679654,0.8847288082611597,1.0,60/295,14.84%,DLEC1;ATF5;CCDC61;REEP2;MDM1;MAP4K4;GJA1;EFHC1;IRAG2;MTCL1;FMR1;CCT5;NEFH;LRRK2;CENPE;STARD9;CEP295;SUN2;CLIP3;LRPPRC;TTLL6;IFT81;UNC5C;SNPH;TERF1;HAUS8;FAM161A;GOLGA2;STMN2;NAV3;PHF6;OPA1;BRCA2;CCSAP;CAPN6;STMN4;ARL8B;IFT74;KATNA1;TBCE;FYN;NUSAP1;GAS8;AGBL4;RMDN1;DNM1;TUBGCP4;SYBU;POLB;KIF5C;CLIP2;KIF9;EML1;TPGS1;MAP9;STMN1;CLASP2;KIF3C;TUBGCP6;KIFC2
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.42252647432493207,-1.0971930721623113,0.3466981132075472,0.7013130639126972,1.0,7/13,11.86%,PDGFD;PTPRJ;IL1R1;VEGFD;PDGFA;PDGFC;ITGB3
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.45873446909090393,-1.097089021298472,0.3592233009708738,0.695843303299037,1.0,4/10,13.13%,PIK3C2B;PIK3CB;PIK3CD;ATM
prerank,Tat protein binding (GO:0030957),-0.4626856131907515,-1.0949107260114181,0.3477272727272727,0.6957448028094191,1.0,3/10,6.18%,ACTB;SMARCA4;GABARAPL1
prerank,receptor tyrosine kinase binding (GO:0030971),0.35231275896996755,1.0938923689160922,0.3223965763195435,0.8902878608558694,1.0,10/56,11.42%,PIK3R1;NRG1;CBLB;FLT3LG;GAB2;PIK3R2;IRS1;FIZ1;TP53;NRG3
prerank,CoA hydrolase activity (GO:0016289),-0.4000994451139294,-1.0938478214658454,0.3198090692124105,0.6928811323735822,1.0,5/16,15.36%,ACOT8;NUDT7;ACOT13;ACAA2;ACOT6
prerank,regulatory RNA binding (GO:0061980),0.3757141501451844,1.0918650740023588,0.3318840579710145,0.8914011559588456,1.0,9/38,11.21%,AGO4;SPOUT1;FMR1;DND1;ZC3H7B;ZNF346;HNRNPA2B1;SOX2;AGO3
prerank,snoRNA binding (GO:0030515),-0.33402602258281106,-1.0899011595868133,0.32085561497326204,0.6979442907914125,1.0,12/30,30.39%,PRKDC;DDX21;NUDT4;NUDT7;IMP3;NUFIP1;TSR1;NUDT16;NUDT16L1;NHP2;BMS1;RRP9
prerank,GTPase binding (GO:0051020),-0.2326245419756578,-1.0897413097149191,0.1640625,0.6929496164751409,1.0,44/195,14.30%,PLCE1;PICALM;ERC1;DOCK4;FGD5;CAV1;FNBP1L;AFDN;RNF152;RAPGEF6;BECN1;IQGAP1;EXOC4;RIN3;YBX3;NDRG1;UNC13B;RASIP1;EXOC5;SH3BP4;SRGAP2;ARHGDIB;RANGAP1;PPP6R1;RALBP1;RUSC2;EXOC2;SGSM2;RRAGC;OPTN;STK19;RNF41;MYO1C;MAPKAP1;TBC1D7;ALS2;GOLGA4;EVI5L;ENO1;CCDC186;FLNA;YBX1;LSM2;BICD2
prerank,zinc ion binding (GO:0008270),0.2840314452025191,1.0897299895809378,0.2959738846572361,0.8929353727212361,1.0,62/293,18.02%,ENPP1;ECE1;ZEB1;HRG;ADH1A;TIMM10;MYCBP2;PAM;HIF1AN;CBLB;PDXK;GRIN2B;EPRS1;DUSP12;MYT1;SLC30A5;DNAJC24;KMT2A;CHD4;ZFP37;DHX58;SIRT6;GRIN2A;ACR;TARS1;ENPP3;CALB1;MDM4;TRIM8;DPYS;BIRC2;NSD1;SLU7;SEC24B;PITRM1;PGGT1B;TP53;GLRA1;ZFPM2;P2RX4;USP33;PTGR2;KDM1B;TRIM2;HDAC10;RABIF;KDM5C;ZBTB32;TMEM163;ZKSCAN5;KDM2A;ZNF3;USP16;DPEP1;SEC24A;CALR;RNPEP;SEC23A;ADAM8;PEX12;SUV39H2;MBD1
prerank,mRNA binding (GO:0003729),0.2910687643905888,1.0883914400494579,0.2973893303064699,0.8915738375541151,1.0,58/249,18.68%,RBFOX1;EIF4G3;RBMS1;CPEB1;GNL3;TRA2B;EIF4A3;NANOS3;NOVA1;MYEF2;RBM46;RBM24;LSM14A;SNRNP35;RNF40;SF3B6;ZC3H12D;RBMS3;FMR1;DND1;LARP6;CCT5;BOLL;KHDRBS3;ELAVL4;PCBP3;HNRNPA2B1;CELF4;NUDT21;LUC7L2;TP53;RBFOX3;DHX36;EDC3;CSDC2;RBM20;HDLBP;EIF4ENIF1;RBM4B;SLBP;DHX9;RC3H2;SNRNP70;FYTTD1;HNRNPLL;SRRM2;IGF2BP3;RBM5;PPP1R8;THOC5;HNRNPL;SRRM3;CALR;SRSF6;DXO;LSM14B;KHDRBS1;YTHDF1
prerank,protein kinase binding (GO:0019901),-0.2155017586715938,-1.0880536937955292,0.06060606060606061,0.6915733278940042,1.0,100/479,14.67%,PRKAG2;EPHA4;MAP3K1;MAPK4;RHOBTB1;SLC12A7;IL31RA;CAV1;PDLIM5;PTPRJ;BCL2L1;ACTB;TRIB2;ITGB1;PTPRK;EZR;BMPR2;BECN1;ELAVL1;RICTOR;SIRPA;IQGAP1;NEK6;CSPG4;SQSTM1;CCND2;CAVIN2;ATG13;RHOBTB2;MAPK8IP3;SKI;APC;RAC1;NEDD9;DVL1;MAVS;ACE;CAV2;TFRC;ADAM10;SYN1;CDC42;RPS7;WNK1;TRIM5;ERRFI1;TJP2;PARN;RPS19;TRIM14;CALM1;SIK1;MVP;PFKFB2;GSK3B;ACVR1;RHOC;ACVRL1;GCH1;MAPT;SMAD3;ANK2;YWHAG;MAP2K7;AP2A1;EXOC2;FRMD5;BAD;EEF1A1;CAVIN3;PPM1D;PPEF2;ADCY6;PTPN2;SPAG9;PTPN1;KCNQ1;CCDC88A;MAPKAP1;HSPB1;CEACAM1;ACTA2;SPRED3;PLCG2;SMAD1;NR3C1;NOX4;PRKAG3;PRKAR2A;CYLD;TRPV4;IRAK4;GATA6;NBEAL2;HINT1;PRKAR2B;CCND1;GRB2;TICAM1;CDH5
prerank,protein phosphatase binding (GO:0019903),-0.25957323650627223,-1.0875072516287185,0.26291079812206575,0.6876650853521153,1.0,37/117,17.80%,FOXO1;EGFR;SIRPA;IQGAP1;SHOC2;MAP3K5;VRK3;FBXL2;PPP1R16A;MAPK14;AKAP11;MVP;PPP1R3B;MTMR9;SH3RF2;ITGA1;PPP6R1;VCP;PPP1R16B;MAPT;MAP2K7;CTTNBP2NL;BAD;PHACTR4;AP3B1;KCNQ1;CEACAM1;SMG5;FLT4;PPP1R3C;CDH5;TRAF3;MET;TBK1;SKAP1;ERBB2;PPP1R11
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.4898072268544423,1.0862249662603505,0.36429872495446264,0.8930247200862278,1.0,3/10,13.55%,CDKN2A;CDKN2D;CDKN2C
prerank,water transmembrane transporter activity (GO:0005372),-0.4434401359060583,-1.0828648777532162,0.4004282655246253,0.6946193766757663,1.0,8/11,55.32%,PDPN;AQP11;AQP1;SLC4A11;AQP9;AQP6;AQP7;SLC5A1
prerank,active ion transmembrane transporter activity (GO:0022853),-0.317315147525848,-1.082790709999001,0.2985507246376812,0.6894828260687668,1.0,11/37,21.21%,SLCO2A1;SLCO1C1;SLC22A4;SLC22A6;SLC22A8;COX15;COX5B;COX4I1;COX6B1;SLCO5A1;UQCRQ
prerank,adrenergic receptor binding (GO:0031690),-0.3958707559728205,-1.0813521927195382,0.3690773067331671,0.6880032213404758,1.0,4/16,3.34%,RAPGEF2;ARRDC3;GNAS;MAGI2
prerank,transcription cis-regulatory region binding (GO:0000976),0.28052191757540407,1.0790679334977202,0.2962962962962963,0.9102401041717397,1.0,63/406,15.74%,TBX18;RORA;GBX1;ZBTB20;ISL2;BHLHA9;TRPS1;MSC;ATF5;HOXC10;TEAD1;ETV5;HDAC1;TCF7L2;BASP1;ERBB4;THRA;NR1H4;PER3;REST;FOS;SOX6;FOXN2;ZFP37;EPAS1;CREB3L2;PRDX5;BCOR;ZBTB46;ALX4;PER2;TWIST1;SOX2;MXI1;GLI1;GLI3;ZBTB43;HOXC8;SOX10;TP53;NFXL1;DHX36;ZNF25;MSX1;SOX9;TWIST2;TFEB;PRDM5;CARM1;PEG3;SREBF1;CUX2;LONP1;ELK1;CREB3L1;FOXM1;TFAP4;PBX2;AR;ATF2;MYC;CRY2;KLF11
prerank,kinase activity (GO:0016301),0.3130463551700455,1.078261809798025,0.33883248730964466,0.9073611958828317,1.0,26/109,14.06%,PDXK;MAP4K4;PKMYT1;PRKD3;CDC7;CDKL5;SCYL3;PSTK;LRRK2;IPMK;NADK;COASY;PI4KA;DGKQ;PAPSS2;PINK1;PRKD1;MTOR;CKM;IRAK1;CHKA;GK;DGKI;AGK;IP6K1;LYN
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",-0.40121855010785096,-1.0774411553542174,0.35038363171355497,0.6931506656742829,1.0,3/16,19.42%,PIR;ETHE1;ALOX12
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",-0.443349444479317,-1.0766413629011864,0.33182844243792325,0.6898472636509542,1.0,10/11,55.70%,DDAH1;DDAH2;PADI2;ARG2;ARG1;PADI1;PADI4;AGMAT;PADI3;PADI6
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.27175048948490665,1.0743604993326552,0.27603640040444893,0.9145731234866409,1.0,147/831,17.29%,TBX18;RORA;GBX1;ZNF367;ZEB1;ZBTB20;BHLHA9;ZFHX3;TRPS1;MSC;ATF5;ETV1;PKNOX2;RUNX2;PPARA;HOXC10;MEIS1;TEAD1;ETV5;TEF;HDAC1;NR2F2;TCF7L2;TCF4;SALL1;THRA;SMAD5;NR1H4;ZFHX4;ZIC4;MEIS2;PGR;NFATC3;ZNF740;MYT1;POU3F3;PPARD;NR1H2;TEAD2;REST;TBX3;FOS;ZBTB24;SOX6;ZIC1;FOXO6;GTF2A1;HOXC9;ZNF423;ZBTB16;MYCN;DMRTA2;ZFP37;EPAS1;HLF;FOXS1;E2F4;ZBTB46;GLIS1;SRF;NPAS2;PAX9;ZBTB2;BCL6;ALX4;NR2C1;ZKSCAN3;TWIST1;CHD2;SOX2;MXI1;GLI1;OLIG2;WIZ;BHLHE22;NSD1;GLI3;ZBTB43;HOXC8;TBPL1;SOX10;TP53;NFXL1;DHX36;ZBTB39;ZNF25;MED8;MSX1;HOXB9;ZBTB26;RFX2;FOXJ2;ESR2;PROX2;SOX9;MYT1L;ZNF112;TWIST2;TFEB;HOXB4;ST18;HIVEP3;HIC2;DMRTA1;ZNF628;PRDM5;NRIP1;NFIX;HOXC4;ZFP1;RFX4;PEG3;SREBF1;CUX2;ARNT2;ELK1;BPTF;ZSCAN18;ZBTB32;MYNN;FOXM1;HOXC5;TFAP4;DHX9;PBX2;ZBTB25;AR;ATF2;MYC;FOXJ3;KLF11;HOXA9;MAFB;ZKSCAN5;ZBTB7A;ZNF467;ONECUT2;ZNF3;ZFP62;ZIC5;CIART;MAZ;NR1D2;ZBTB12;DNMT3A;SARS1;ZBTB11
prerank,mechanosensitive ion channel activity (GO:0008381),-0.44016397620834624,-1.073600922534899,0.38954869358669836,0.691927594908156,1.0,5/12,21.47%,PIEZO2;TMC7;TMC6;TMEM63B;PIEZO1
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.47799156381508495,1.07342917114405,0.4032258064516129,0.9120198009345413,1.0,2/11,15.27%,RDH11;AKR1B1
prerank,acid-thiol ligase activity (GO:0016878),0.46459474439168513,1.072273959287459,0.38070175438596493,0.910386078116043,1.0,1/13,1.09%,ACSS3
prerank,alkali metal ion binding (GO:0031420),0.45851239569895585,1.072154729179435,0.3902027027027027,0.9055410160173163,1.0,3/13,6.54%,ATP1A2;PDXK;CAPN3
prerank,symporter activity (GO:0015293),-0.4588250062766759,-1.0721487099896077,0.3764172335600907,0.6901554617140194,1.0,10/10,54.15%,MFSD2A;SLC5A6;SLC5A5;SLC4A4;SLC46A2;SLC28A2;SLC28A3;SLC5A8;SLC28A1;SLC5A12
prerank,methylation-dependent protein binding (GO:0140034),0.34029674650247643,1.0717897496559874,0.3442389758179232,0.9013920724595087,1.0,21/57,22.66%,KMT2E;L3MBTL1;PYGO1;FMR1;RRP8;CXXC1;ZCWPW1;SPIN1;WDR5;MORC4;MPHOSPH8;BPTF;CHD8;MBTD1;MSH6;THAP7;ING3;RBBP5;KDM5A;ATRX;ZMYND8
prerank,protein serine/threonine kinase activity (GO:0004674),-0.222421700747186,-1.0704198701730387,0.15789473684210525,0.6897529747458153,1.0,105/335,23.57%,DAPK1;MAP3K1;MAPK4;ROCK2;PRKCH;MARK1;EGFR;MYLK;BMPR2;IRAK2;CSNK1D;MARK4;NEK6;CAMK2D;SQSTM1;PRKDC;MAP3K5;TOP1;SIK3;MINK1;WNK4;VRK3;PRKAA2;TLK1;MAPK9;CDK6;SNRK;WNK1;HIPK3;MAPK14;NRBP2;SIK1;GSK3B;HIPK1;ACVR1;CDC42BPB;RIOK1;ACVRL1;TLK2;NEK7;STK38L;MAST3;DYRK2;RPS6KA5;CDK19;CAMK2B;STK19;MAP3K8;ATR;CDKL2;CAMK2G;RPS6KA1;RIOK3;FASTK;SRPK1;GAK;PRKCZ;HIPK2;ATM;CSNK1G3;IRAK4;BCR;PTK2B;MAP3K4;CPNE3;STK17B;CDC42BPG;ERN1;MARK3;PRKCD;PRKAA1;DYRK1B;TBK1;PAK2;PKN2;MAP3K10;ACVR2B;STK32B;CDK9;AKT1;CSNK2B;NUAK2;CSNK1A1;SBK1;VRK2;MARK2;MAP4K3;ULK3;MKNK1;ALPK1;PKN3;PIM2;TGFBR2;NEK10;CDKL4;TTBK1;PASK;STK39;IKBKE;ACVR2A;BRD2;CDK16;PLK4;IKBKB;PAK4
prerank,phosphatase binding (GO:0019902),-0.25739429726344887,-1.0683311945209413,0.2972972972972973,0.6898035262764696,1.0,35/105,18.81%,CTSC;EGFR;SIRPA;MAGI2;IQGAP1;CNST;SHOC2;MAP3K5;VRK3;WNK1;FBXL2;MAPK14;MVP;MTMR9;SH3RF2;ITGA1;PPP6R1;VCP;SMAD3;MAP2K7;BAD;PPP3R1;AP3B1;CEACAM1;FLT4;PPP1R3C;CDH5;TRAF3;MET;TBK1;SKAP1;ERBB2;DLG1;CHCHD3;SNX3
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.44041066554876385,1.0666810176081585,0.3961937716262976,0.9126204192058146,1.0,7/15,21.55%,KMT2A;CXXC1;WDR5;ASH2L;SETD4;KMT2C;RBBP5
prerank,alpha-tubulin binding (GO:0043014),0.38195863204755787,1.06596846443943,0.37597503900156004,0.9097275123525655,1.0,5/31,11.12%,DLEC1;EFHC1;ARL8B;TBCE;FYN
prerank,C-C chemokine binding (GO:0019957),0.39445204919194554,1.0650587429763767,0.36900958466453676,0.9074474334249438,1.0,2/22,3.26%,ACKR2;CCR9
prerank,voltage-gated calcium channel activity (GO:0005245),0.3617934729834952,1.0647444104920065,0.3502235469448584,0.9033869209365587,1.0,9/37,15.95%,CACNA1E;ITGAV;CACNG3;CACNA1G;CATSPER3;CACNB4;CACNG4;CACNA2D1;NCS1
prerank,intracellular chloride channel activity (GO:0061778),-0.38825577388637145,-1.0639308939029632,0.3588516746411483,0.6905286034785219,1.0,2/16,2.46%,ANO6;ANO1
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.38825577388637145,-1.0639308939029632,0.3588516746411483,0.6905286034785219,1.0,2/16,2.46%,ANO6;ANO1
prerank,phosphatase activator activity (GO:0019211),-0.3957203462967081,-1.0635784962380095,0.4052132701421801,0.6863819864932785,1.0,7/14,30.22%,CALM1;PHACTR4;FRS2;PPP2R5D;PPP2R5B;PPP2R5C;PPP1R15A
prerank,acyl-CoA hydrolase activity (GO:0047617),-0.37877871268472235,-1.0631656819755497,0.35990338164251207,0.6824622487183484,1.0,5/17,15.36%,ACOT8;PLA2G6;ACOT13;ACAA2;ACOT6
prerank,methylated histone binding (GO:0035064),0.3343320917021648,1.0628753074120907,0.35185185185185186,0.9043923164916738,1.0,22/62,22.66%,KMT2E;L3MBTL1;PYGO1;FMR1;RRP8;CXXC1;ZCWPW1;SPIN1;WDR5;MORC4;MPHOSPH8;DPF2;BPTF;CHD8;MBTD1;MSH6;THAP7;ING3;RBBP5;KDM5A;ATRX;ZMYND8
prerank,protein kinase regulator activity (GO:0019887),-0.2517460249649187,-1.0595640248297002,0.3348623853211009,0.686050659268173,1.0,31/95,21.10%,PRKAG2;CCNYL1;RPLP1;CCND2;GPRC5C;APC;WNK1;YWHAB;NCK1;CCNG1;MADD;CAB39;PRKAG3;PRKAR2A;PRKAR2B;CCND1;MAPK8IP1;CDKN1A;KIDINS220;CCNE2;CCNL2;CSNK2B;WNT11;GSKIP;MARK2;HEXIM1;RGCC;NPM1;DNAJC3;ELP3;DUSP19
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",-0.2673710853624318,-1.0584112917788995,0.302491103202847,0.6837961925343298,1.0,15/72,11.60%,PICALM;PLCB1;MARK1;ACTN2;SNX18;HIP1R;PARD3;GSN;SNX21;FZD7;VILL;KCNJ2;RAB35;KCNQ1;MAPKAP1
prerank,fibroblast growth factor binding (GO:0017134),0.4072844082480634,1.0571162304007737,0.3996815286624204,0.9172591825906559,1.0,3/21,3.03%,ITGAV;FGFBP3;FGFR1
prerank,mRNA 3'-UTR binding (GO:0003730),0.3168775801817707,1.0548561774538143,0.36535859269282817,0.9192516247154233,1.0,17/79,12.15%,RBMS1;CPEB1;RBM24;RNF40;RBMS3;FMR1;DND1;CCT5;BOLL;ELAVL4;ZFP36L2;HNRNPA2B1;NUDT21;TP53;DHX36;CSDC2;EXOSC9
prerank,GTPase activity (GO:0003924),-0.22906844236327628,-1.0547602331578747,0.26277372262773724,0.6881158706785713,1.0,55/192,19.48%,RHOBTB1;MRAS;KRAS;RRAS2;GNAS;GBP7;RASL12;RAP1A;DRG1;RAB23;RHOQ;RHOBTB2;RAC1;GBP5;CDC42;RAB21;ARHGDIB;GBP4;RAB5A;RHOC;RAB5C;DNM3;GBP2;GCH1;GPN1;RAB31;DRG2;EEF1A1;RRAGC;ARL2;RAB35;NKIRAS1;GBP6;RALB;RAN;RAB38;RRAS;GNL1;RAP2C;GNAZ;ATL3;GPN3;GNA14;ARL1;RAB1A;RAB6A;GTPBP1;RAP2B;GNG11;TSR1;RERG;GSPT2;RAB4A;RAB8B;RRAGB
prerank,calcium channel activity (GO:0005262),0.3124762063088065,1.0539798789153751,0.37367021276595747,0.9169287107471019,1.0,14/84,12.51%,SLC24A5;CACNA1E;ITGAV;CACNG3;RYR2;TRPV3;CATSPER3;TRPC3;CACNB4;CACNG4;P2RX4;TRPM2;TRPC7;CUL5
prerank,alpha-actinin binding (GO:0051393),-0.3414413208586331,-1.0524914661428415,0.3743169398907104,0.6893084699073041,1.0,14/24,38.65%,CACNA1C;PDLIM5;DAG1;PDLIM3;MAGI1;PKD2L1;TTN;PPARG;SYNPO2;PDLIM2;PDLIM1;NRAP;MYPN;KCNA5
prerank,potassium channel regulator activity (GO:0015459),0.34019161291970185,1.0524541687813627,0.40585774058577406,0.9167106441214314,1.0,10/49,15.57%,DPP6;DPP10;KCNIP1;KCNIP2;KCNAB1;KCNIP4;KCNE4;KCNAB3;WNK2;SGK1
prerank,endopeptidase inhibitor activity (GO:0004866),-0.2610937786079712,-1.0498875567947281,0.32456140350877194,0.6908819148506135,1.0,15/82,14.02%,SPOCK2;APP;CST3;COL4A3;PSMF1;SERPIND1;PTTG1;RENBP;NGF;SERPINE1;SERPINI1;SERPINA2;GAPDH;SERPINE2;FURIN
prerank,small GTPase binding (GO:0031267),-0.2312135921646909,-1.0493121562860557,0.3395061728395062,0.6876550742842391,1.0,38/170,14.30%,PLCE1;PICALM;ERC1;DOCK4;FGD5;CAV1;AFDN;RNF152;RAPGEF6;IQGAP1;EXOC4;RIN3;YBX3;NDRG1;UNC13B;EXOC5;SH3BP4;SRGAP2;ARHGDIB;RANGAP1;PPP6R1;RALBP1;RUSC2;EXOC2;SGSM2;OPTN;STK19;RNF41;MYO1C;MAPKAP1;TBC1D7;ALS2;GOLGA4;EVI5L;CCDC186;FLNA;LSM2;BICD2
prerank,poly(U) RNA binding (GO:0008266),0.4077514183301545,1.0483831695329198,0.39365079365079364,0.9244984333497549,1.0,3/20,5.01%,RBMS1;RBMS3;FMR1
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.4339418863307851,1.0482485744164636,0.4048865619546248,0.9198926559790227,1.0,4/16,15.03%,SLC1A5;SLC25A22;SLC25A30;SLC25A14
prerank,peptide N-acetyltransferase activity (GO:0034212),0.4836149224967079,1.0474791467266074,0.4194139194139194,0.9172781710076606,1.0,2/10,9.92%,NAA10;NAA50
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.39975650684657826,-1.0461713288694858,0.40792540792540793,0.6908076909884869,1.0,6/13,30.74%,AGPAT4;LCLAT1;PNPLA3;AGPAT2;AGPAT5;LPCAT2
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.28836690572937224,1.0452469318613307,0.36923076923076925,0.9188645494560732,1.0,27/173,15.40%,TBX18;ZEB1;ZBTB20;ZFHX3;TRPS1;PPARA;NFATC3;PPARD;REST;TBX3;ZBTB16;ZFP37;ZBTB2;BCL6;ZKSCAN3;MXI1;ZBTB39;ZNF25;ZBTB26;MYT1L;HIC2;PRDM5;PEG3;CREB3L1;ZBTB32;ZBTB25;MYC
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.40946980196039606,1.0441115986346396,0.423728813559322,0.917406099424062,1.0,6/17,15.02%,AK4;NME6;NOL9;AK8;NME1;AK3
prerank,chemokine binding (GO:0019956),0.3626427034380868,1.0439107452245444,0.39473684210526316,0.9132484865944153,1.0,4/30,8.42%,ITGAV;ACKR2;CCR9;PLP2
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.3789828078243676,-1.0433570093852047,0.400990099009901,0.6886447953452853,1.0,6/16,22.25%,ATP6V0A4;ATP5F1B;ATP6V0E2;ATP6V0A2;ATP6V0D2;ATP6V0A1
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.3789828078243676,-1.0433570093852047,0.400990099009901,0.6886447953452853,1.0,6/16,22.25%,ATP6V0A4;ATP5F1B;ATP6V0E2;ATP6V0A2;ATP6V0D2;ATP6V0A1
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.47289458655354843,1.0430921629438967,0.41114982578397213,0.9109945204583549,1.0,3/10,11.25%,FAN1;DAXX;FAAP20
prerank,retinoic acid binding (GO:0001972),-0.4153296076712931,-1.0419400508339935,0.4295942720763723,0.6872898252673452,1.0,2/12,6.39%,CYP26B1;RXRA
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.4177694184076126,-1.040716632753057,0.4,0.6858821520372964,1.0,5/12,8.58%,IGF1;GNAS;INSR;SOCS2;YWHAG
prerank,nucleoside-diphosphatase activity (GO:0017110),0.44801589742300363,1.0406974244718192,0.4172661870503597,0.9136144694301884,1.0,2/12,4.54%,ENTPD2;ENTPD5
prerank,C-C chemokine receptor activity (GO:0016493),0.3999185219004677,1.040594512282298,0.3899159663865546,0.909173975284296,1.0,2/21,3.26%,ACKR2;CCR9
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.4284701331365175,1.0389560726457139,0.4116666666666667,0.9093938355933233,1.0,4/16,6.30%,PTEN;SACM1L;MTMR4;MTMR1
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.47028135437806806,1.0379310276305236,0.42985611510791366,0.9078002874302353,1.0,3/10,10.51%,GABRA1;GABRG3;GABRG2
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.4312542631979918,1.0378227809037466,0.40932642487046633,0.9033988672785048,1.0,3/15,8.98%,PIK3R1;PIK3R2;CCKBR
prerank,calcium activated cation channel activity (GO:0005227),-0.3666296400105603,-1.036538994550311,0.4119047619047619,0.6915114982736098,1.0,2/17,2.46%,ANO6;ANO1
prerank,ephrin receptor activity (GO:0005003),0.43020789609663684,1.0359935888218057,0.44310344827586207,0.8994177393819086,1.0,5/17,10.40%,EPHA7;EPHB1;EPHA6;EPHB6;EPHA3
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.43020789609663684,1.0359935888218057,0.44310344827586207,0.8994177393819086,1.0,5/17,10.40%,EPHA7;EPHB1;EPHA6;EPHB6;EPHA3
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.32131321117266415,1.034628530531928,0.39919354838709675,0.898840801876301,1.0,12/73,16.06%,RXFP3;SORCS3;CALCRL;NPFFR1;GPR37L1;CRHR2;CCKBR;F2R;S1PR2;LGR5;LHCGR;GPR37
prerank,protein tyrosine phosphatase activity (GO:0004725),0.31331211576756807,1.031796117801022,0.3955119214586255,0.9023159957101654,1.0,15/71,11.70%,CDC14B;PTPRT;PTEN;PTPRR;PTPRN2;DUSP1;PTPN22;DUSP22;PALD1;PTPRU;PTPRO;PTPN13;TNS2;PTPRA;UBASH3B
prerank,RNA stem-loop binding (GO:0035613),0.4415204040169433,1.0314543787015704,0.4381443298969072,0.8988366261698778,1.0,5/12,15.33%,EPRS1;FMR1;LARP6;DHX9;RC3H2
prerank,protein phosphatase activator activity (GO:0072542),-0.38928562051613413,-1.0306401926167306,0.39902676399026765,0.7010067913631819,1.0,5/13,18.58%,IGFBP3;CALM1;PHACTR4;PPP2R5D;PPP2R5B
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.4396045643221295,1.0303659901492566,0.42810457516339867,0.8973131205410477,1.0,2/13,4.12%,FAN1;FEN1
prerank,N-acyltransferase activity (GO:0016410),0.3638571218561526,1.0298983977246348,0.4114114114114114,0.8941998700652263,1.0,8/32,16.38%,NAA10;NAT10;CERS4;TLCD3B;NAA50;NAT8L;CERS6;GNPNAT1
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.26073353188741727,1.0272475888805626,0.4094165813715456,0.8971572859412739,1.0,127/732,17.29%,TBX18;RORA;ZNF367;ZEB1;ZBTB20;ISL2;ZFHX3;MSC;ETV1;PKNOX2;RUNX2;PPARA;HOXC10;MEIS1;TEAD1;TEF;HDAC1;NR2F2;TCF7L2;TCF4;SALL1;THRA;SMAD5;NR1H4;ZFHX4;ZIC4;MEIS2;PGR;NFATC3;ZNF740;MYT1;POU3F3;PPARD;NR1H2;TEAD2;REST;TBX3;FOS;ZBTB24;SOX6;ZIC1;FOXO6;HOXC9;ZNF423;ZBTB16;FOXN2;MYCN;DMRTA2;HLF;FOXS1;E2F4;GLIS1;SRF;NPAS2;PAX9;ZBTB2;BCL6;NR2C1;ZKSCAN3;CHD2;SOX2;MXI1;GLI1;OLIG2;WIZ;BHLHE22;NSD1;GLI3;SOX10;TP53;DHX36;ZBTB39;MED8;HOXB9;ZBTB26;RFX2;FOXJ2;ESR2;PROX2;SOX9;MYT1L;ZNF112;TFEB;HOXB4;ST18;HIVEP3;HIC2;DMRTA1;ZNF628;PRDM5;NRIP1;NFIX;HOXC4;ZFP1;RFX4;SREBF1;ARNT2;ELK1;BPTF;ZSCAN18;ZBTB32;MYNN;HOXC5;TFAP4;DHX9;PBX2;ZBTB25;AR;ATF2;MYC;FOXJ3;KLF11;HOXA9;MAFB;ZKSCAN5;ZBTB7A;ZNF467;ONECUT2;ZFP62;ZIC5;CIART;MAZ;NR1D2;ZBTB12;DNMT3A;SARS1;ZBTB11
prerank,calcium-dependent phospholipid binding (GO:0005544),-0.28910738759384136,-1.0237973914446814,0.41914191419141916,0.7131497082111412,1.0,6/49,5.01%,ANXA3;ANXA5;MCTP1;SYT9;PLA2G4A;ANXA1
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.4453020586465045,1.0226610037702244,0.4381625441696113,0.9059106550895899,1.0,4/12,13.82%,GABRA1;GABRG3;GABRG2;GABRB1
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),-0.32206124454419915,-1.0196250759679457,0.3740053050397878,0.7188933736644737,1.0,9/27,22.04%,CRCP;POLR2B;POLR2G;PRIMPOL;POLR2C;POLR1H;POLRMT;POLR1C;POLR3K
prerank,flavin adenine dinucleotide binding (GO:0050660),-0.2760713094449392,-1.0172183872386185,0.4228187919463087,0.7203371871473799,1.0,17/53,17.98%,DDO;MICAL2;NOS3;PRODH;CYB5R3;XDH;ETFDH;NQO2;PPOX;MTHFR;NOS1;NOX4;CYB5R1;SDHA;MICAL3;AIFM1;NDOR1
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.3732835777192324,1.0165696102752355,0.4757433489827856,0.9194590035010114,1.0,7/25,13.62%,GAB2;FCHSD2;ADAP2;PLEKHA1;COMMD1;MYO1G;DAPP1
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.3587243356848214,1.015785208886468,0.4147465437788018,0.9171909539380632,1.0,11/33,20.81%,NCOA3;ERCC5;UVSSA;ELP4;ZNF326;DHX9;AR;AGO1;LLPH;CDC73;GTF2B
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.25799521348268,1.0153772493297308,0.4452405322415558,0.9139726328536336,1.0,128/731,17.29%,TBX18;RORA;ZNF367;ZEB1;ZBTB20;ZFHX3;MSC;ETV1;PKNOX2;RUNX2;PPARA;HOXC10;MEIS1;TEAD1;TEF;HDAC1;NR2F2;TCF7L2;TCF4;SALL1;THRA;SMAD5;NR1H4;ZFHX4;ZIC4;MEIS2;PGR;NFATC3;ZNF740;MYT1;POU3F3;PPARD;NR1H2;TEAD2;REST;TBX3;FOS;ZBTB24;SOX6;ZIC1;FOXO6;HOXC9;ZNF423;ZBTB16;MYCN;DMRTA2;HLF;CREB3L2;FOXS1;E2F4;GLIS1;SRF;NPAS2;PAX9;ZBTB2;BCL6;NR2C1;ZKSCAN3;TWIST1;CHD2;SOX2;MXI1;GLI1;OLIG2;WIZ;BHLHE22;NSD1;GLI3;SOX10;TP53;DHX36;ZBTB39;MED8;HOXB9;ZBTB26;RFX2;FOXJ2;ESR2;PROX2;SOX9;MYT1L;ZNF112;TFEB;HOXB4;ST18;HIVEP3;HIC2;DMRTA1;ZNF628;PRDM5;NRIP1;NFIX;HOXC4;ZFP1;RFX4;SREBF1;ARNT2;ELK1;BPTF;ZSCAN18;CREB3L1;ZBTB32;MYNN;HOXC5;TFAP4;DHX9;PBX2;ZBTB25;AR;ATF2;MYC;FOXJ3;KLF11;HOXA9;MAFB;ZKSCAN5;ZBTB7A;ZNF467;ONECUT2;ZFP62;ZIC5;CIART;MAZ;NR1D2;ZBTB12;DNMT3A;SARS1;ZBTB11
prerank,lipoprotein particle receptor binding (GO:0070325),0.3701502134081339,1.0152595303120164,0.43636363636363634,0.9098643312583812,1.0,7/27,18.61%,LRP1;HSPG2;RELN;HSP90B1;CLU;LDLRAP1;SYT1
prerank,DNA binding (GO:0003677),0.2577742626560253,1.0149938198046717,0.42350557244174264,0.9062214494222431,1.0,152/694,19.87%,RORA;C1D;ISL2;RBMS1;ATF5;ARID3A;PPARA;MEIS1;TEAD1;ETV5;NR2F2;TCF7L2;TCF4;POLG;TAF12;ERCC1;NR1H4;MBD6;ZIC4;MEIS2;TIPIN;PGR;MCM7;POU3F3;PPARD;NR1H2;FAN1;FEN1;POLQ;TBX3;SOX6;ERCC5;GTF2A1;ZNF423;ZBTB16;CHD4;MYCN;MSH3;RTF1;EPAS1;HLF;FOXS1;TLR8;E2F4;NEIL3;MBD3;ACR;POLA1;CSRNP3;HP1BP3;NPAS2;RPA1;LYAR;BCL6;ALX4;HMCES;NR2C1;ERCC4;TERF1;CSRNP2;ZKSCAN3;POLL;WBP11;SPTY2D1;CHD2;SOX2;GLI1;APLP2;XPC;SRRT;BRCA2;RFC3;CR2;SOX10;TP53;MCM4;SMARCA1;DHX36;TOP3A;ZNF292;GTF3C4;RFX2;ESR2;SOX9;CENPC;CDT1;POLG2;SPRTN;HIC2;RAD52;PRDM5;TSG101;MBD4;SREBF1;CUX2;MYRF;LONP1;MCM10;ERCC2;SSBP2;BPTF;ZBTB32;CHD8;TFAP4;DHX9;SAFB2;MLF1;AIFM2;RC3H2;MYC;CRY2;FOXJ3;WDR76;MAFB;ZBTB7A;ZNF3;ZCCHC3;RBM5;NHEJ1;CALR;TRIM26;DNMT3A;TOP2A;SAFB;MCMDC2;SMC1A;MSH6;MBD1;WRN;FBH1;HDGFL2;ILF3;SSBP1;REXO4;KHDRBS1;ATAD5;HIF1A;DEDD2;ZNF711;CARF;RBM6;CREBZF;ARNT;CBFB;GTF3C3;NR2C2;SP1;CNBP;HIVEP2;LRRFIP1;HOXB2;POLE
prerank,aspartic-type peptidase activity (GO:0070001),-0.42090470770040167,-1.014869234768281,0.4587737843551797,0.7217218382313028,1.0,1/10,2.50%,DDI2
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",-0.21880991706268352,-1.0145255348893536,0.41414141414141414,0.7179912230522498,1.0,55/254,17.73%,NFIB;MECOM;FOXO1;MEF2C;RBPJ;LEF1;ELK3;ERG;FOXC1;ELF1;MEF2A;KLF4;NFKB1;FOXC2;KLF7;RUNX1;MLXIP;ATF6;NFYC;PRDM2;SIX1;ELF4;SOX4;PLAG1;IRF2;SOX17;PLAGL1;SMAD3;PRDM16;IRF1;MYBL1;NR4A1;NR4A2;ETS1;CASZ1;MZF1;ZNF76;RLF;SMAD1;NR3C1;ZIC3;GTF2I;CDC5L;ZNF585A;ZNF585B;ELK4;NFYB;CREB1;NFKB2;CLOCK;ESR1;UBP1;CREB3;HHEX;SOX18
prerank,single-stranded telomeric DNA binding (GO:0043047),0.4465712191296987,1.0131939812902604,0.4506283662477558,0.9071977710097371,1.0,3/11,7.80%,RPA1;HNRNPA2B1;TERF1
prerank,RNA polymerase core enzyme binding (GO:0043175),0.3538602487120141,1.0103173005668034,0.44,0.9106867864645087,1.0,16/33,27.62%,NCOA3;ERCC5;SPTY2D1;UVSSA;ELP4;ZNF326;DHX9;AGO1;CDC73;GTF2B;MAF1;RRN3;RPRD2;ELP2;CTR9;WDR43
prerank,ubiquitin binding (GO:0043130),-0.251245504903104,-1.0089144540027994,0.4230769230769231,0.7271361112274008,1.0,25/73,22.98%,NPLOC4;DDI2;MARK4;SQSTM1;RNF185;ASCC2;TOLLIP;SMAD3;HSPB1;OTUB1;UBE2N;USP25;UCHL1;RAE1;UBE2L6;RAD23B;BUB3;TNFAIP3;FAF2;VPS28;MVB12B;ILRUN;WDR48;ADRM1;VPS36
prerank,chemorepellent activity (GO:0045499),0.371515807951518,1.0083346842014227,0.42995169082125606,0.9118836950440078,1.0,3/25,1.98%,EPHA7;NRG1;SEMA5A
prerank,cell adhesion mediator activity (GO:0098631),0.37838688623066696,1.006584062689295,0.4481658692185008,0.9124652019022995,1.0,8/24,10.71%,DSCAM;CNTN4;DSCAML1;JAM3;PALLD;NEXN;CNTN6;LRRC4C
prerank,5'-3' exonuclease activity (GO:0008409),0.42422531277700465,1.0049496364731692,0.4560530679933665,0.9128649351933615,1.0,5/14,23.44%,FAN1;FEN1;DXO;TRIR;DCP2
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.2567588594442326,1.0041101281643778,0.4660493827160494,0.9110965619804217,1.0,113/597,18.42%,TBX18;ZBTB20;ISL2;MSC;ATF5;ETV1;PKNOX2;RUNX2;HOXC10;TEAD1;ETV5;TEF;TCF7L2;TCF4;BASP1;ERBB4;THRA;SMAD5;ZIC4;PER3;MEIS2;MCM7;NFATC3;ZNF740;PPARD;TEAD2;REST;TBX3;FOS;SOX6;ZIC1;HOXC9;FOXN2;MYCN;DMRTA2;HLF;CREB3L2;LIN28B;BCOR;E2F4;GLIS1;POLA1;SRF;NPAS2;PAX9;ZBTB2;BCL6;ALX4;NR2C1;PER2;SOX2;GLI1;OLIG2;BHLHE22;GLI3;ZBTB43;HOXC8;SOX10;TP53;MCM4;DHX36;MSX1;HOXB9;ZBTB26;RFX2;FOXJ2;SOX9;CENPC;TFEB;HOXB4;DMRTA1;PRDM5;NFIX;CARM1;HOXC4;ZFP1;RFX4;MBD4;SREBF1;CUX2;ARNT2;MCM10;ELK1;TSPYL2;CREB3L1;ZBTB32;TFAP4;DHX9;AR;ATF2;CRY2;ORC2;FOXJ3;KLF11;HOXA9;ZBTB7A;ONECUT2;NONO;HNRNPL;ATMIN;ZIC5;NR1D2;ZBTB12;MBD2;ASH2L;ZNF32;MCMDC2;SUV39H2;KAT7;NFAT5;SKOR2;HEY1;BRD7
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.29400567782135056,1.0030363968339933,0.45157232704402517,0.9097880401646001,1.0,21/100,14.84%,ZFYVE28;OGT;GAB2;WDR45B;MYO10;GBF1;MYO1B;FCHSD2;ADAP2;CYTH3;COMMD1;ZFYVE26;ARAP2;GSDMD;MYO1G;PLEKHA5;ARFIP1;DAPP1;CLVS1;SNX12;FERMT2
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",-0.32468359193437,-1.001623859192969,0.4797843665768194,0.7407539782337981,1.0,4/25,4.46%,MICAL2;CYP26B1;NOS3;FMO2
prerank,RNA polymerase II complex binding (GO:0000993),0.3532204648307984,1.0014645555967214,0.4440944881889764,0.9099895447913655,1.0,10/32,20.81%,NCOA3;ERCC5;UVSSA;ELP4;ZNF326;DHX9;SCAF1;AGO1;CDC73;GTF2B
prerank,nuclear import signal receptor activity (GO:0061608),0.4177261417908927,1.0010122489960938,0.4648370497427101,0.9070740511733687,1.0,7/15,22.51%,TNPO1;KPNA1;TNPO2;IPO9;KPNB1;KPNA2;IPO4
prerank,purine ribonucleoside triphosphate binding (GO:0035639),-0.20037604028071176,-1.0000279039728655,0.5428571428571428,0.7401684742517914,1.0,129/431,23.33%,PRKAG2;DAPK1;RHOBTB1;MARK1;MRAS;KRAS;RRAS2;GBP7;MARK4;ABCD3;NEK6;RASL12;MAP3K5;RAP1A;INSR;DRG1;ABCD4;HSPA8;TOP1;RHOQ;RHOBTB2;SIK3;MINK1;WNK4;RAC1;TLK1;CDK6;SYN1;GBP5;SNRK;PEX1;CDC42;WNK1;PRAG1;ARL6;RAB21;SIK1;PGK1;ADSS2;ACVR1;ABCC6;GBP4;RAB5A;CDC42BPB;RHOC;ACVRL1;GBP2;GCH1;RAB31;TLK2;STK38L;ABCF1;DYRK2;DRG2;RPS6KA5;EEF1A1;RRAGC;RAB13;TAP2;ABCF2;SMARCA5;ARL2;RAB35;REM1;GBP6;RALB;RTEL1;SRPK1;SYN3;TGM2;CLPX;PSMA6;MYH10;GUK1;PMVK;RAN;RAB38;PFKL;RRAS;GNL1;P2RX7;TBCK;RAP2C;STK17B;ABCB8;CDC42BPG;ERN1;ATL3;NOA1;ARL1;TUBB2A;RAB6A;ATP5F1D;AKT1;RAP2B;NUAK2;TSR1;RERG;DYNC1LI1;MARK2;MCM6;MAP4K3;CLP1;RAB4A;RRAGB;MLKL;TRNT1;MKNK1;MFHAS1;ARL4C;TUBA1C;ABCB9;RAB1B;SCG5;RHOH;TWF2;TUBA4A;TUBB2B;AK6;MTG2;MYO18A;LANCL2;NDUFA13;DDX25;CAD;RAB9A;MYH9;RAP1B;PRPS2
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.32472589400898033,-0.9992322895705446,0.44472361809045224,0.7376014511402235,1.0,8/24,22.43%,OSBPL8;PLA2G4A;CERT1;GOLPH3L;JPH2;SNX3;PLA2G4E;LANCL2
prerank,tRNA binding (GO:0000049),0.33087080364557003,0.9982059297613625,0.45875542691751087,0.9107801359327495,1.0,20/43,27.23%,NAT10;CTU1;ELP1;PSTK;CARS1;TRNAU1AP;PTCD1;SARS2;SARS1;SEPSECS;MRPS27;TRMT10A;AIMP1;AARS1;TRMT10C;SSB;NSUN6;YARS2;IGHMBP2;ALKBH8
prerank,poly-pyrimidine tract binding (GO:0008187),0.3782454866524028,0.9980223674583297,0.4365079365079365,0.9071753442183884,1.0,3/23,5.01%,RBMS1;RBMS3;FMR1
prerank,potassium ion leak channel activity (GO:0022841),0.420052140503053,0.9978792690283196,0.44368600682593856,0.9034194888673585,1.0,4/15,15.93%,KCNK2;TMEM175;KCNK1;KCNK13
prerank,DNA replication origin binding (GO:0003688),0.3774731294641004,0.9958827137349578,0.462992125984252,0.9047127669415871,1.0,9/23,20.91%,MCM7;POLA1;MCM4;MCM10;DHX9;ORC2;MCMDC2;KAT7;ORC5
prerank,amyloid-beta binding (GO:0001540),0.3013583834494722,0.9951267272991716,0.448871181938911,0.9026240952373366,1.0,12/79,7.19%,LRP1;HSPG2;GRIA3;GRIN2B;GRIA4;GRIA1;NGFR;TLR6;SORL1;ATP1A3;GRIN2A;C1QA
prerank,lysine N-methyltransferase activity (GO:0016278),0.38769344681470536,0.9950980857674174,0.46353322528363045,0.8986153167034368,1.0,7/20,23.36%,EEF1AKMT4;VCPKMT;SETD4;EHMT2;ATPSCKMT;EHMT1;ANTKMT
prerank,growth factor receptor binding (GO:0070851),-0.23675205366027907,-0.9942508074842774,0.48444444444444446,0.7450206520085606,1.0,22/95,18.62%,PDGFD;PTPRJ;FER;IL1R1;ERAP1;VEGFD;VEGFC;IL6ST;PDGFA;FGF1;PDGFC;FRS2;CCDC88A;ITGB3;TRIP6;HIP1;GRB2;ERN1;ESM1;EGF;SDCBP;EFEMP1
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.34621661307222684,0.9914489806708318,0.4723926380368098,0.9046887439546917,1.0,3/32,4.87%,SLC1A5;SLC43A1;SLC7A8
prerank,double-stranded DNA binding (GO:0003690),0.25367328113361176,0.9910917951803717,0.510351966873706,0.9016608057668555,1.0,91/531,18.37%,TBX18;ZBTB20;ISL2;RBMS1;MSC;ETV1;PKNOX2;RUNX2;HOXC10;TEAD1;ETV5;TEF;TCF4;SMAD5;ZIC4;MEIS2;NFATC3;ZNF740;PPARD;FEN1;TEAD2;TBX3;FOS;ZIC1;ERCC5;HOXC9;FOXN2;MYCN;MSH3;DMRTA2;HLF;LIN28B;E2F4;GLIS1;NEIL3;SRF;NPAS2;PAX9;ZBTB2;BCL6;ALX4;NR2C1;TERF1;OLIG2;BHLHE22;GLI3;ZBTB43;HOXC8;SOX10;MSX1;HOXB9;ZBTB26;RFX2;FOXJ2;SOX9;POLG2;SPRTN;TFEB;HOXB4;DMRTA1;NFIX;HOXC4;ZFP1;RFX4;SREBF1;CUX2;ARNT2;ELK1;CREB3L1;ZBTB32;TFAP4;DHX9;ATF2;FOXJ3;KLF11;HOXA9;ZBTB7A;ONECUT2;ZCCHC3;ZIC5;NR1D2;ZBTB12;SAFB;ZNF32;MSH6;MBD1;NFAT5;FBH1;SKOR2;HDGFL2;HEY1
prerank,syntaxin-1 binding (GO:0017075),0.3782641148012758,0.9874464049396614,0.47516556291390727,0.9075178820012406,1.0,9/22,18.61%,VAMP2;LRRK2;SNPH;SYP;SYNPR;UNC13A;STXBP5;UNC13C;SYT1
prerank,syntaxin binding (GO:0019905),0.31035357930339674,0.9859868983595235,0.47191011235955055,0.9075711514783247,1.0,24/61,23.47%,VAMP2;LRRK2;NAPB;SNAP23;SNPH;SYT3;SYP;GOLGA2;SNAP29;SYNPR;SCFD1;SYT5;UNC13A;VPS52;STXBP5;TMED9;UNC13C;SYT6;SYT1;NAPG;CACNA1A;ABL1;BLOC1S6;STXBP4
prerank,microtubule minus-end binding (GO:0051011),-0.38314269668225,-0.9846792497377772,0.4894117647058824,0.7641753718382115,1.0,5/13,19.65%,CEP290;TUBGCP5;MACF1;CAMSAP2;NUMA1
prerank,carboxy-lyase activity (GO:0016831),0.37397666692344145,0.9840928366633959,0.4904153354632588,0.90892899412418,1.0,3/23,9.38%,ODC1;UXS1;GGCX
prerank,ribosome binding (GO:0043022),0.3278930584081842,0.9839814158921742,0.4706766917293233,0.9052416061371774,1.0,18/46,27.73%,CPEB1;NAA10;FMR1;SEC61B;EIF2S1;BAG6;EFL1;EIF3C;YTHDF1;MRPS27;NAA16;GEMIN5;CCDC47;ETF1;SHFL;SEC61A1;IGHMBP2;MAIP1
prerank,nuclear receptor coactivator activity (GO:0030374),0.3192199487984699,0.9838589790366706,0.49857142857142855,0.901577908980808,1.0,11/52,14.22%,NCOA2;MED12;NCOA3;ACTN1;BRD8;NCOA1;PRKCB;ENY2;CARM1;MED1;ELK1
prerank,bHLH transcription factor binding (GO:0043425),-0.34858879893581624,-0.9814182440690737,0.4641975308641975,0.7674319463553184,1.0,8/19,25.65%,LMO2;PSMD9;SMAD3;SIRT1;MAP3K10;BHLHE40;BHLHE41;KDM1A
prerank,receptor antagonist activity (GO:0048019),0.39985355214959645,0.9812275794484536,0.4813614262560778,0.9046323378282043,1.0,1/17,0.62%,IL1RN
prerank,SH2 domain binding (GO:0042169),0.3492055674574348,0.9742508009880936,0.48589341692789967,0.9196681618962923,1.0,5/31,7.70%,DLC1;PAG1;IRS1;RUFY1;PTK2
prerank,potassium ion antiporter activity (GO:0022821),0.39956516069097103,0.974181152849007,0.49238578680203043,0.9158987986519308,1.0,3/15,6.00%,SLC24A5;SLC9A9;SLC9A1
prerank,chloride channel activity (GO:0005254),0.3081430002986535,0.9729264187507497,0.49445983379501385,0.9154373026211683,1.0,14/59,15.70%,ANO4;GABRA1;GABRD;CLCC1;GABRG3;CLCN3;CLCN2;GLRA3;GABRG2;GLRA1;CLCN6;GLRA2;GABRB1;GLRB
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.2672542154683165,0.9725600044859729,0.54292343387471,0.9124719861818044,1.0,44/181,20.70%,PPARA;PTPRT;MIER2;HDAC1;HIF1AN;TCF7L2;CDKN2A;NR1H4;NCOA2;JUP;PPARD;TBX3;FOS;NCOA3;MDFIC;CHD4;BRMS1;FIZ1;PIAS2;NCOA1;TP53;ZFPM2;SNW1;ATN1;NRIP1;MED1;ARNT2;ELK1;DHX9;DMAP1;AR;ATF2;TRIP4;LDB2;LDB1;BBS1;HIF1A;ARNT;SP1;DDRGK1;MTA3;MTA1;RERE;BBS4
prerank,solute:sodium symporter activity (GO:0015370),-0.3174375578857864,-0.9720642319838959,0.5041782729805014,0.7866386060693171,1.0,22/27,56.38%,SLC4A10;SLC20A1;SLC4A8;SLC4A7;SLC5A6;SLC4A9;SLC4A5;SLC4A4;SLC34A3;SLC5A3;SLC28A2;SLC13A5;SLC28A3;SLC5A10;SLC5A8;SLC17A7;SLC28A1;SLC5A1;SLC34A2;SLC5A2;SLC5A9;SLC17A1
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.3281440876611839,-0.9711864546010149,0.5148514851485149,0.784272625564475,1.0,5/20,20.68%,LPGAT1;AGPAT4;LCLAT1;PNPLA3;AGPAT2
prerank,transition metal ion binding (GO:0046914),0.2488555129732969,0.9711086402127508,0.5661764705882353,0.9124369479940523,1.0,79/397,18.07%,ENPP1;ECE1;ZEB1;HRG;ADH1A;TIMM10;MYCBP2;PAM;HIF1AN;CBLB;PDXK;GRIN2B;EPRS1;TYR;DUSP12;MYT1;FEN1;LOXL3;LOXL2;SLC30A5;DNAJC24;KMT2A;CHD4;ZFP37;DHX58;SIRT6;GRIN2A;CCS;ACR;TARS1;ENPP3;CALB1;ADCY2;MDM4;TRIM8;DPYS;COMMD1;BIRC2;AGMO;NSD1;SLU7;SEC24B;PITRM1;PGGT1B;TP53;GLRA1;ZFPM2;P2RX4;USP33;ENDOU;PTGR2;HEPH;KDM1B;TRIM2;HDAC10;B4GALT7;PIM1;ATP7A;RABIF;KDM5C;ZBTB32;TMEM163;AOX1;ZKSCAN5;KDM2A;ZNF3;CYP2R1;USP16;DPEP1;SEC24A;CALR;RNPEP;GALNT2;SEC23A;ADAM8;PEX12;SUV39H2;MBD1;WRN
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.38758913991151256,0.9675001871312454,0.5025906735751295,0.9179035729830333,1.0,3/18,8.98%,PIK3R1;PIK3R2;CCKBR
prerank,epidermal growth factor receptor binding (GO:0005154),-0.3071464824017719,-0.9673569696026662,0.4973544973544973,0.7892627912605279,1.0,11/25,28.29%,FER;CCDC88A;HIP1;GRB2;EGF;EFEMP1;LINGO1;CNOT9;FAM83B;ARF4;SNX2
prerank,nuclear receptor binding (GO:0016922),0.28051309885157716,0.966333155220555,0.5241116751269036,0.9173362143712753,1.0,28/111,17.04%,PPID;TCF7L2;NR1H4;NCOA2;GRIP1;DNAAF4;MED12;JUP;NCOA3;BRD8;NCOA1;PRKCB;DAXX;NSD1;HMGN3;SNW1;CNOT1;NRIP1;MED1;MED25;ASXL1;GTF2H1;PRMT2;DCAF1;MMS19;ZBTB7A;TRIP4;CALR
prerank,phosphoric ester hydrolase activity (GO:0042578),0.31601363725372567,0.9646561308626431,0.5050505050505051,0.9178332431457303,1.0,8/49,7.72%,ATP1A2;SACM1L;DUSP12;PTPN22;PLCXD3;PLCXD1;PTPRO;ENPP6
prerank,phosphatase activity (GO:0016791),0.2967346450783063,0.963349630942314,0.5251700680272109,0.9174795430973001,1.0,13/73,15.59%,LPIN3;ATP1A2;SACM1L;DUSP12;PTPN22;PLPPR3;PTPRO;PLPPR2;PLPP6;DUSP8;PLPP5;LPIN2;ACP2
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.38632280315400913,0.9618468260756207,0.5026362038664324,0.9172846071824802,1.0,5/17,18.06%,BLVRB;DHCR24;PTGR2;PECR;DPYD
prerank,translation initiation factor activity (GO:0003743),0.33043977730418883,0.9595384190280369,0.530827067669173,0.9196339279058655,1.0,8/36,18.71%,EIF4G3;EIF3H;EIF2B1;EIF4A2;EIF2S1;EIF5B;EIF3C;EIF3G
prerank,endopeptidase activity (GO:0004175),0.25478733425368544,0.9548348933704696,0.5948945615982242,0.9278683746794276,1.0,51/257,19.87%,ECE1;ECE2;ADAMTS14;MASP1;ADAMTS6;MBTPS2;FAP;MMP28;MMP24;MMP25;PCSK2;HTRA3;USP1;CASP6;ADAM19;CASP4;OMA1;ACR;ADAMTS12;PSMA5;USP42;MMP11;PSMB5;PLAU;LGMN;ADAMTS2;RHBDL3;NRDC;PITRM1;PSMA4;USP33;HTRA2;SPRTN;PSMB9;ADAMTS20;ADAMTS10;USP34;PSMA7;ADAMTS19;USP16;USP13;USP49;PSMA2;USP14;EEF1AKMT4-ECE2;RHBDD1;TASP1;CTSK;USP46;PLAT;PRTN3
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.3983658945304267,0.9530215934655875,0.5251677852348994,0.9286277726873032,1.0,3/14,6.30%,PTEN;MTMR4;MTMR1
prerank,mannosyltransferase activity (GO:0000030),-0.3199221077892811,-0.9510701395749108,0.5438144329896907,0.8254281257547841,1.0,5/21,10.16%,TMTC2;TMTC1;ALG9;TMTC4;ALG12
prerank,protein tyrosine kinase activator activity (GO:0030296),0.3752150655495229,0.9499249251555134,0.5170178282009724,0.9326196025093624,1.0,4/19,11.42%,NRG1;DGKQ;GRM5;NRG3
prerank,endoribonuclease activity (GO:0004521),-0.29082842760372396,-0.9498398320393896,0.5101449275362319,0.8238546807403401,1.0,10/32,22.60%,KHNYN;SMG6;NYNRIN;DICER1;RNASEL;ENDOV;ERN1;AGO2;LACTB2;YBEY
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.34432495953118214,0.9498021385604717,0.5273010920436817,0.9292120771393666,1.0,6/28,17.67%,EDA;TRAF4;TRIM37;RIPK1;FEM1B;MYD88
prerank,estrogen receptor binding (GO:0030331),0.33609210744343526,0.9483309405586086,0.5254777070063694,0.929286260571032,1.0,12/32,18.17%,PPID;DNAAF4;NCOA1;NSD1;CNOT1;NRIP1;MED1;PRMT2;DCAF1;MMS19;TRIP4;TAF10
prerank,ion channel inhibitor activity (GO:0008200),-0.2754913966685514,-0.9480019137965143,0.5611285266457681,0.8237844407187994,1.0,7/35,9.43%,CAMK2D;WNK4;WNK1;STX1A;CALM1;MCUB;STX7
prerank,histone methyltransferase activity (GO:0042054),-0.2857177904247671,-0.9478919531855176,0.5121951219512195,0.8192554968060268,1.0,6/32,10.67%,SMYD3;KMT5B;NTMT1;PRMT7;SMYD2;PRMT8
prerank,microtubule binding (GO:0008017),0.2556562237194324,0.9470859428063803,0.5975197294250282,0.9286842328912783,1.0,54/222,19.14%,CCDC61;REEP2;MDM1;MAP4K4;IRAG2;MTCL1;FMR1;NEFH;LRRK2;CENPE;STARD9;CEP295;SUN2;CLIP3;LRPPRC;SNPH;TERF1;HAUS8;FAM161A;GOLGA2;NAV3;OPA1;CCSAP;CAPN6;KATNA1;NUSAP1;GAS8;RMDN1;DNM1;TUBGCP4;SYBU;POLB;KIF5C;CLIP2;KIF9;EML1;TPGS1;MAP9;CLASP2;STIM1;KIF3C;TUBGCP6;KIFC2;KIF2A;CLASP1;CEP44;CDK5;ALMS1;MAST1;KIF21A;SPEF1;PEX14;KIF13B;SVBP
prerank,muscle alpha-actinin binding (GO:0051371),-0.3534273069333819,-0.9454288638965637,0.508235294117647,0.8206926235530405,1.0,9/15,37.65%,PDLIM5;PDLIM3;PKD2L1;TTN;SYNPO2;PDLIM2;PDLIM1;NRAP;MYPN
prerank,histone deacetylase activity (GO:0004407),0.3682365929473364,0.9449954096681659,0.5203252032520326,0.9302488272711249,1.0,3/19,5.74%,MIER2;HDAC1;SIRT6
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.38927857650545605,0.9434302655563932,0.5467741935483871,0.9305413761527748,1.0,2/15,5.02%,ALDH1A1;ALDH3B1
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.4138499834388698,0.9429049411217801,0.5133689839572193,0.9280962235414799,1.0,5/11,22.76%,SLC35B3;LRRC8A;SLC25A17;SLC19A1;SLC25A24
prerank,vitamin D receptor binding (GO:0042809),0.40566611907320693,0.9428636740967543,0.5390070921985816,0.9244820836240749,1.0,5/14,20.83%,MED12;SNW1;MED1;TAF11;MED14
prerank,ATPase binding (GO:0051117),-0.23986711049779308,-0.9396981432483317,0.5787401574803149,0.8305557579829153,1.0,24/71,23.67%,CAV1;EGFR;EZR;PTPN3;ATP6V0A4;RDX;SNTA1;ATP1B3;TMTC4;ANK2;RALB;PEX26;USP25;ESR1;CHMP4A;NUFIP1;ATP6V0A2;CLPP;SELENOS;TOR1AIP1;ATP6V0A1;ATP6V1G1;PLN;DNAJB1
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.29886578745993886,0.938659631319755,0.5401662049861495,0.9313746981878703,1.0,8/55,12.51%,SLC24A5;ITPR1;RYR2;ATP2A2;TRPV3;TRPC3;TRPM2;CUL5
prerank,calcium-activated potassium channel activity (GO:0015269),0.4086702830807499,0.9385603163136206,0.5109612141652614,0.927969455399843,1.0,2/11,12.29%,KCNMA1;KCNN2
prerank,galactosyltransferase activity (GO:0008378),0.40976813180730176,0.9383584200883396,0.533213644524237,0.9248439288105477,1.0,5/11,13.63%,B4GALT2;A3GALT2;B4GALT3;B4GALT4;B4GALT7
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.32860275025879915,0.9382788163462743,0.5488721804511278,0.9214343778896711,1.0,12/34,23.36%,EEF1AKMT4;KMT2E;VCPKMT;DOT1L;N6AMT1;SETD4;EHMT2;ATPSCKMT;MEN1;CAMKMT;EHMT1;ANTKMT
prerank,omega peptidase activity (GO:0008242),0.28059056763818835,0.9382040207440777,0.5577427821522309,0.9181113101643928,1.0,31/89,25.20%,GGT5;STAMBPL1;GGT7;USP1;UCHL3;USP42;USP33;JOSD1;USP19;ATXN3;YOD1;USP34;USP4;USP21;USP16;USP13;STAMBP;PSMD14;USP49;USP14;USP46;USP45;USP48;USP31;UFD1;USP24;USP22;OTUD7A;JOSD2;USP2;USP36
prerank,amino acid transmembrane transporter activity (GO:0015171),0.30749726338531846,0.9367648196317417,0.577683615819209,0.9181021899057811,1.0,6/47,7.31%,SLC1A5;SLC6A13;SLC7A11;SLC43A1;SLC7A8;SLC66A1
prerank,carboxylic ester hydrolase activity (GO:0052689),-0.23300828310524038,-0.9365278083749848,0.5951417004048583,0.8336919388794016,1.0,26/85,24.52%,PLA2G4A;MGLL;PON3;NDST3;GDPD3;PAFAH2;LIPA;LIPE;ENPP2;ABHD2;PLA2G6;TARS2;PAFAH1B2;PTRH2;PLAAT3;DDHD2;ESD;PLA2G4E;PNPLA3;PLA2G4C;MRPL58;LYPLA1;FAAH;GDPD1;AOAH;PGLS
prerank,histone deacetylase binding (GO:0042826),0.28012662576261843,0.9360870012730447,0.5851755526657998,0.9161300758997796,1.0,24/88,20.99%,MIER2;HDAC1;TOP2B;CHD4;BCOR;GMNN;BRMS1L;BRMS1;PHF6;KAT2A;GLI3;NUDT21;TP53;DHX36;ZMYND15;HDAC10;TFAP4;TOP2A;THAP7;NACC1;SP1;MTA3;MTA1;MEF2B
prerank,double-stranded RNA binding (GO:0003725),0.28442705560751275,0.9355572127554045,0.5825105782792666,0.9138731383876738,1.0,26/70,22.26%,AGO4;ADARB2;FMR1;DHX58;ZNF346;ACTN1;TLR8;DUS2;MRPL44;DHX30;STAU2;EIF2AK2;DHX36;AGO3;DHX9;RC3H2;ADAR;PRKRIP1;AGO1;ILF3;FXR1;LRRFIP1;EIF4A1;DHX15;DHX33;EIF4B
prerank,phospholipase activity (GO:0004620),0.2859255098340266,0.9348117644931602,0.5568022440392707,0.9120319543665888,1.0,10/67,12.04%,PLCL1;GPLD1;PRDX6;LIPH;LIPC;SMPD4;PNPLA7;ABHD16A;LYPLA2;ABHD12
prerank,phosphotyrosine residue binding (GO:0001784),0.32229161228237957,0.9328150517757697,0.5596465390279823,0.9133803301054289,1.0,11/37,20.63%,PIK3R1;PIK3R2;IRS1;FGR;CRK;LDLRAP1;PIK3R3;SH3BP2;PTPN11;BCAR3;NCK2
prerank,protein phosphorylated amino acid binding (GO:0045309),0.31565516145366584,0.9307596665432745,0.5770925110132159,0.9149234892150555,1.0,16/42,25.27%,PIK3R1;PIK3R2;NEDD4;IRS1;FGR;CRK;LDLRAP1;PIK3R3;SH3BP2;PTPN11;BCAR3;NCK2;ABL1;VAV2;YWHAE;CRKL
prerank,nucleoside-triphosphatase activity (GO:0017111),-0.1974108849250602,-0.930229480607115,0.71,0.8447571998721155,1.0,67/248,19.48%,RHOBTB1;MRAS;KRAS;RRAS2;GNAS;GBP7;MYL6;RASL12;RAP1A;DRG1;RAB23;RHOQ;RHOBTB2;RAC1;GBP5;CDC42;ATP2B1;RAB21;ARHGDIB;ABCA3;VCP;GBP4;RAB5A;RHOC;RAB5C;DNM3;GBP2;GCH1;GPN1;RAB31;DRG2;EEF1A1;RRAGC;ARL2;RAB35;NKIRAS1;MYO1E;GBP6;RALB;CLPX;RAN;RAB38;RRAS;GNL1;SMCHD1;TOR1A;RAP2C;GNAZ;ATL3;GPN3;CHD3;GNA14;ARL1;RAB1A;RAB6A;DYNC1I1;GTPBP1;KIF1C;RAP2B;ABCB10;GNG11;TSR1;RERG;GSPT2;RAB4A;RAB8B;RRAGB
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.3682064587316657,-0.9300076396737372,0.5278450363196125,0.8405209797231542,1.0,5/12,15.24%,PIK3C2B;PIK3CB;PIK3CD;ATM;PIK3R6
prerank,low-density lipoprotein particle receptor binding (GO:0050750),-0.3137197997015749,-0.9284323810194323,0.5972972972972973,0.8395088190960145,1.0,5/22,13.08%,PICALM;MESD;APOE;AP2A1;SNX17
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.4040996891546881,0.927862129334288,0.5674255691768827,0.9179832641363315,1.0,4/11,12.28%,CASP6;CASP4;PYCARD;CASP12
prerank,MHC class I protein binding (GO:0042288),-0.3587893100626909,-0.9273313827841227,0.5560538116591929,0.8376259109974505,1.0,3/13,10.50%,ATP5F1B;TAPBP;TAP2
prerank,acetylcholine receptor activity (GO:0015464),0.3447893688762417,0.923313602251542,0.5522875816993464,0.9256965764220116,1.0,1/22,2.20%,CHRNB4
prerank,cyclic nucleotide binding (GO:0030551),0.3561459103647707,0.9224093526640804,0.5515548281505729,0.924276342157729,1.0,5/21,14.26%,RAPGEF4;PDE4B;CNBD2;HCN1;PDE4A
prerank,ubiquitin-dependent protein binding (GO:0140036),0.4168342272203122,0.9172748905798338,0.5384615384615384,0.933235508841268,1.0,5/10,25.27%,FAN1;FAAP20;ANKRD13B;IDE;DNAJC2
prerank,protease binding (GO:0002020),0.27104104656100286,0.9168741994459726,0.6140127388535032,0.930816835186635,1.0,22/99,17.51%,SLC2A13;NTRK2;PTEN;ITGAV;POLG;ITGA3;FAP;BFAR;NOL3;COL1A2;PINK1;BRCA2;TP53;PYCARD;ATP9A;STIM1;BAG6;SERPINC1;TRIP4;DVL3;COL3A1;A2M
prerank,chemokine receptor activity (GO:0004950),0.3423132378921133,0.9164317336330507,0.5564648117839607,0.9284734196239581,1.0,2/24,3.26%,ACKR2;CCR9
prerank,sterol transfer activity (GO:0120015),0.3732092851709959,0.9154643590471101,0.5774193548387097,0.9272565297556805,1.0,4/17,19.35%,GRAMD1B;MTTP;OSBP;NPC2
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.38177287731838644,0.915150886763914,0.5620805369127517,0.9245597907628339,1.0,1/15,1.30%,PLA2G2C
prerank,transferrin receptor binding (GO:1990459),0.41031665508240156,0.9147676939443935,0.5902527075812274,0.9220740531341489,1.0,2/10,12.93%,RGMA;CD81
prerank,metalloexopeptidase activity (GO:0008235),-0.24898876079776322,-0.9122292652364391,0.6020408163265306,0.8704827153532986,1.0,6/51,5.43%,AEBP1;CPE;CPD;XPNPEP3;ERAP1;ACE
prerank,exopeptidase activity (GO:0008238),0.30117089721342527,0.9120750482836354,0.5814285714285714,0.9248445097713105,1.0,7/50,6.96%,DPP6;FAP;DPP10;METAP1D;BLMH;DPEP3;CPM
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.24802573712861123,0.9084043237807939,0.6619883040935672,0.9299282980980572,1.0,33/188,16.89%,TBX18;ZBTB20;ATF5;ETV5;TCF7L2;BASP1;ERBB4;THRA;PER3;REST;FOS;SOX6;CREB3L2;BCOR;PER2;SOX2;GLI1;SOX10;TP53;DHX36;TFEB;PRDM5;CARM1;ELK1;CREB3L1;TFAP4;DHX9;AR;CRY2;KLF11;NONO;HNRNPL;ATMIN
prerank,mitogen-activated protein kinase binding (GO:0051019),-0.28196291587863886,-0.908395561312966,0.6246575342465753,0.8749623417943568,1.0,5/29,9.87%,PTPRJ;ACE;MAPK14;GCH1;PPM1D
prerank,phospholipase A2 activity (GO:0004623),0.334040134447238,0.9074134713937806,0.5775316455696202,0.9289068250899281,1.0,3/26,8.18%,PLA2G2C;PRDX6;PLA2G7
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.38406712517346164,0.9070507612399331,0.5653710247349824,0.9264448514418656,1.0,4/14,18.55%,KCNIP2;KCNE4;KCNJ8;KCNJ3
prerank,G protein-coupled receptor binding (GO:0001664),0.2576157143694876,0.906835344637608,0.630407911001236,0.9235556839738753,1.0,15/132,11.54%,XCL1;NPB;RTP4;WNT5A;REEP2;PTCH2;PDYN;TUB;CALCA;NPY;GNA11;WNT3;CCL25;USP33;PSMC5
prerank,sodium:proton antiporter activity (GO:0015385),-0.3647339755034482,-0.9054913736186231,0.5925925925925926,0.8767022661310959,1.0,2/11,3.16%,SLC9A2;SLC9B2
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.3633225754167115,-0.905363596055541,0.5704387990762124,0.8722613176645088,1.0,5/12,26.31%,AGO2;DCPS;NCBP2;CYFIP2;NCBP3
prerank,metalloaminopeptidase activity (GO:0070006),-0.32682019826650643,-0.9045325462765641,0.5853658536585366,0.869555826133516,1.0,4/16,20.36%,XPNPEP3;ERAP1;MMP15;TRHDE
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.36450262324688754,-0.9032890316792792,0.5895196506550219,0.8679060289272476,1.0,3/12,8.83%,PARN;PAN3;CNOT8
prerank,motor activity (GO:0003774),0.28626743712200237,0.9022630922304941,0.6225352112676056,0.9304102497141982,1.0,20/60,23.59%,GPR88;CENPE;STARD9;MYO6;KIF5C;KIF9;KIF3C;KIFC2;KIF2A;KIF21A;KIF13B;KIF6;SMC3;KIF3A;KIF7;KIF11;KIF1B;KIF15;KIF14;KIF23
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.3819356362391463,-0.9020424221777307,0.5648148148148148,0.8661248472719975,1.0,1/10,0.82%,CACNA1C
prerank,channel activity (GO:0015267),0.3123501702312387,0.9009924310120397,0.6242603550295858,0.9298814395839847,1.0,3/41,6.18%,TRPA1;SLC14A1;TRPV3
prerank,nucleosomal DNA binding (GO:0031492),0.345829835677646,0.9008157292213428,0.6,0.9269352941876009,1.0,4/21,11.15%,HDAC1;CHD4;MBD3;RCC1
prerank,5'-3' RNA polymerase activity (GO:0034062),-0.28481486064153,-0.9006952984465467,0.6021220159151194,0.8647050081838925,1.0,9/27,22.04%,CRCP;POLR2B;TERT;POLR2G;POLR2C;POLR1H;POLRMT;POLR1C;POLR3K
prerank,E-box binding (GO:0070888),0.31557627945905364,0.9006188693474337,0.5828313253012049,0.9240272520051447,1.0,6/34,16.99%,ZEB1;TCF4;TWIST1;TFAP4;MYC;CIART
prerank,exoribonuclease activity (GO:0004532),0.40253885847528265,0.9006007707693663,0.6010928961748634,0.9207812918284515,1.0,5/12,15.88%,EXOSC9;EXOSC10;CNOT7;EXOSC8;EXOSC5
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),-0.29858187740329645,-0.8993329000812005,0.6297229219143576,0.8630676180429508,1.0,10/22,24.53%,SQSTM1;PARP10;OPTN;RNF169;TAB2;TNFAIP3;IKBKE;ZRANB3;IKBKG;ATRIP
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.2664645324085577,-0.8984023421558559,0.6448598130841121,0.860600878898929,1.0,7/34,12.86%,RICTOR;IQGAP1;CALM1;CAB39;MAP2K2;ALS2;ETAA1
prerank,anion channel activity (GO:0005253),0.2866114829408978,0.8967321510397585,0.6176066024759285,0.9260784406647603,1.0,13/61,13.84%,VDAC2;ANO4;GABRA1;GABRD;CLCC1;GABRG3;CLCN3;GLRA3;GABRG2;GLRA1;GLRA2;GABRB1;LRRC8A
prerank,adenyl ribonucleotide binding (GO:0032559),0.23622340714521325,0.8962056529674312,0.7214912280701754,0.9239636382430376,1.0,52/291,14.93%,ENPP1;RAPGEF4;ATP1A2;PEAK1;ABCD2;EIF4A3;PDE4B;PDXK;P2RY1;MAP4K4;MYO1B;CDKL5;ATP1A3;PRKCI;CNBD2;MTHFD1L;CARS1;TARS1;RHOBTB3;MYO6;CDC42BPA;PRKACB;PIF1;PINK1;PFKM;ABCB6;HCN1;GCK;NOL9;PRPS1L1;PRPS1;PTPA;DHX36;P2RX4;HSPA13;TGFBR1;MTREX;PDK2;ACLY;KCNJ8;MAP4K1;LONP1;PIM1;ATP7A;NME1;WNK2;PDE4A;HSPA5;SYN2;HSPA4;CHD8;DHX9
prerank,cholesterol transfer activity (GO:0120020),0.36915936653102704,0.8960833681973155,0.5983739837398374,0.9209615514946667,1.0,1/16,1.24%,GRAMD1B
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.3977608977298205,0.8956508897074773,0.5692041522491349,0.9187211833323728,1.0,3/11,11.67%,ITPR1;TRPC3;TRPC7
prerank,metallocarboxypeptidase activity (GO:0004181),-0.2930745818345677,-0.8950719561687066,0.6395663956639567,0.8637131406126877,1.0,3/26,3.07%,AEBP1;CPE;CPD
prerank,organic anion transmembrane transporter activity (GO:0008514),0.2544409995995902,0.8928450418071476,0.6584158415841584,0.9214151510196394,1.0,9/134,4.87%,SLC1A3;SLC1A5;SLC6A13;SLC6A8;SLC16A12;SLC25A21;SLC35B3;GJA1;SLC7A8
prerank,cation channel activity (GO:0005261),0.2632562790696131,0.8920823958513892,0.6534526854219949,0.9199343776709343,1.0,14/94,12.51%,TRPA1;SLC24A5;CACNA1E;NALCN;RYR2;TRPV3;KCNG1;TRPC3;TMEM38B;TMEM175;HCN1;TRPM2;KCNK1;CUL5
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.39984597946862716,0.8914361144009862,0.5800344234079173,0.9180706781489529,1.0,4/11,15.19%,PRMT3;NDUFAF7;CARM1;PRMT2
prerank,MAP-kinase scaffold activity (GO:0005078),0.3998317486303375,0.890349560526043,0.626057529610829,0.9173421577715904,1.0,1/11,0.33%,SH3RF1
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.3959608268507752,0.8903394583718006,0.5923344947735192,0.9142096337063448,1.0,5/12,21.60%,CDK8;CDK13;CCNK;MAPK1;CDK7
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.34335758459216353,-0.8879863843538941,0.6348837209302326,0.8752826228890715,1.0,7/13,23.01%,PIK3C2B;PIK3CB;PIK3CD;PIP4K2C;PIP5K1A;PIP5K1B;PIK3C2A
prerank,sulfuric ester hydrolase activity (GO:0008484),0.38420568430855634,0.8868865533689763,0.5907473309608541,0.9185943468644873,1.0,4/12,19.65%,SULF1;GNS;ARSK;ARSJ
prerank,myosin II binding (GO:0045159),-0.37353937591864234,-0.8859852559129965,0.5952380952380952,0.8753411532382261,1.0,4/10,16.17%,SHROOM4;GSN;SHROOM1;LLGL2
prerank,mRNA 5'-UTR binding (GO:0048027),0.3303386374293171,0.8858543189217573,0.6153846153846154,0.917700600836199,1.0,4/24,5.48%,GNL3;FMR1;LARP6;CCT5
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),-0.2614613367690893,-0.8855643217198101,0.6666666666666666,0.8718338258116625,1.0,11/38,23.10%,APP;SERPIND1;SERPINE1;SERPINI1;SERPINA2;SERPINE2;FURIN;SPINT2;AGT;SERPINB8;TFPI
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.3955286544615043,0.8846354150993034,0.6203866432337434,0.9172420009128943,1.0,3/11,17.46%,NEIL3;HMCES;APEX2
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),-0.2725647154212488,-0.8838623892784304,0.6647887323943662,0.8711286679516135,1.0,7/32,9.18%,KDM4A;KDM4C;TET3;EGLN3;RIOX2;PHF8;ALKBH5
prerank,iron ion binding (GO:0005506),0.2874097847966957,0.8831945644510669,0.6438746438746439,0.9172663492678346,1.0,11/48,18.49%,HIF1AN;DNAJC24;EGLN2;FXN;AGMO;HEPH;FTO;ALKBH3;AOX1;CYP2R1;ALOX5
prerank,histone acetyltransferase binding (GO:0035035),0.33597608001594637,0.8830624332988107,0.6182108626198083,0.9144667693943126,1.0,9/21,23.87%,EPAS1;GLI3;KANSL1;TP53;ZBTB7A;TRIP4;HIF1A;TRIM68;STAT1
prerank,NAD binding (GO:0051287),0.3230925989826452,0.8815462254459933,0.6134585289514867,0.9145359625368444,1.0,5/26,9.56%,ALDH1A1;GRHPR;SIRT6;UXS1;HSD17B8
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.28405178322896457,0.8809621681114982,0.6480218281036835,0.9127143512235546,1.0,10/54,13.60%,MIER2;HDAC1;NIT1;SIRT6;ASPA;ACR;ACY1;AGA;PIGL;HDAC10
prerank,methyl-CpG binding (GO:0008327),0.335063817198486,0.8774072911830036,0.6148867313915858,0.9171656608902233,1.0,6/22,19.18%,MBD3;ZCWPW1;ERH;MBD2;MBD1;CHTOP
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.36763492464447756,0.8765963658081425,0.6252189141856392,0.9157422344014946,1.0,2/14,4.16%,RSAD1;SDHB
prerank,WW domain binding (GO:0050699),0.32177009711243226,0.8755461370128204,0.6256,0.914875319588359,1.0,4/26,10.46%,TRAF4;WBP11;TCEAL5;NDFIP2
prerank,MAP kinase kinase activity (GO:0004708),-0.3287671007688197,-0.8749426625425936,0.6454767726161369,0.8859678962198341,1.0,5/15,15.15%,MAP2K4;MAPK14;MAP2K7;MAP2K2;MAP2K5
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.27024307163439926,0.874718463776591,0.6797297297297298,0.9135613716616855,1.0,9/75,9.56%,ADH1A;RDH10;RDH11;MDH1;H6PD;GRHPR;KCNAB1;PRXL2B;HSD17B8
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.34160004754866946,-0.874033980816902,0.6503496503496503,0.8834288734173013,1.0,2/12,3.16%,SLC9A2;SLC9B2
prerank,cardiolipin binding (GO:1901612),0.38991412863281383,0.8735368663296454,0.6395147313691508,0.9129075923852163,1.0,3/10,19.67%,OPA1;GSDMD;GSDME
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.2574285165603062,0.8724028753395141,0.6837387964148528,0.9121599194974417,1.0,22/91,17.76%,SVIL;STXBP6;WDR45B;GBF1;MYO1B;GRAMD2A;SLC9A1;ADAP2;COMMD1;SYT7;GSDMD;EXOC1;MYO1G;PLEKHA5;SDCBP2;CLVS1;AMER2;TIRAP;LDLRAP1;FCHO2;SYTL2;WIPI2
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.3188567585410146,-0.872339541271567,0.6153846153846154,0.8825131372709666,1.0,6/15,30.74%,AGPAT4;LCLAT1;PNPLA3;AGPAT2;AGPAT5;LPCAT2
prerank,histone acetyltransferase activity (GO:0004402),0.3100095180818342,0.8720387485311871,0.6224648985959438,0.909803826106636,1.0,12/30,24.32%,NCOA3;BRCA2;KAT2A;NAA50;EPC1;ATF2;KAT7;TAF10;MCM3AP;CREBBP;SRCAP;USP22
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.3497269143484172,-0.8715337481111848,0.6410835214446953,0.8799417783168174,1.0,2/11,9.81%,LEF1;GATA2
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.3895756438680408,0.8705484759065778,0.6172413793103448,0.9100120973654177,1.0,2/11,9.92%,NAA10;NAA50
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.3866296635144453,0.8682130484268907,0.6290322580645161,0.9117371360839691,1.0,3/11,18.55%,KCNE4;KCNJ8;KCNJ3
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.3597969789688584,0.8671597349192,0.6470588235294118,0.9109748354873458,1.0,4/14,14.15%,AK4;NME6;AK8;NME1
prerank,I-SMAD binding (GO:0070411),-0.33022005904837737,-0.8660764258803174,0.6397228637413395,0.8873460227323802,1.0,7/13,26.16%,SMAD6;SMAD3;SMAD1;TGFB1I1;SMAD7;SMURF1;SMAD4
prerank,pseudouridine synthase activity (GO:0009982),-0.32800472787461443,-0.8656553871297727,0.6141176470588235,0.8837360716183492,1.0,7/13,34.72%,PUS10;PUS1;PUS7L;RPUSD1;PUSL1;RPUSD2;RPUSD3
prerank,single-stranded RNA binding (GO:0003727),0.29199130675471274,0.8652687490302812,0.6425196850393701,0.9118691177619612,1.0,14/43,19.77%,AGO4;ADARB2;FMR1;DHX58;TLR8;AGO3;LONP1;DHX9;EXOSC10;SRA1;AGO1;ILF3;FXR1;CNBP
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.26178496003217205,0.864049836354058,0.6697860962566845,0.9113535982354086,1.0,14/74,12.14%,PDXK;ADK;IPMK;NADK;COASY;PI4KA;DGKQ;PAPSS2;CHKA;GK;NOL9;FGGY;DGKI;AGK
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.29041998667848024,0.8640335904182465,0.6685962373371924,0.9084572598716487,1.0,12/42,22.78%,CDKN2A;CCNJ;CDKN2D;CCNB2;CDKN2C;CCNA2;CCNK;CCNE1;CDK5R1;CCND3;CCNT2;CCNQ
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),-0.2551212252306785,-0.8623994058057813,0.6847826086956522,0.8861754610968942,1.0,15/33,26.85%,RNF185;ARIH1;TOLLIP;RNF125;RNF144B;UBE3D;SIAH3;SIAH2;DCUN1D3;ANKIB1;RNF5;RNF19A;FOXL2;PARK7;DCUN1D1
prerank,ubiquitin protein ligase activity (GO:0061630),-0.18727915741294945,-0.8608102300305077,0.9365079365079365,0.8849730449642037,1.0,41/228,13.77%,WWP1;RNF152;XIAP;MGRN1;ASB2;RNF43;RNF185;KCMF1;PELI1;WWP2;ARIH1;UBE2D3;TRIM24;HLTF;TRIP12;TRIM25;CDC42;TRIM5;TRIM11;VPS18;TRIM14;SH3RF2;RNF8;MSL2;SMURF2;UBR1;RC3H1;RNF125;RNF11;RNF144B;RNF41;NEURL2;RNF114;UBR2;RCHY1;HERC2;VPS11;TRIM63;UBE3D;RING1;AMFR
prerank,Notch binding (GO:0005112),-0.2764583289232561,-0.8589063481550276,0.710455764075067,0.8845234626719941,1.0,4/22,11.60%,SNED1;CCN3;DNER;GALNT11
prerank,protein kinase C binding (GO:0005080),-0.24311847772017123,-0.8582781343195466,0.7084639498432602,0.8815681430788996,1.0,14/43,21.46%,PDLIM5;SQSTM1;CAVIN2;YWHAG;CAVIN3;ADCY6;CCDC88A;HSPB1;TRPV4;HINT1;DACT2;PKP2;ADAM9;TWF2
prerank,deubiquitinase activity (GO:0101005),0.2570615317940515,0.8578199687582335,0.7171581769436998,0.9175329370223976,1.0,32/88,25.20%,STAMBPL1;EIF3H;USP1;UCHL3;USP42;MINDY4;USP33;JOSD1;USP19;ATXN3;YOD1;USP34;USP4;USP21;USP16;USP13;STAMBP;PSMD14;USP49;USP14;USP46;USP45;MINDY2;USP48;USP31;UFD1;USP24;USP22;OTUD7A;JOSD2;USP2;USP36
prerank,neuropeptide binding (GO:0042923),0.34781256779019976,0.8574445365497886,0.6328257191201354,0.9153398803271344,1.0,2/18,16.06%,SORL1;GPR37
prerank,Hsp70 protein binding (GO:0030544),0.304351148579619,0.8571619177935025,0.6600609756097561,0.9129829237925964,1.0,8/31,18.22%,PPID;DNAJB12;DNAJC10;GPR37;TSC1;DNAJB14;DNAJC8;SACS
prerank,metal ion:proton antiporter activity (GO:0051139),-0.32478296162503406,-0.8556660883128254,0.660377358490566,0.8822375915998207,1.0,2/13,3.16%,SLC9A2;SLC9B2
prerank,ATP binding (GO:0005524),0.2265787269501229,0.8552929196405854,0.7761852260198456,0.9139760756437659,1.0,79/266,24.36%,ENPP1;ATP1A2;PEAK1;ABCD2;EIF4A3;PDXK;P2RY1;MAP4K4;MYO1B;CDKL5;ATP1A3;PRKCI;MTHFD1L;CARS1;TARS1;RHOBTB3;CDC42BPA;PRKACB;PIF1;PINK1;PFKM;ABCB6;GCK;NOL9;PRPS1L1;PRPS1;PTPA;DHX36;P2RX4;HSPA13;TGFBR1;MTREX;PDK2;ACLY;KCNJ8;MAP4K1;LONP1;PIM1;ATP7A;NME1;WNK2;HSPA5;SYN2;HSPA4;CHD8;DHX9;BRSK2;HARS1;SARS2;MAST1;MSH6;NVL;PEX6;STK26;KSR1;ABCA2;PDK3;PPIP5K1;TRIP13;LATS2;PXK;HSPA9;PI4K2A;BMPR1B;MYO9B;BCKDK;BMPR1A;NLK;ABL1;TDG;BTK;MVK;KIF14;AARS1;DAPK3;UBA2;MAP4K5;PIP4K2B;MTHFS
prerank,RNA methyltransferase activity (GO:0008173),-0.2922175157873977,-0.8532266876671758,0.6917098445595855,0.8829626849863111,1.0,8/19,29.31%,TRMT9B;FTSJ1;TRDMT1;TRMT5;MEPCE;MRM2;TRMT12;TGS1
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.30586363585144694,0.8528866729093209,0.6403785488958991,0.915986829913495,1.0,5/29,15.03%,SLC1A5;SLC25A21;SLC25A22;SLC25A30;SLC25A14
prerank,carboxypeptidase activity (GO:0004180),-0.2561778530722312,-0.8526864222158997,0.7138888888888889,0.8796918248713936,1.0,9/35,19.43%,AEBP1;CPE;CPD;MINDY1;SCPEP1;AGBL1;CTSZ;ACE2;VASH1
prerank,cysteine-type endopeptidase activity (GO:0004197),0.2588479215062262,0.8520166879126128,0.6993377483443709,0.9147558512243247,1.0,21/78,19.75%,CAPN5;USP1;CASP6;CASP4;CAPN3;USP42;LGMN;CAPN6;PYCARD;USP33;CASP12;USP34;CAPN15;USP16;USP13;USP49;CAPN10;USP14;CAPN2;CTSK;USP46
prerank,antiporter activity (GO:0015297),0.3360535475100093,0.8478172260592491,0.6563517915309446,0.9201248338619314,1.0,8/20,22.00%,ATP1A3;CLCN3;SLC25A30;SLC35E1;SLC25A14;SLC35E3;SLC25A16;SLC35A1
prerank,ubiquitin-like protein ligase activity (GO:0061659),-0.1836810913741579,-0.8448370702939373,0.9495798319327731,0.8910646570835636,1.0,41/232,13.77%,WWP1;RNF152;XIAP;MGRN1;ASB2;RNF43;RNF185;KCMF1;PELI1;WWP2;ARIH1;UBE2D3;TRIM24;HLTF;TRIP12;TRIM25;CDC42;TRIM5;TRIM11;VPS18;TRIM14;SH3RF2;RNF8;MSL2;SMURF2;UBR1;RC3H1;RNF125;RNF11;RNF144B;RNF41;NEURL2;RNF114;UBR2;RCHY1;HERC2;VPS11;TRIM63;UBE3D;RING1;AMFR
prerank,protein phosphatase regulator activity (GO:0019888),0.27305568052879303,0.844550631520865,0.701280227596017,0.9236580340030012,1.0,23/53,27.24%,PTN;BOD1;PPP6R2;PPP2R2A;PPP2R3A;EIF2AK2;PTPA;RCAN3;ANKLE2;PPP6R3;RCAN1;PPP4R2;B3GAT3;PPP2R2D;BOD1L1;PPP2R1B;PPP2R5A;STYXL1;CALM2;IGBP1;PPME1;SAG;PPP2R2B
prerank,acylglycerol lipase activity (GO:0047372),-0.34947655695046503,-0.8440097751582313,0.678646934460888,0.8884243768714497,1.0,3/11,9.86%,MGLL;LIPE;ABHD2
prerank,protein heterodimerization activity (GO:0046982),0.23385794569822074,0.8424208824889435,0.7926689576174112,0.9248370253627346,1.0,40/178,19.24%,BHLHA9;TENM3;ATP1A2;TCF4;ITGA3;PIK3R2;TOP2B;TENM4;GTF2A1;FMR1;TLR6;EPAS1;ADCY8;TENM2;QTRT2;TENM1;TLR4;CYBA;IRAK1;SAE1;TP53;KATNA1;RCC1;BCL2L2;IL12A;SDCBP2;ARNT2;BAK1;HEXA;ZHX3;MTTP;GABBR2;RRAGA;ADRA2A;TOP2A;SMC1A;RRAGD;HIF1A;ARNT;FXR1
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.3290791103102485,-0.8399250545388177,0.6973365617433414,0.8920170697584308,1.0,5/13,18.07%,FTSJ1;TRMT5;THUMPD2;TRMT11;TRMT10B
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),-0.26258643959250394,-0.8394281729908255,0.7207207207207207,0.8889169840703397,1.0,11/30,26.61%,XIAP;CST3;PTTG1;RPS6KA1;TNFAIP8;PRDX3;CAST;BIRC3;MT3;CD27;RPS6KA3
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.2620722817022943,0.8362364181365471,0.7237960339943342,0.9339941938469177,1.0,8/60,12.08%,CDC14B;PTEN;DUSP1;LRRK2;PPP6C;PPP3CB;PDP1;LRRC39
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.3226723674022623,-0.8355111799289616,0.6861313868613139,0.8920910181105411,1.0,5/13,13.96%,EZR;GSK3B;KCNQ1;PRKAR2A;PRKAR2B
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.29531242547540015,0.8351662454278568,0.6812688821752266,0.9329417225705856,1.0,7/35,14.06%,PEAK1;TXK;PTK2;FGR;FYN;MELK;LYN
prerank,cysteine-type peptidase activity (GO:0008234),0.2560343693996243,0.8349876335335856,0.7333333333333333,0.9304319763488559,1.0,19/73,19.75%,ATG4A;USP1;CASP6;BLMH;CASP4;CAPN3;OTULINL;USP42;LGMN;USP33;USP34;USP21;USP16;USP13;USP49;USP14;CAPN2;CTSK;USP46
prerank,phosphate ion binding (GO:0042301),-0.34806168677872407,-0.8342409123685921,0.6813186813186813,0.8902818373490023,1.0,5/10,37.21%,ADSS2;PNP;RELA;CHST14;MTHFD2
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.3312533565774095,0.8337266490937856,0.662771285475793,0.929940880476836,1.0,5/18,18.57%,ALDH1A1;ALDH3B1;AKR1B1;ALDH9A1;ALDH3A2
prerank,serine-type peptidase activity (GO:0008236),0.24767454486016316,0.8310184490643383,0.7819843342036553,0.9323120051269244,1.0,9/96,12.25%,MASP1;FAP;PCSK2;HTRA3;ACR;PLAU;RHBDL3;HTRA2;ENDOU
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.29755521328945744,-0.8300278395596674,0.681265206812652,0.8940479524256839,1.0,11/16,36.99%,CD38;OARD1;SARM1;MACROD1;NEIL1;ADPRH;NTHL1;SMUG1;RPS3;NEIL2;BST1
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.27233392862076017,0.8279211837758028,0.7167630057803468,0.9351618694770718,1.0,16/44,21.55%,KMT2E;KMT2A;CXXC1;SETD5;WDR5;NSD1;SMYD5;DOT1L;N6AMT1;ASH2L;SUV39H2;SETD4;EHMT2;MEN1;KMT2C;RBBP5
prerank,sodium channel regulator activity (GO:0017080),0.28136762363956624,0.8256401697089082,0.7041420118343196,0.936636760724189,1.0,8/37,15.57%,GPLD1;SCN2B;NEDD4;COMMD1;FXYD4;FGF12;FGF14;SGK1
prerank,potassium:proton antiporter activity (GO:0015386),0.36965017220148355,0.8246941755346087,0.6466431095406361,0.9354986039584134,1.0,2/10,6.00%,SLC9A9;SLC9A1
prerank,heme binding (GO:0020037),0.2561092045787006,0.8243570145012128,0.7428958051420839,0.9332258841303228,1.0,5/65,4.27%,SLC48A1;HRG;PGRMC2;RSAD1;PTGES2
prerank,cytochrome-c oxidase activity (GO:0004129),-0.3044944269798324,-0.8242115444413007,0.7057356608478803,0.9008405351056864,1.0,4/15,18.81%,COX15;COX5B;COX4I1;COX6B1
prerank,methyltransferase activity (GO:0008168),0.2716588682509754,0.8226988660524678,0.7051282051282052,0.9333713765147986,1.0,8/46,15.53%,EEF1AKMT4;PRMT3;RRP8;COQ3;GAMT;NDUFAF7;AMT;N6AMT1
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.3516279439705538,0.8223948992139734,0.6660899653979239,0.9312060915538545,1.0,5/12,22.76%,SLC35B3;LRRC8A;SLC25A17;SLC19A1;SLC25A24
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.2712711182429867,-0.8200958340249029,0.7308707124010554,0.9044191780908354,1.0,7/22,22.25%,ATP6V0A4;ATP5F1B;ATP2A3;ATP6V0E2;ATP6V0A2;ATP6V0D2;ATP6V0A1
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.3068051904909816,0.8198672259299027,0.6704180064308681,0.9330129362120011,1.0,6/22,22.62%,DUSP12;DUSP1;DUSP8;DUSP10;DUSP6;DUSP7
prerank,acetylgalactosaminyltransferase activity (GO:0008376),-0.2644961999175381,-0.8173961095723622,0.7620396600566572,0.9048627270049627,1.0,2/26,1.41%,CSGALNACT1;B3GALT1
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.3082188910199441,-0.8171622706456035,0.7088305489260143,0.9011181519445337,1.0,4/15,13.13%,PIK3C2B;PIK3CB;PIK3CD;ATM
prerank,cation:chloride symporter activity (GO:0015377),-0.3443831817910923,-0.8135385439758237,0.6926503340757239,0.9037648020180681,1.0,2/10,10.68%,SLC12A7;SLC12A8
prerank,ubiquitin-protein transferase activity (GO:0004842),-0.17051466872589172,-0.8127007127326354,1.0,0.9011697130228824,1.0,95/346,24.48%,WWP1;RNF152;XIAP;LMO7;MGRN1;RNF146;KLHL13;UBE2G1;ASB2;RNF43;RNF185;KCMF1;PELI1;WWP2;ARIH1;CDC23;UBE2D3;TRIM24;HLTF;TRIP12;TRIM25;CUL1;CDC42;TRIM5;TRIM11;VPS18;TRIM14;SH3RF2;RNF8;MSL2;UBE2H;MIB1;SMURF2;UBR1;TRIM36;FBXO25;TSPAN17;RC3H1;UBE2A;RNF125;KLHL20;RNF11;ZFP91;RNF144B;RNF41;NEURL2;RNF114;UBR2;RCHY1;HERC2;VPS11;TRIM63;UBE3D;RING1;AMFR;UBE2N;TRAF3;TRIM35;SIAH3;TRIM27;UBE2L6;HECTD3;FBXL14;SIAH2;CUL3;ANAPC11;PPP1R11;CHFR;ANKIB1;RNF141;CDC34;TNFAIP3;MAEA;RNF166;PRPF19;IRF2BPL;RNF5;TNFAIP1;TRAF1;FBXO3;MEX3C;RFFL;FBXO22;BIRC3;MKRN1;FBXW2;FBXO10;RFWD3;SMURF1;RLIM;RNF111;RNF20;TRIM39;RNF2;RNFT2
prerank,3'-5' exonuclease activity (GO:0008408),0.2715543598832061,0.8121479190035982,0.7375366568914956,0.9443255765468013,1.0,13/45,21.29%,POLG;PDE12;REV3L;EXOSC9;DIS3L2;EXOSC10;CNOT7;EXOSC5;WRN;REXO4;TRIR;REXO2;PNLDC1
prerank,chemoattractant activity (GO:0042056),0.29858696310679655,0.8086550700428529,0.7223926380368099,0.9477026023144218,1.0,2/26,5.33%,CXCL10;CCL15
prerank,RNA binding (GO:0003723),0.20260636224142256,0.8079287214123763,0.9799599198396793,0.946284996784875,1.0,292/1321,20.73%,DCN;C1D;LRP1;RBFOX1;EIF4G3;RBMS1;GNL3;TEP1;TRA2B;NAT10;FNDC3A;EIF4A3;BICC1;NANOS3;AGO4;CDKN2A;ISY1;RPP40;NOVA1;SPOUT1;CTU1;FNDC3B;ARL6IP4;EPRS1;ELP1;HTATSF1;WDR36;MYEF2;AFF2;SPTBN1;POP5;RBM46;EIF3H;BZW1;FSCN1;GTPBP10;YWHAZ;ADARB2;LRRC59;EIF1AX;SPATS2L;LSM14A;SNRNP35;SF3B6;MTCL1;ZMAT3;ZC3H12D;RBMS3;FMR1;DND1;RRP8;LARP6;ADK;PSTK;ZC3H7B;CAPRIN1;IFIT2;RTF1;DHX58;TBL2;RRBP1;NOL3;LIN28B;KHDRBS3;ZNF346;LSM4;ACTN1;TLR8;LRPPRC;TRIM56;CARS1;TAF15;SRF;DUS2;STAU1;KRR1;ZFP36L2;PCBP3;UTP11;LYAR;HNRNPA2B1;MRPL44;SEC63;EIF4A2;SRSF11;MPHOSPH10;TRNAU1AP;RALYL;WBP11;ERH;DDX19B;SNUPN;TENT4B;DHX30;NMD3;CDK13;CHD2;PNO1;MRM3;NOC2L;EDF1;PHF6;ALG13;GPATCH8;CELF4;MRPS31;CFAP65;DDX19A;DDX17;SRRT;MRPS24;RP9;CWC22;STAU2;DDX41;POP7;TENT5A;SRPRA;FAM32A;NUDT21;LUC7L2;NOC3L;DBR1;EIF2AK2;SEC61B;ZC3H8;RBFOX3;DHX36;NUP42;RCAN3;NTPCR;RIMS1;RPL37;NAP1L1;AGO3;TEFM;MKI67;SNW1;EDC3;MTREX;MRPS26;NUSAP1;PRPF38B;CASC3;CSDC2;TNPO1;R3HDM2;DNM1;SRSF10;DNAJC21;EXOSC9;UTP15;NDUFV3;ENDOU;SYF2;HSP90B1;CISD2;RBM20;SSRP1;PPAN;MRPL28;FAM98B;CLNS1A;PPIL4;HDLBP;DDX18;CNOT1;MRPS30;LGALS1;EIF2S1;SYNE1;MRPL10;RBM18;DIMT1;PRR3;MRTO4;TDRD9;DAP3;DDX31;EIF4ENIF1;LONP1;CDC42EP4;NME1;ZNF326;RBM4B;SLBP;PUS7;RRS1;HNRNPUL1;DUS3L;HNRNPD;DHX9;UTP6;RNASEH1;SNRPF;ERAL1;ISG20L2;DDX59;SAFB2;YARS1;ZCCHC9;CSNK1E;EXOSC10;RC3H2;SNRNP70;ADAR;TNRC6B;FYTTD1;PTCD1;HNRNPLL;SRRM2;NOL4;HEATR6;SRSF9;IGF2BP3;ZCCHC3;RBM5;NONO;CHERP;PPP1R8;THOC5;HNRNPL;SRRM3;ZCCHC24;EIF5B;SF3A3;MRPS23;PRKRIP1;MRPL3;MAZ;SUGP2;CALR;MTIF2;SARS2;SARS1;AGO1;SRSF6;RPP21;EIF3C;DMGDH;RPS17;TOP2A;SAFB;HABP4;DXO;SMC1A;RRP1B;SEPSECS;ILF3;LSM14B;SSBP1;MRPS5;REXO4;KHDRBS1;YTHDF1;PPIG;EIF3G;KPNB1;FKBP3;NVL;ZCRB1;RBM6;LLPH;CHTOP;FXR1;BYSL;CANX;RBM28;HSPE1;DHX29;RO60;SUMO2;CNBP;ZC3H14;LRRFIP1;NOL12;ZC3H7A;URB1;NOL10;DDX1;CCDC86;LUC7L3;PRPF8;MRPS27;UTP20;KMT2C;ZNFX1;TRMT10A;FLNB;DDX39B;HEATR1;RPL35
prerank,ephrin receptor binding (GO:0046875),0.31148078614149377,0.8060471899487689,0.7512274959083469,0.9467873848109004,1.0,10/21,22.80%,CHN1;ANKS1B;FYN;CRK;LYN;EFNA1;PIK3CG;EFNB3;CBL;ABL1
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",-0.23681393985627847,-0.8058835071760442,0.7848484848484848,0.9091648538810584,1.0,14/35,26.06%,TRMT9B;FTSJ1;TRDMT1;TARS2;PTRH2;TRMT5;MTFMT;ELAC2;MRPL58;GATC;PUS10;DUS1L;TRMT12;TRPT1
prerank,DNA-binding transcription factor binding (GO:0140297),0.21863318686102065,0.8056401979890057,0.831081081081081,0.944677988724595,1.0,43/189,20.70%,PPARA;MIER2;HDAC1;TCF7L2;PPARD;YWHAZ;TBX3;FOS;RUNX1T1;CHD4;TLE2;CRTC2;SRF;LYAR;FIZ1;DGKQ;PIAS2;TWIST1;NOC2L;TLE1;TP53;ZFPM2;PSMC5;PRDM5;ATN1;ELK1;DHX9;DMAP1;AR;ATF2;MYC;ZBTB7A;LDB2;LDB1;BBS1;SP1;DDRGK1;CRTC3;MTA3;MTA1;RERE;FHL2;BBS4
prerank,endonuclease activity (GO:0004519),0.2652024299871782,0.8048989749287393,0.7624466571834992,0.9431565605966877,1.0,11/49,19.33%,ANKLE1;FEN1;ERCC5;ZC3H12D;ERCC4;AGO3;ENDOU;MBD4;AGO1;REXO4;NOB1
prerank,voltage-gated anion channel activity (GO:0008308),0.3320420560028916,0.8041899658047581,0.7081911262798635,0.9416867165195729,1.0,4/15,12.66%,VDAC2;CLCN3;CLCN2;CLCN6
prerank,kinesin binding (GO:0019894),-0.2546955015257898,-0.8038218262754498,0.7728531855955678,0.9085198353398038,1.0,7/27,15.39%,ACTB;NEK6;MAPK8IP3;SPAG9;TOR1A;MAPK8IP1;CROCC
prerank,peptidase inhibitor activity (GO:0030414),-0.24058533003782334,-0.8035930010087162,0.7913907284768212,0.904871523223957,1.0,5/33,6.59%,CST3;PSMF1;GPC3;SERPIND1;RENBP
prerank,ion gated channel activity (GO:0022839),0.3046220627231661,0.8028128476177657,0.725752508361204,0.9414405253991956,1.0,2/24,3.06%,KCNT2;ANO4
prerank,pre-mRNA binding (GO:0036002),0.2907820331010769,0.8011700483584655,0.7488653555219364,0.9414753421562241,1.0,8/28,17.43%,TRA2B;RBM24;ZRSR2;CELF4;SLU7;SLBP;HNRNPL;SRSF6
prerank,lysine-acetylated histone binding (GO:0070577),0.3140858126431438,0.8008465558581918,0.719672131147541,0.9366313948747395,1.0,11/20,26.16%,PHIP;KMT2A;DPF2;CARM1;BRD7;THAP7;ATAD2B;BRD9;ZMYND8;BRDT;YEATS4
prerank,acetylation-dependent protein binding (GO:0140033),0.3140858126431438,0.8008465558581918,0.719672131147541,0.9366313948747395,1.0,11/20,26.16%,PHIP;KMT2A;DPF2;CARM1;BRD7;THAP7;ATAD2B;BRD9;ZMYND8;BRDT;YEATS4
prerank,kinase inhibitor activity (GO:0019210),-0.23769032373544557,-0.8006386918559772,0.8328358208955224,0.9059516614388455,1.0,13/33,23.69%,YWHAB;NCK1;LRP6;MAPK8IP1;CDKN1A;GSKIP;HEXIM1;NPM1;DNAJC3;DUSP19;RHOH;SOCS3;QARS1
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.3370334609364262,0.7996760203564557,0.6993127147766323,0.9359912721959048,1.0,5/13,24.18%,BMP7;PYCARD;BMP2;BMP5;BMP4
prerank,lipid phosphatase activity (GO:0042577),0.34173029010542266,0.7981970019663973,0.7117750439367311,0.935960537227466,1.0,3/14,10.68%,PLPPR3;PLPPR2;PLPP6
prerank,aspartic-type endopeptidase activity (GO:0004190),-0.31596060222643413,-0.7978433052249386,0.7414187643020596,0.9062114215997127,1.0,8/12,46.79%,DDI2;BACE2;SPPL3;CTSE;HM13;NAPSA;PSEN1;SPPL2A
prerank,delayed rectifier potassium channel activity (GO:0005251),0.2794124430101957,0.7966377800155166,0.7623604465709729,0.9359271968470982,1.0,7/32,20.65%,KCNQ3;KCNG1;KCNC2;KCNE4;KCNA6;KCNH1;KCNS3
prerank,disordered domain specific binding (GO:0097718),0.30113541183682835,0.7956868820413763,0.7305699481865285,0.9348700550588789,1.0,5/23,11.49%,TEAD2;NCOA3;TP53;FYN;BCL2L2
prerank,kinase binding (GO:0019900),0.2041159021435595,0.7951352999477037,0.9257322175732218,0.9332102320679443,1.0,55/434,11.89%,PTN;GHR;IL15RA;UTRN;ATF5;RND3;TCF7L2;ERCC6L2;PTPRR;CDKN2A;DLG3;YWHAZ;SPRED1;FBXO5;RAC3;PTPN22;DLG2;MYCN;NEFH;DCTN2;SGO1;TBL2;MTCP1;LLGL1;CADPS;SIKE1;POLA1;TEX14;CEP68;CDKN2D;RHOBTB3;UNC5C;DGKQ;PTK2;LRRC14;SPRED2;GOLGA2;PFKM;PRKACA;JTB;CEP192;SP100;RB1CC1;DAXX;CNKSR2;CACUL1;TNS2;IRAK1;FGR;TP53;TTC28;DLG4;WDCP;FBXW5;DNM1
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.3204250709956441,-0.792867811582994,0.7380952380952381,0.910330174586436,1.0,4/11,24.22%,PPP1R1A;PABIR1;PPP1R11;PPP1R2
prerank,myosin binding (GO:0017022),0.25260070355589104,0.7900023624763999,0.775886524822695,0.9393296802092006,1.0,8/55,12.75%,NPC1L1;LARP6;RAB8A;LLGL1;RAB3C;NKD2;PYCARD;TRIOBP
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.30876450659300675,-0.787160773935331,0.7581863979848866,0.915230371249762,1.0,7/12,35.25%,B3GALT1;B3GALNT1;B3GNT2;B3GNT9;B3GNT3;B4GAT1;B3GNT6
prerank,BMP receptor binding (GO:0070700),0.33704863341180613,0.7840861540453252,0.7280550774526678,0.9467100055057424,1.0,5/12,24.18%,BMP7;PYCARD;BMP2;BMP5;BMP4
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.23453416524724502,-0.783098038413974,0.8407643312101911,0.9171725677908574,1.0,13/38,22.43%,PARD3;PLA2G4A;SNX21;SH3PXD2B;ATG2B;HIP1;DENND1A;JPH2;ATG2A;SNX3;PLA2G4E;WDR45;LANCL2
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.3481672005125537,0.7820000499553772,0.7385159010600707,0.9474338780052765,1.0,3/10,12.28%,CASP6;CASP4;CASP12
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.29440883248121497,0.7815451546624024,0.7480314960629921,0.9455602584563755,1.0,6/23,17.76%,WDR45B;GBF1;COMMD1;PLEKHA5;CLVS1;WIPI2
prerank,MHC protein binding (GO:0042287),-0.2650900863176311,-0.7774950550825646,0.7965260545905707,0.9220746255863571,1.0,5/20,20.40%,ATP5F1B;TAPBP;TAP2;CD74;ABCB9
prerank,SUMO binding (GO:0032183),-0.2984550919886484,-0.7772415428340085,0.7785388127853882,0.9184227554497072,1.0,5/13,23.64%,CASP8AP2;HERC2;USP25;SERBP1;RNF111
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.3532336556055483,0.7771113751381782,0.7402135231316725,0.949976839450415,1.0,3/10,14.87%,DSE;GALE;GNE
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),-0.23193720521540817,-0.773624172359739,0.8411764705882353,0.919877940301501,1.0,7/34,15.97%,UBE2G1;UBE2D3;UBE2F;UBE2H;UBE2A;UBE2N;UBE2L6
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.31819417956639495,0.7728342355229069,0.7377326565143824,0.9540393266587067,1.0,2/14,7.03%,BLVRB;PYCR1
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.32260040649581767,0.7727583090042436,0.7535211267605634,0.9514766675789713,1.0,3/14,9.13%,RECK;SPOCK3;LXN
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.3559518677915552,0.7701098432364775,0.7395104895104895,0.9531804997123332,1.0,2/10,11.00%,ADARB2;DCTD
prerank,SH3 domain binding (GO:0017124),0.2384409560429655,0.7679370262715586,0.8319559228650137,0.9537607943051453,1.0,9/62,11.25%,WIPF1;AKAP5;CBLB;ELMO1;PTPN22;RUFY1;CYBA;ADAM12;CABYR
prerank,thiol-dependent deubiquitinase (GO:0004843),0.23161642066522325,0.7673658256416563,0.8521970705725699,0.9520246332879375,1.0,29/83,25.20%,STAMBPL1;USP1;UCHL3;USP42;USP33;JOSD1;USP19;ATXN3;YOD1;USP34;USP4;USP21;USP16;USP13;STAMBP;PSMD14;USP49;USP14;USP46;USP45;USP48;USP31;UFD1;USP24;USP22;OTUD7A;JOSD2;USP2;USP36
prerank,ATP hydrolysis activity (GO:0140603),0.2604259461476605,0.7665759616420785,0.8067846607669616,0.9506307485592916,1.0,9/41,17.34%,ABCD2;VWA8;RHOBTB3;ABCB6;ABCA4;TDRD9;DHX9;CLU;VPS4B
prerank,glucose transmembrane transporter activity (GO:0005355),-0.2779290074325875,-0.7662553394971411,0.774818401937046,0.9267144167553345,1.0,13/17,55.95%,SLC2A1;SLC2A4;SLC2A2;PPBP;SLC5A3;SLC2A5;SLC2A3;SLC2A6;SLC2A10;SLC5A10;SLC5A1;SLC5A2;SLC5A9
prerank,neurexin family protein binding (GO:0042043),0.34100309683486857,0.7654661518215399,0.7569573283858998,0.9496511833417954,1.0,1/10,2.79%,CEL
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),-0.23833393079858367,-0.7654046490616794,0.8511749347258486,0.9240694715298449,1.0,8/28,17.86%,PRKAA2;MAP2K4;MAPK14;MAP2K7;RPS6KA1;MAP2K2;MAP2K5;AKT1
prerank,ribosomal small subunit binding (GO:0043024),0.3082524594628944,0.7609230537962309,0.761437908496732,0.953913211441849,1.0,6/17,22.26%,PIM1;NME1;ERAL1;MTIF2;DHX29;EIF4B
prerank,telomerase RNA binding (GO:0070034),0.2842697655302486,0.7584129818778277,0.785234899328859,0.9549117368414032,1.0,4/22,15.30%,TEP1;TENT4B;DHX36;EXOSC10
prerank,serine-type endopeptidase activity (GO:0004252),0.2321980785935195,0.7579640598208828,0.8596491228070176,0.9529018657664131,1.0,7/80,12.13%,MASP1;FAP;PCSK2;ACR;PLAU;RHBDL3;HTRA2
prerank,carbohydrate:cation symporter activity (GO:0005402),0.34297909735735366,0.7551742443200583,0.7584973166368515,0.9543103728123673,1.0,11/11,65.73%,SLC2A9;SLC5A11;SLC5A9;SLC5A2;SLC5A1;SLC5A10;SLC2A10;SLC5A3;SLC23A1;SLC23A2;SLC17A5
prerank,magnesium ion binding (GO:0000287),-0.17260906004747117,-0.7545828633943638,0.9844559585492227,0.9353339197312929,1.0,22/135,15.33%,EYA2;MARK1;NEK6;MAP3K5;GCLC;SIK3;SNRK;NUDT3;AASDHPPT;SIK1;CDC42BPB;MAP2K7;STK38L;DYRK2;RRAGC;RP2;SRPK1;RAN;PGP;CDC42BPG;ENDOV;ERN1
prerank,lysophospholipase activity (GO:0004622),-0.2631835846495501,-0.7544627530060237,0.7889447236180904,0.9315172018517869,1.0,5/20,11.59%,PLA2G4A;MGLL;GDPD3;ENPP2;PLA2G6
prerank,microtubule motor activity (GO:0003777),0.24546788917085988,0.754098099921985,0.8273381294964028,0.9532470845825866,1.0,18/51,23.59%,CENPE;STARD9;KIF5C;KIF9;KIF3C;KIFC2;KIF2A;KIF21A;KIF13B;KIF6;SMC3;KIF3A;KIF7;KIF11;KIF1B;KIF15;KIF14;KIF23
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.25854221863178456,0.7532154663478567,0.8102189781021898,0.9519370315984275,1.0,8/37,17.22%,EPRS1;CARS1;TARS1;EARS2;YARS1;HARS1;SARS2;SARS1
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.2660048004845814,0.7518114335039803,0.8364197530864198,0.9513163114389475,1.0,6/31,11.98%,SLC12A6;KCNG1;TMEM38B;TMEM175;HCN1;KCNK1
prerank,enoyl-CoA hydratase activity (GO:0004300),-0.3129542901440528,-0.7485842132641388,0.7846153846153846,0.9352547549843038,1.0,3/10,16.91%,ECHDC1;HADHA;AUH
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.24164350449289113,0.7472763760057358,0.836764705882353,0.9552520079316565,1.0,8/46,15.26%,OGT;PIGQ;GCNT2;B3GNT8;PIGP;PIGA;B3GALT5;HEXA
prerank,transaminase activity (GO:0008483),-0.30247735078125076,-0.7435869214261627,0.8210290827740492,0.9377454125825577,1.0,4/11,20.22%,GOT2;OAT;PSAT1;AGXT
prerank,SUMO transferase activity (GO:0019789),-0.26578669194430155,-0.7392704058446211,0.8395348837209302,0.9392828007245879,1.0,1/16,1.93%,HDAC4
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.25825991204713966,0.7389682971713378,0.8320726172465961,0.9643568674820461,1.0,6/35,10.80%,HDAC1;FOS;GTF2A1;TBPL1;TP53;TAF1B
prerank,death receptor binding (GO:0005123),-0.27475718166112195,-0.7366848236909863,0.8280871670702179,0.9386379912937162,1.0,4/15,12.22%,CASP8AP2;NGF;MADD;BID
prerank,purinergic nucleotide receptor activity (GO:0001614),0.309265903406853,0.7361106421589755,0.789279112754159,0.9657896508251199,1.0,2/15,11.17%,P2RY1;P2RX4
prerank,glutamate receptor binding (GO:0035254),0.29107748801385963,0.7359203377695331,0.8089285714285714,0.9634408063794738,1.0,7/17,21.36%,AKAP5;SYNDIG1;SHISA6;DLG4;CAMK2A;HOMER3;HOMER2
prerank,cation transmembrane transporter activity (GO:0008324),-0.20907389216707217,-0.7356668485277006,0.8921568627450981,0.9358604870015292,1.0,22/48,30.79%,SLC6A6;SLC7A1;SLC3A2;SLC41A1;SLC38A5;SLC7A5;SLC1A1;SFXN1;SLC6A7;SLC36A4;SLC22A2;SLC38A6;SLC38A7;SLC38A2;MMGT1;PKD2L1;MFSD12;SLC39A1;PKD1L3;SLC8B1;SLC7A2;SLC36A2
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.2285954125409307,-0.729287827526103,0.8868421052631579,0.9394537829616436,1.0,9/27,18.71%,ARIH1;TOLLIP;RNF125;RNF144B;UBE3D;SIAH3;SIAH2;DCUN1D3;ANKIB1
prerank,adenylyltransferase activity (GO:0070566),0.2793289240436509,0.7282125476527804,0.8037676609105181,0.9713034968741262,1.0,4/21,11.83%,NMNAT3;COASY;TENT4B;TENT2
prerank,Hsp90 protein binding (GO:0051879),-0.21779593507516784,-0.7269298340100341,0.9006211180124224,0.9384151040651715,1.0,8/33,17.04%,PTGES3;KDR;MAPT;PPEF2;HDAC8;NR3C1;ERN1;UNC45B
prerank,thioesterase binding (GO:0031996),0.32169587000578476,0.7262454293590214,0.8112874779541446,0.9711984695509618,1.0,1/11,1.93%,TRAF4
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.3318585482631823,0.7257534580484462,0.8056042031523643,0.9691758430802744,1.0,5/10,20.89%,CXCL10;PKIG;PRKAR1A;PKIB;PRKAR1B
prerank,lipase activity (GO:0016298),0.24102842374616348,0.724749646457699,0.872992700729927,0.9678367797524098,1.0,5/43,12.04%,CEL;LIPH;LIPC;ABHD16A;ABHD12
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.283342796719596,0.7243495505564154,0.8118811881188119,0.9657621441161445,1.0,4/20,16.65%,EIF3H;OTULINL;YOD1;USP21
prerank,endopeptidase regulator activity (GO:0061135),-0.2066659756073383,-0.7223854403005419,0.9186440677966101,0.9398390796919074,1.0,12/40,23.10%,CST3;PSMF1;SERPIND1;RENBP;APH1A;APH1B;PSME3;SPINT2;PSME2;CAST;ADRM1;TFPI
prerank,ubiquitin-specific protease binding (GO:1990381),-0.24928207599032826,-0.7211811813462747,0.8598382749326146,0.9372770729131125,1.0,7/19,26.33%,LCOR;VCP;AMFR;SELENOS;RHBDD2;SUMO1;PARK7
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.3274206562603653,0.7170611304560077,0.7863720073664825,0.9725591177094277,1.0,3/10,16.77%,DPYSL2;DPYS;DPEP1
prerank,carbohydrate kinase activity (GO:0019200),-0.2863152998960732,-0.7168154502422591,0.8082191780821918,0.9384023289556281,1.0,2/11,7.72%,HK1;HK2
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",-0.2797900919078601,-0.7162947006786938,0.8365384615384616,0.9351341010459133,1.0,4/13,29.81%,SREBF2;MIF;EBP;DDT
prerank,H4 histone acetyltransferase activity (GO:0010485),0.32730653153094336,0.7161401744995977,0.8116197183098591,0.9711172852660148,1.0,3/10,15.32%,BRCA2;NAA50;ATF2
prerank,microtubule plus-end binding (GO:0051010),0.2805605472527472,0.7158551144366424,0.8519736842105263,0.9688903489071937,1.0,5/20,15.81%,CLIP3;CLIP2;CLASP2;STIM1;CLASP1
prerank,translation elongation factor activity (GO:0003746),-0.27296874983955294,-0.7157894080858447,0.8218527315914489,0.9319484844996843,1.0,5/14,30.99%,EEF1A1;EEFSEC;GTPBP1;GTPBP2;TUFM
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.25871238227100907,0.7139395362169771,0.8452012383900929,0.9688290835148916,1.0,10/29,20.89%,CDKN2A;SPRED1;CDKN2D;SPRED2;CDKN2C;PKIG;PRKAR1A;PKIB;SPRY2;PRKAR1B
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.31512720820285345,0.7137734643577709,0.8171140939597316,0.9664909450794174,1.0,4/12,18.92%,TENT4B;TENT5A;TENT2;PAPOLB
prerank,GABA receptor binding (GO:0050811),0.3162448782736347,0.7132942453558689,0.8014705882352942,0.9645003135146444,1.0,1/11,1.57%,AKAP5
prerank,nucleotidyltransferase activity (GO:0016779),0.2857373342868629,0.7117681803145549,0.8284789644012945,0.9637646108869539,1.0,5/19,15.96%,PAPSS2;TENT4B;TENT2;REV1;CRPPA
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.29737498978120874,0.7062008213386041,0.8240131578947368,0.9677045155926934,1.0,1/13,1.50%,ALDH1A1
prerank,ribonuclease activity (GO:0004540),0.22741983214232706,0.7059092336896484,0.9015256588072122,0.9655186479231243,1.0,15/56,19.33%,RPP40;ZC3H12D;AGO3;EXOSC9;ENDOU;DIS3L2;RNASEH1;EXOSC10;CNOT7;EXOSC8;EXOSC5;PPP1R8;AGO1;RNASE12;NOB1
prerank,protein kinase inhibitor activity (GO:0004860),0.23203378740095323,0.704426352828234,0.8870967741935484,0.9647560889843049,1.0,4/42,8.14%,SPRY4;SPRED1;DUS2;SPRED2
prerank,N-methyltransferase activity (GO:0008170),0.27022454972653687,0.6981487915746624,0.8573667711598746,0.9694889800101886,1.0,5/20,23.62%,HNMT;DIMT1;N6AMT1;METTL15;METTL5
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.2407013335783502,0.6979384331938258,0.8940298507462686,0.9647074461336925,1.0,13/34,26.69%,NDUFS7;NDUFS5;NDUFV2;NDUFV3;NDUFC2;NDUFA12;NDUFS4;NDUFB3;NDUFA10;NDUFS1;NDUFB6;NDUFB8;NDUFB10
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.2407013335783502,0.6979384331938258,0.8940298507462686,0.9647074461336925,1.0,13/34,26.69%,NDUFS7;NDUFS5;NDUFV2;NDUFV3;NDUFC2;NDUFA12;NDUFS4;NDUFB3;NDUFA10;NDUFS1;NDUFB6;NDUFB8;NDUFB10
prerank,protein phosphatase 2A binding (GO:0051721),0.26280912412877344,0.6966788800179867,0.8603066439522998,0.9636214620791792,1.0,5/23,12.98%,BOD1;ADCY8;TP53;PTPA;ANKLE2
prerank,RNA polymerase binding (GO:0070063),-0.24411448049743073,-0.6959650537164335,0.858560794044665,0.948429936725366,1.0,2/18,4.28%,PHRF1;STOM
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",-0.17947578815468468,-0.6957171864098698,0.9888888888888889,0.9448908973472838,1.0,16/69,20.94%,LPGAT1;KAT6B;ZDHHC21;PLA2G4A;DBT;ESCO1;ZDHHC16;ZDHHC14;SOAT1;PLAAT3;ZDHHC18;PLA2G4E;CERS2;ZDHHC3;PLA2G4C;ELP3
prerank,3'-5'-exoribonuclease activity (GO:0000175),-0.2110629357727453,-0.6892572238047954,0.9382022471910112,0.9472305651667755,1.0,8/34,15.85%,PARN;PAN3;ERI1;CNOT8;DIS3L;EXOSC2;ANGEL2;EXOSC3
prerank,tRNA methyltransferase activity (GO:0008175),0.27702182199946357,0.6864030123457373,0.8545454545454545,0.9721482926561379,1.0,7/16,21.93%,TRMT13;TYW3;TRMT44;THUMPD3;METTL2A;METTL2B;LCMT2
prerank,DNA secondary structure binding (GO:0000217),0.24257795707876223,0.6848575648045773,0.8848484848484849,0.9713313634612373,1.0,10/31,22.80%,KMT2A;ERCC5;NEIL3;XPC;MSH6;WRN;MEN1;LIN54;HMGB1;ABL1
prerank,calcium channel inhibitor activity (GO:0019855),0.3054303741586909,0.682652057360687,0.8586387434554974,0.971079695545443,1.0,1/11,2.31%,ITPR1
prerank,mannose binding (GO:0005537),0.30021652143886557,0.6822701795106966,0.852233676975945,0.968942524465889,1.0,2/12,9.26%,ACR;MBL2
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.3093436358638403,0.6811286576348916,0.8302238805970149,0.9677059820992151,1.0,2/10,9.83%,SETD5;NSD1
prerank,hormone receptor binding (GO:0051427),0.2877373259986448,0.6811160283278997,0.8529411764705882,0.9652720068157746,1.0,1/14,3.37%,JAK1
prerank,diacylglycerol kinase activity (GO:0004143),0.3007982083798285,0.6809620485382735,0.8589065255731922,0.9629836984998333,1.0,3/11,12.14%,DGKQ;DGKI;AGK
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.27557419920033027,-0.6801836258148833,0.8744493392070485,0.9518297217855575,1.0,3/11,21.38%,AMFR;ANAPC11;PRPF19
prerank,P-type ion transporter activity (GO:0015662),-0.2666761893484729,-0.6761885286098116,0.8953488372093024,0.9514012228317645,1.0,3/12,12.90%,ATP2B1;ATP2B2;ATP2A3
prerank,acetyltransferase activity (GO:0016407),0.23993153850830798,0.6752591075823441,0.9033280507131537,0.9660490423888127,1.0,4/31,10.37%,NAA10;NAT10;NAA50;NAT8L
prerank,CARD domain binding (GO:0050700),0.276551233912938,0.6680178273637415,0.8481228668941979,0.9706218700049214,1.0,2/14,6.84%,CASP4;CARD19
prerank,four-way junction DNA binding (GO:0000400),-0.23739095902694154,-0.6618714927582832,0.8802816901408451,0.9594937375341375,1.0,8/17,30.56%,RAD51D;RAD51C;HMGB2;XRCC2;GEN1;MSH2;YY1;XRCC3
prerank,actin monomer binding (GO:0003785),-0.22368005374928643,-0.6600125940912447,0.8834688346883469,0.9571568188157448,1.0,9/22,32.24%,NOS3;COBL;LIMA1;TMSB4X;TWF2;MYL4;PRKCE;PFN2;MRTFA
prerank,aminopeptidase activity (GO:0004177),-0.2065651112342767,-0.6591181659088065,0.9413407821229051,0.9540600839307853,1.0,4/26,13.17%,XPNPEP3;ERAP1;CTSH;MMP15
prerank,retinoid X receptor binding (GO:0046965),0.2860587200607664,0.6513095161840048,0.8848797250859106,0.9825503801147881,1.0,3/11,14.16%,NSD1;NRIP1;MED25
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.24107456530463608,0.6508888474005665,0.9223140495867769,0.9804699381182049,1.0,6/24,15.02%,AK4;NME6;IP6K1;AK8;NME1;AK3
prerank,gap junction channel activity (GO:0005243),0.25106732113197183,0.648619906947132,0.9082278481012658,0.9799209124120506,1.0,4/22,15.14%,GJA1;GJC3;GJA4;GJA5
prerank,wide pore channel activity (GO:0022829),0.24656223765079738,0.6465014197740326,0.902668759811617,0.9791189418119612,1.0,4/23,15.14%,GJA1;GJC3;GJA4;GJA5
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.3027810280082552,0.6456645381984231,0.8863232682060391,0.9773079449591996,1.0,1/10,4.12%,FEN1
prerank,O-methyltransferase activity (GO:0008171),0.29908176490602967,0.6456321955053332,0.8647686832740213,0.9749186152794037,1.0,1/10,5.60%,COQ3
prerank,RNA cap binding (GO:0000339),-0.24001269628955232,-0.6444327631842721,0.9301745635910225,0.9609889011536168,1.0,6/16,26.31%,EIF3D;AGO2;DCPS;NCBP2;CYFIP2;NCBP3
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.27342035797387226,0.6441810893829738,0.8977469670710572,0.9735538055295777,1.0,3/13,12.95%,SLC66A1;SLC7A3;SLC25A29
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",-0.19193780889819803,-0.6320656559046662,0.970108695652174,0.9648418565542987,1.0,8/33,19.33%,PARN;ERI1;CNOT8;DIS3L;EXOSC2;ANGEL2;EXOSC3;ANGEL1
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.2219787019265411,0.631850925410178,0.9262048192771084,0.9808456229752558,1.0,9/31,20.86%,UBE2QL1;UBE2G2;UBE2Q2;UBE2D1;UBE2E3;UBE2E2;BIRC6;UBE2J1;UBE2K
prerank,ATPase regulator activity (GO:0060590),0.21444260551425012,0.6303670668216244,0.9424242424242424,0.9794588155710637,1.0,7/38,16.23%,DNAJC19;DNAJC1;DNAJC24;DNAJC10;DNAJC15;BRSK2;TSC1
prerank,ankyrin binding (GO:0030506),-0.21778553541045192,-0.6272693196498775,0.949874686716792,0.9641454669813992,1.0,2/19,3.96%,CDH1;PLEC
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.2616249634975324,0.6271210366593204,0.92573402417962,0.9793689912602294,1.0,5/14,21.42%,MINDY4;ATXN3;YOD1;USP13;MINDY2
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.24569335077774457,0.6196439057540365,0.9375,0.9821238083463537,1.0,3/18,9.55%,NOL3;PRDX5;BIRC2
prerank,ribosomal large subunit binding (GO:0043023),0.2723971113241695,0.6196420767508924,0.9089285714285714,0.979736555631312,1.0,3/11,21.58%,NMD3;MALSU1;DHX33
prerank,cAMP response element binding (GO:0035497),0.2815999416536449,0.6166060984590198,0.8848797250859106,0.9792774274940955,1.0,3/10,15.32%,CREB3L2;CREB3L1;ATF2
prerank,store-operated calcium channel activity (GO:0015279),0.27714133703057076,0.6155060132343059,0.9026217228464419,0.9775428169982824,1.0,3/10,19.43%,TRPC3;TRPC7;TRPC1
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.27047928261697934,0.6138702694530185,0.9016100178890877,0.9761701303564503,1.0,2/11,12.95%,SLC25A20;SLC25A29
prerank,proton transmembrane transporter activity (GO:0015078),-0.17673353762640287,-0.6115028655982871,0.9757575757575757,0.9692457179730483,1.0,12/39,29.16%,CLCN5;COX15;SLC33A1;NNT;COX5B;COX4I1;COX6B1;UQCRQ;SLC11A2;UQCRC1;ATP6V1B2;NDUFA4L2
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",-0.24274160251413446,-0.6111371537743416,0.9241706161137441,0.9657024902983796,1.0,5/12,25.59%,NQO2;CBR4;CRYZ;CBR1;NQO1
prerank,fatty acid synthase activity (GO:0004312),0.2813012763846063,0.6092493122917997,0.9181494661921709,0.9767531474331759,1.0,5/10,26.23%,ELOVL2;ELOVL6;ELOVL1;ELOVL5;OXSM
prerank,inward rectifier potassium channel activity (GO:0005242),0.22692298933940042,0.6091090816254386,0.928125,0.9744838851647845,1.0,7/24,21.24%,KCNK1;KCNN2;KCNJ8;KCNJ10;KCNJ3;KCNJ16;ABCC9
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.1898208206940484,0.600988843747017,0.9848066298342542,0.9769570872456917,1.0,15/57,22.58%,NDUFS7;NDUFS5;NDUFV2;NDUFV3;NDUFC2;NDUFA12;UQCRH;CYBRD1;COX7A2L;NDUFS4;COX5A;NDUFB3;UQCR11;NDUFA10;NDUFS1
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.1925339390748431,0.5766142516636094,0.9742489270386266,0.9868778043861162,1.0,9/40,21.03%,RRP8;HNMT;GAMT;METTL9;N6AMT1;DNMT3A;THUMPD3;METTL2A;METTL2B
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.19785551351038966,-0.5755452408732211,0.9690721649484536,0.9779678683360854,1.0,8/21,41.39%,FGF1;FRS2;FGF2;NPTN;FGF18;KLB;FGF22;FGF20
prerank,snRNA binding (GO:0017069),0.18945307314231913,0.5644186649217752,0.9854439592430859,0.9896428592926179,1.0,4/42,8.46%,SNRNP35;LSM4;LSM11;SNRPB2
prerank,telomeric DNA binding (GO:0042162),0.19557129736341738,0.5490251387008653,0.9906687402799378,0.9930733924362305,1.0,4/32,8.12%,RPA1;HNRNPA2B1;TERF1;PIF1
prerank,neuropeptide receptor binding (GO:0071855),0.22927498999235935,0.5456224988707378,0.956989247311828,0.9919268036323903,1.0,2/14,14.72%,NPY;NMU
prerank,palmitoyltransferase activity (GO:0016409),-0.17012977327459225,-0.5363972700195843,0.997289972899729,0.9869025364961012,1.0,10/28,30.47%,ZDHHC21;ZDHHC16;ZDHHC14;ZDHHC18;ZDHHC3;GLUL;GOLGA7;ZDHHC5;ZDHHC23;ZDHHC12
prerank,peptide hormone receptor binding (GO:0051428),-0.20329713933418384,-0.506589380958877,0.9846827133479212,0.9893481091474026,1.0,3/11,27.69%,PTHLH;GNRH1;CCK
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.17917474661825233,0.5022186598108112,0.9936507936507937,1.0,1.0,10/29,26.72%,ENGASE;PGGHG;GUSB;IDUA;NEU3;GANAB;CTBS;GLA;PARG;MGAM
prerank,glutathione transferase activity (GO:0004364),0.18796771350341404,0.49849598123498334,0.9922839506172839,0.9996481008132104,1.0,2/23,8.13%,GSTA3;PTGES
prerank,U6 snRNA binding (GO:0017070),0.20720312053244,0.4895111872470374,0.987410071942446,0.9990800596834151,1.0,6/14,28.32%,LSM4;PRPF8;DDX39B;LSM3;TUT1;EIF5A
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.22256060357044333,0.4850775971082371,0.9742268041237113,0.9975154972725673,1.0,2/10,16.78%,CYBA;NOX1
prerank,O-acyltransferase activity (GO:0008374),0.17194262655095557,0.48419423107154863,0.9939485627836612,0.9953276207239575,1.0,4/30,14.41%,PRDX6;SOAT2;MBOAT7;GPAT3
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.17394608983819732,0.46518158606347787,0.9983633387888707,0.9957749684877873,1.0,6/24,20.03%,ZDHHC24;ZDHHC19;ZDHHC2;ZDHHC6;ZDHHC9;ZDHHC8
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.1946969425742608,0.45139354210025023,0.9879310344827587,0.9950525456103998,1.0,3/14,17.55%,CYBA;NOX1;KMO
